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Abstract 
Molecular and mechanistic understanding of evolution is essential for our ability to 
comprehend the development of life on Earth. Life appeared around 4 billion years 
ago, and has ever since adapted and diversified through the process of evolution. The 
focus of this thesis has been to increase our understanding of how bacteria evolve and 
genetically adapt in a natural environment. In particular we sought to identify the 
genes that are targeted by mutation to optimize fitness in a given environment, and to 
understand the evolutionary mechanisms that govern the genetic change. 
Pseudomonas aeruginosa is the dominating pathogen of chronic airway infections in 
patients with cystic fibrosis (CF), and the bacterial long-term persistence in CF hosts 
involves mutation and selection of genetic variants with increased fitness in the CF 
airways. We performed a retrospective study of the P. aeruginosa DK2 clone type, 
which is a transmissible clone isolated from chronically infected Danish CF patients 
over a period of 38 years. Whole-genome analysis of DK2 isolates enabled a fine-
grained reconstruction of the recent evolutionary history of the DK2 lineage and an 
identification of bacterial genes targeted by mutations to optimize pathogen fitness. 
The identification of such pathoadaptive genes gives new insight into how the 
pathogen evolves under the selective pressures of the host immune system and drug 
therapies. Furthermore, isolates with increased rates of mutation (hypermutator 
phenotype) emerged in the DK lineage. While this phenotype may accelerate 
evolution, we also showed that hypermutators display differential mutagenesis of 
certain genes which enable them to follow alternative evolutionary pathways. 
Overall, our study identifies genes important for bacterial adaptation to a human host 
environment and provides insight into the different mutational mechanisms that 
govern the adaptive genetic changes.   
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Dansk	  resumé	  
Molekylær og mekanistisk forståelse af evolution er essentiel for vores evne til at 
begribe livets udvikling på Jorden. Livet opstod for omkring 4 milliarder år siden og 
har lige siden tilpasset og forskelliggjort sig gennem den evolutionære proces. Fokus i 
denne afhandling har været at øge vores forståelse af, hvordan bakterier udvikler og 
genetisk tilpasser sig i naturlige omgivelser. Vi søgte især efter at identificere gener, 
som er mål for mutationer, der optimerer fitness I et givet miljø, og at forstå de 
evolutionære mekanismer som styrer den genetiske forandring. 
Pseudomonas aeruginosa er den dominerende patogen i kroniske luftvejsinfektioner 
hos patienter med cystisk fibrose (CF), og langstrakt bakteriel vedbliven i CF værter 
involverer mutationer og selektion af genetiske varianter med øget fitness i CF 
luftvejene. Vi udførte et tilbageskuende studie af P. aeruginosa DK2 klontypen, som 
er en overførbar klontype, der er isoleret fra kronisk inficerede danske CF patienter 
over periode på 38 år. Analyse af den samlede arvemasse hos DK2 isolaterne 
muliggjorde en finkornet rekonstruktion af DK2 linjens nylige evolutionære historie 
og identifikation af bakteriegener, som var mål for mutationer, der optimerede 
patogen-fitness. Identifikationen af sådan pathoadaptive gener giver ny indsigt i, 
hvordan patogenet udvikler sig under selektionspresset fra værten og 
lægemiddelsbehandling. Endvidere opstod der isolater med forøgede 
mutationshastigheder (hypermutator fænotype) i DK linjen. Mens denne fænotype 
måske kan accelerere evolutionen viste vi også, at hypermutatorer udviser uens 
mutagenese af særlige gener, hvilket gør dem i stand til at følge alternative 
evolutionære veje. 
Samlet set  identificerede vores studie gener, som er vigtige for bakteriel tilpasning til 
et menneskeligt værtsmiljø, og gav indsigt i de forskellige mutationsmekanismer som 
styrer de tilpassende genetiske forandringer.  	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Chapter	  1 	  
Introduction	  and	  thesis	  overview	  
A molecular and mechanistic understanding of evolution is central for our ability to 
comprehend the development of life on Earth. Life appeared around 4 billion years 
ago [1], and since then life has adapted and diversified through the process of 
evolution to withstand environmental changes and to spread to new niches. 
Bacteria constitutes the most abundant and diverse form of life on Earth, and these 
unicellular organisms show a remarkably ability to evolve and genetically adapt to 
changing environments. The diversity and adaptability of bacteria offer a great 
potential in industrial applications, but the same features make the bacteria a threat as 
infectious agents. In both industrial and clinical settings, however, insight into the 
evolution and genetic adaptation of bacteria is important for our ability to engineer 
bacteria and fight bacterial infections. 
The focus of this thesis has been to increase our understanding of how bacteria evolve 
and genetically adapt in a natural environment. In particular we sought: (a) to identify 
the genes that are targeted by mutation to optimize fitness in a given environment; and 
(b) to understand the evolutionary mechanisms that govern the genetic change. 
The model system used for our investigation has been long-term chronic airway 
infections in cystic fibrosis (CF) patients caused by the opportunistic pathogen 
Pseudomonas aeruginosa. In this model system we are able to follow the molecular 
evolution of P. aeruginosa within its human host, and thereby decipher the genetic 
adaptation of P. aeruginosa to the human host after transition from its environmental 
habitat. 
1.1 Thesis	  outline	  
This thesis is organized into six chapters. While the current chapter (Chapter 1) 
introduces the thesis, Chapter 2 gives a general introduction to molecular evolution. 
This includes an introduction to mutation, natural selection, and genetic drift that all 
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  Introduction	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together serve to explain the principles and mechanisms of genetic adaptation. In 
addition, Chapter 2 also describes the phylogenetic methods that have been used in 
the research articles presented later in the thesis. Chapter 3 presents how whole-
genome sequencing (WGS) of clinical collections of bacteria offers an opportunity to 
study microevolution, i.e. evolutionary events between closely related organisms. 
This leads to an introduction of P. aeruginosa infections in CF patients that represent 
the infectious-disease model, which we use to study molecular evolution and genetic 
adaptation in vivo. A special emphasis has been put on the description of pathogen 
phenotypes and host factors relevant to the findings of this thesis. The thesis’ findings 
are then presented in Chapter 4. This includes an introduction to the background 
leading to the thesis aims and the context of the resulting research articles. The 
research articles themselves are enclosed in full length in Chapter 6, and Chapter 5 
provides an overall conclusion and perspective of the thesis. 
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Chapter	  2 	  
Molecular	  evolution	  
Evolution is the process by which life has evolved from a single origin to the vast 
diversity of organisms present today. To understand life as it is today, it is therefore 
essential to study the evolutionary processes that have shaped it. 
All living organisms carry hereditary genetic material stored in the form of 
deoxyribonucleic acid (DNA), which they pass on to their progeny. The entirety of an 
organism’s hereditary material is referred to as the genome. The genome encodes the 
genetic instructions used for the functioning of the organism, and as such the 
underlying genome ultimately determines the phenotypic repertoire of an organism. 
Thereby, understanding molecular evolution is a keystone in understanding the 
evolutionary process itself. 
2.1 Mutation,	  natural	  selection,	  and	  genetic	  drift	  
The genetic content of organisms can change either by de novo mutation of already 
present DNA or by acquisition of DNA from other organisms, i.e. horizontal gene 
transfer (HGT). Mutation of present DNA includes single nucleotide substitutions, 
insertions, deletions, and rearrangements such as duplications, inversions, and 
translocations. Mutations are stochastic, and they result from errors in DNA 
replication and repair, recombination, exposure to mutagens, or mobile genetic 
elements. 
Mutations can either be beneficial, neutral, or detrimental to the reproductive success, 
i.e. the fitness, of an organism (or rather a population of organisms) in its 
environment. Natural selection will act on the genetic diversity created by mutation 
within a population to increase the frequency of beneficial genetic variants till they 
eventually become fixed in the population. Nonetheless, neutral and even detrimental 
mutations can become fixed in a population due to genetic drift or hitchhiking.  
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Genetic drift is the change in the frequency of a genetic variant due to random 
sampling of offspring from a population (Figure 1), whereas hitchhiking refers to an 
increase of a genetic variant by virtue of being genetically linked to a beneficial 
genetic variant in another locus. Hitchhiking on beneficial mutations is particular 
strong in asexual populations in which the entire genome acts as a single a linkage-
group. 
 
 
Figure 1: Genetic drift and bottle-neck effects. (A) The principle of genetic drift can be illustrated 
by sampling of marbles from a jar where marbles with different colors represents different genetic 
variants. If sampling of “offspring” marbles is done randomly and with replacement, a random shift in 
the frequency of the different colors might occur in the resulting jar of marbles. Several rounds of such 
random sampling can therefore result in a jar of marbles with only a single color and with the other 
color being lost permanently. The effect of genetic drift is dependent on the population size. Thus, the 
effect of genetic drift is large for small population sizes and negligible for very large population sizes. 
(B) Nonetheless, even large populations can encounter a sudden decrease in population size, i.e. a 
bottle-neck, leading to radical changes in allele frequencies by genetic drift.  
Identification of genetic variation is not per se followed by information on if the 
variation has become fixated due to natural selection or genetic drift. Nonetheless, 
general conclusions about to what extent natural selection has been the driving force 
in the fixation of genetic variants, can be inferred from measuring the relative rates of 
nonsynonymous (dN) and synonymous (dS) genetic changes, where nonsynonymous 
changes alter the amino acid sequence of encoded proteins and synonymous changes 
do not. This measure is calculated based on substitution mutations, and its logic is that 
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only nonsynonymous substitutions (missense and nonsense substitutions) are potential 
subjects to natural selection, whereas synonymous substitutions (silent substitutions) 
are regarded as neutral and therefore not subjects of natural selection. The dN/dS ratio 
can be interpreted as the selection pressure acting on the protein coding genome [2]. 
A ratio greater than one implies that there has been a positive selection for mutations; 
whereas a ratio less than one implies that there has been a selection for removal of 
mutations, i.e. negative selection.  However, note that the dN/dS ratio should be 
interpreted as an average signal of selection not giving any information on if both 
positive and negative selection has acted at different times during the evolution. 
𝑑𝑁𝑑𝑆 = No. of  fixated  nonsynonymous  substitutionsNo. of  fixated  synonymous  substitutions × No. of  synonymous  sitesNo. nonsynonymous  sites 
Equation 1: Equation used to calculate the rate of nonsynonymous substitutions relative to the rate of 
synonymous substitutions.  
In this thesis the dN/dS ratio is calculated based on the simplistic assumption that the 
rates of different base substitutions are the same. Given this, the codon usage in P. 
aeruginosa predicts a 25% probability that a random mutation would be synonymous, 
and we can calculate the dN/dS according to Equation 1. However, note that this is an 
approximate measure, as it does not take into account selection on codon usage, 
mutational skews, selection for higher GC content, and bottle-neck effects [2, 3]. 
Nonetheless, for the conclusions of this thesis we find it most transparent and 
appropriate to use a simple and approximate measure. At the same time, we compare 
our findings to Smith et. al. (2006) and Barrick et al. (2009) who also assume a 
random distribution of mutations, when calculating the percentage of synonymous 
substitutions [4, 5]. 
2.2 Mutation	  rate	  
The most common type of mutation is substitutions that give rise to single nucleotide 
polymorphisms (SNPs; in this thesis the term SNP refers to substitutions only and 
does not include single nucleotide deletions or insertions). The spontaneous rate of 
substitutions is estimated to be 7.2×10-11 per site per generation for P. aeruginosa [6]; 
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however, the rate is dependent on several factors such as physiological factors (e.g. 
mutagens or stress responses) and the efficiency of DNA repair systems [7-10]. 
As substitution mutations appear stochastically and typically randomly across the 
genome, the mutation rate should be calibrated to supply enough beneficial mutations, 
but at the same time not too many detrimental mutations. If the mutation rate is too 
low, the population may not generate the genetic diversity necessary for an efficient 
exploration of novel phenotypic solutions. However, a high mutation rate also 
increases the number of detrimental mutations that will be a burden to the population 
(also known as the genetic load). 
Two key factors that should be taken into account, when inferring the optimal 
mutation rate, are the population size and the strength of selection for beneficial 
mutations relative to the selection against deleterious mutations. Together with the 
mutation rate the population size determines the mutation supply rate, which is 
defined as the product of the mutation rate and the population size. As beneficial 
mutations are rare, a low mutation rate and a small population size will increase the 
amount of time it takes for a beneficial mutation to arise. As time becomes a limiting 
factor, it might be advantageous to increase the mutation rate on the expense of a 
higher genetic load. Accordingly, the direct selection of rare beneficial mutations can 
hereby indirectly promote the selection, i.e. a second-order selection, for alleles 
increasing the mutation rate, also referred to as hypermutator alleles [3, 11, 12]. 
2.3 Genetic	  adaptation	  
Adaptation of an organism to changing environmental conditions can be facilitated by 
either phenotypic acclimation or genetic adaptation. 
Phenotypic acclimation is the change of phenotype in response to environmental cues 
without any inheritable genetic change. Nonetheless, the capacity of an organism to 
produce different phenotypes is limited, and phenotypic acclimation will therefore be 
inadequate for long-term adaptation of an organism to novel and permanent changes 
in its environment [13]. 
Genetic adaptation is the process by which adaptation is accommodated by selection 
of genetic variants with improved fitness in the environment. Hence, the success of 
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this mechanism to facilitate adaptation is dependent on the organism’s (or a 
population of organisms’) ability to generate adaptive genetic diversity. Natural 
selection will then act to increase the frequency of genetic variants giving rise to 
phenotypes with improved fitness in the given environment. If the imposed selection 
pressure remains constant, the beneficial genetic variant will eventually become 
dominant in the population and outcompete all less fit genetic variants. This 
phenomenon illustrated in Figure 2 is known as a selective sweep because all other 
genetic variants are swept away causing a reduction in genetic diversity [14]. The 
time for a selective sweep to happen depends on the strength of the selection for the 
beneficial genetic variant, but may also be prolonged from the interference from other 
beneficial genetic variants that arises at approximately the same time. This 
phenomenon is known as clonal interference and slows down the overall rate of 
genomic evolution. 
 
 
Figure 2: Genotype abundances in an evolving bacterial population. Lineages with new beneficial 
mutations are depicted as shaded wedges that originate in a previous genetic background and rise in 
frequency as they outcompete their ancestor and other lineages. The same shading indicates lineages 
that have equivalent fitness, and the path to the final dominant genotype containing five mutations is 
highlighted by the white curve. (a) A new beneficial mutation sweeps to fixation and the population 
has little diversity. (b) Four lineages with different mutations coexist at appreciable frequencies for a 
time before (c) the descendants of one lineage become a majority. Figure adapted from Barrick and 
Lenski (2009) [15]. 
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2.4 Adaptation	  to	  heterogeneous	  environments	  
According to the above theory, only a single genotype will eventually occupy the sole 
niche offered by a constant and perfectly homogeneous environment [16]. This 
principle of niche exclusion is however not in effect when the environment shows 
either spatial or temporal heterogeneity. 
Heterogeneity allows for the presence of multiple niches within the environment [17]. 
This means that, when a population evolves in a heterogeneous environment, it may 
genetically diversify to establish sub-lineages, each genetically adapting under the 
selection pressure of its niche. This process of genotypic diversification, for example 
shown for Pseudomonas fluorescens [18], is known as adaptive radiation. 
The establishment of multiple niches and adaptive radiation is only possible because 
genetic adaptation towards one niche carries a cost of fitness in another niche. The 
cost may either be directly linked to natural selection of genetic variants that are 
beneficial in the given niche, but detrimental in other niches (a process known as 
antagonistic pleiotropy). Alternatively, the cost of adaptation to one niche may be due 
to nonadaptive accumulation of mutations that are neutral in the selective niche but 
detrimental in other niches. 
Ecological specialization by adaptive radiation may, however, not always be effective 
in heterogeneous environments [17]. It may be the case in an environment with a 
temporal change, so the population needs to adapt to become a generalist with the 
highest possible average fitness (even if temporary suboptimal), rather than evolving 
into specialist populations with only temporary optimums of fitness. 
2.5 Molecular	  phylogenetics	  
The previous sections introduced the fundamental evolutionary drivers that have 
made it possible for life to evolve in a step-wise manner to diversify and adapt to 
almost every possible environment on Earth. Nonetheless, as evolution is a slow 
process (compared to the lifespan of humans), we are impaired in our ability to follow 
the molecular evolution of complex traits as it happens. This section will serve to 
explain how phylogenetics can be applied to “rewind the tape of evolution” in order 
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decipher individual molecular steps and the genetic relationship of different 
organisms. 
Molecular phylogenetics uses hereditary molecular differences (mainly in DNA 
sequences) to make inference about the evolutionary history of organisms. The most 
common approach is to compare homologous DNA sequences from different 
organisms. Assuming that the sequences of the alignment shares a common ancestor, 
it is possible to group organisms based on their similarity and to make hypotheses 
about ancestral states shared by different groups of taxa. 
This cladistics approach to infer phylogeny assumes a vertical inheritance of genetic 
material, i.e. passage of genetic material from parent to offspring. This assumption is 
conflicted by HGT that confounds phylogenetic analysis, as HGT gives rise to 
genomes composed of genetic material with different phylogenies. In addition, 
phylogenetic analysis is also confounded by direct genetic reversion and convergent 
evolution in the same site as such instances may cause homoplastic sites (Figure 3).  
Phylogenetic inference can be made on all types of genetic variation. Nonetheless, 
phylogenic inference based on SNPs in homologous DNA sequences is widely used 
for several reasons including that SNP mutations occur frequently, SNPs are typically 
random, and SNPs can be unambiguously defined in a sequence alignment. 
Furthermore, only a limited number of base substitutions exist for a given position in 
the genome (A/T↔G/C, A/T↔T/A, A/T↔C/G), and the rates of different substitution 
mutations can therefore be readily modeled. This is in contrast to insertion and 
deletion mutations that are unambiguous and define an infinite number of mutation 
types (e.g. with respect to number of nucleotides inserted/deleted). 
In this thesis two different methods were used for phylogenetic inference: (a) 
maximum-parsimony, and (b) Bayesian analysis. 
The optimality criterion for the maximum-parsimony method is to explain the 
observed data with the fewest possible number of evolutionary events (such as 
mutations) (Figure 3) [19]. This makes maximum-parsimony a simple approach not 
based on an explicit evolutionary model of substitution rates. Nonetheless, this means 
maximum-parsimony has no correction for multiple mutations at the same site, and it 
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makes it sensitive to differences in branch lengths or unequal rates of evolution in 
different lineages (leading to long branch attraction; Figure 4) [20]. 
 
 
Figure 3: Maximum-parsimonious tree construction and homoplasy. Examples of two equally 
good maximum-parsimonious trees based on eight polymorphic loci (A-G). Both trees are optimized to 
explain the observed polymorphisms with the fewest possible number of mutational events. The 
occurrence of polymorphisms in the D locus is homoplastic, which means more than a single 
evolutionary event is needed to explain the phylogeny (either by convergent evolution or by direct 
reversion to the ancestral state). Homoplastic loci may lead to equally good maximum-parsimonious 
phylogenetic trees, and it such cases the phylogeny may be represented by a consensus of the different 
tree topologies. 
As a probabilistic alternative to maximum-parsimony, Bayesian analysis is a 
parametric approach that evaluates the phylogeny with reference to an explicit 
evolutionary substitution model. The model allows for assigning parameters to 
describe the relative rate at which one nucleotide substitutes another during evolution, 
e.g. the relative rate of transitions to transversions. This means that for a given set of 
parameter values one can compute the probability of the observed sequence data, and 
the goal of Bayesian analysis is to obtain a full probability distribution over all 
possible parameter values. This again allows to make inference about phylogeny and 
individual parameters such a mutation rates or divergence times, when applying prior 
information on sampling times [21]. 
Overall, the intent of maximum-parsimony is to find the tree(s) that require the fewest 
steps, whereas Bayesian analysis also tries to minimize a function describing the 
amount of evolutionary change, but the priority is the likelihood of trees given an 
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evolutionary substitution model (and other prior information). The two methods may 
therefore produce different phylogenies. Nonetheless, in this thesis the two methods 
are not used for comparative reasons, but rather for separate purposes. 
 
 
Figure 4: Superimposed substitutions and long branch attraction. (A) Comparison of homologues 
DNA sequences may not show all mutational event that have occurred since divergence, because the 
same site might mutate multiple times. The observed number of differences does therefore not scale 
linearly with the total evolutionary separation between sequences. For this reason, evolutionary 
substitution models have been designed to estimate the number of unseen mutational events to estimate 
corrected evolutionary distances. (B) Long branch attraction is a phenomenon that causes taxa to be 
clustered together due to the misinterpretation of shared homoplasies. The problem occurs when two 
taxa that have accumulated relatively many SNPs, by chance exhibits convergent evolution (i.e. they 
have accumulated the same SNPs independently). Maximum-parsimony (MP) may erroneously 
interpret the SNP as a single event (i.e. as a synapomorphy) in the common ancestor of the two taxa, if 
there are not other SNPs to outweigh the misinterpretation and support the correct ancestry. The 
problem may be minimized by using methods that correct for multiple substitutions at the same site, or 
by adding additional taxa to outweigh homoplastic SNPs. 
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The most comprehensive way to acquire information about the genetic relationship 
between organisms is to sequence their entire genomes (i.e. phylogenomics). 
Historically the cost of DNA sequencing has been a limiting factor, so it has been 
prioritized to sequence members of genetically distant organisms to avoid spending 
valuable sequencing resources on re-sequencing of nearly identical genomes [22]. 
However, the advent of next generation sequencing (NGS) techniques has made it 
more affordable to sequence the genomes of more closely related organisms [23-25], 
and it is now feasible to follow the genomic evolution of bacteria by sequencing 
clones that have evolved for only a few generations since divergence. Such studies 
can easily be performed in vitro [4, 26-29], but even natural systems allows for 
sampling and re-sequencing of the same clonal lineage over shorter and longer time-
periods [5, 6, 30, 31].  
These approaches allow us to follow the microevolution of organisms and can 
improve our understanding of the selection pressures and mechanisms that govern 
genetic adaptation in specific settings. In the lab, this means that researchers can carry 
out evolution experiments to elucidate the genetic basis of adaptation of an organism 
to specific conditions, and for example use this information to genetically engineer 
organisms for industrial applications, or to build conclusions that can be extrapolated 
to help understand evolution in natural systems. However, it is not clear to what 
extent the laboratory observations relate to natural systems, why investigations of 
microevolution in complex and diverse natural environments are needed to fully 
understand evolutionary processes. 
3.1 Clinical	  collections	  of	  bacteria	  as	  sources	  of	  insight	  into	  microevolution	  
The study of microbial evolution in natural systems is limited due to the difficulties of 
systematic and consistent sampling. For example, the constant change and progression 
of natural environments makes it difficult to obtain multiple samples from the same 
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niche, and the populations of interest may be small. Nonetheless, the systematic 
sampling of pathogenic bacteria from clinical settings has shown to provide 
researchers with an opportunity to study microevolution within the well-defined 
boundaries and tissues of the human host [6, 30, 32]. Furthermore, insight into 
molecular evolution of pathogenic bacteria is not only interesting from the 
evolutionary biologist’s point of view, but the same knowledge is relevant from a 
clinical perspective in order to understand for example epidemiology and evolution of 
antibiotic resistance [33-38]. 
3.2 The	  cystic	  fibrosis	  model	  
The opportunistic pathogen P. aeruginosa is a common environmental inhabitant, 
which is also capable of causing both acute and chronic infections in a range of hosts 
from amoeba and plants to humans. For example, P. aeruginosa causes chronic 
airway infections in most patients with cystic fibrosis (CF), and it is directly 
associated with the morbidity and mortality connected with this disease. The 
microbiological status of CF patients is therefore followed systematically, and P. 
aeruginosa isolates are sampled at a routine basis when the patients visit the clinic. 
Thereby chronic CF infections provide an opportunity for long-term monitoring of the 
battle between the infecting bacteria and the host immune defense and clinical 
intervention therapy, and thus offer a direct method for observing evolutionary 
mechanisms in vivo [6, 39, 40]. 
3.2.1	  Cystic	  fibrosis	  
Cystic fibrosis is the most common life-limiting inherited genetic disease among the 
Caucasians. Its frequency within this population group is 1 in 2,500 live births [41], 
and approximately 70,000 people per year are diagnosed with CF worldwide. The 
disorder is autosomal recessive, and results from the combination of two parental 
mutant alleles of the CFTR gene encoding the CF transmembrane conductance 
regulator (CFTR) [42]. More than 1,500 different mutations have been associated 
with CF; however, 70% of all CF patients carry the ΔF508 mutation. Defects in CFTR 
result in abnormal ion transport over epithelium surfaces leading to production of 
thick dehydrated mucus in the airways. The viscosity of the mucus impairs the 
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function of cilia to keep the airways free of inhaled material, and as a result CF 
patients are more susceptible to infections from inhaled microbes [43]. 
3.2.2	  Cystic	  fibrosis	  airways	  pathogens	  
A range of organisms is found to cause infection in the airways of CF patients, and 
the species most frequently associated with infection of CF airway infections are P. 
aeruginosa, Staphylococcus aureus, Haemophilus influenza, and Burkholderia 
cepacia complex. In addition, culture-independent investigations have shown the 
diversity of bacteria in CF airways to comprise hundreds of other species [44-46], but 
the relevance of these findings is disputed [47].  
The infection from different species is observed to be age-dependent. S. aureus and H. 
influenzae are the dominant species to cause infection in childhood, whereas P. 
aeruginosa is most frequently found pathogen in adults (Figure 5). Accordingly, 
about 80% of adults with CF have chronic P. aeruginosa infection, and thereby P. 
aeruginosa is major contributor to morbidity and mortality in CF patients. 
 
 
Figure 5: Prevalence of common pathogens in the airways of CF patients as a function of age. 
Organism abbreviations: A. xylosoxidans, Achromobacter xylosoxidans; B. cepacia, Burkholderia 
cepacia; H. influenzae, Haemophilus influenzae; MDR-PA, multidrug-resistant P. aeruginosa; MRSA, 
methicillinresistant S. aureus; S. aureus, Staphylococcus aureus; S. maltophilia, Stenotrophomonas 
maltophilia. P. aeruginosa includes patients with MDR-PA. S. aureus includes patients with MRSA. 
Figure adapted from the Cystic Fibsosis Foundation, Patient Registry Annual Data Report 2011 
(www.cff.org). 
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It is not clear why P. aeruginosa, despite only being classified as an opportunistic 
pathogen, in the long run is a more successful colonizer of CF airways than pathogens 
like S. aureus and H. influenza. One possibility is that the genetic repertoire of P. 
aeruginosa inherits a better potential for genetic adaptation to the CF airways. The 
following paragraphs serves to introduce the environment of the CF airways and P. 
aeruginosa itself. 
3.2.3	  The	  environment	  of	  the	  CF	  airways	  
The CF airways constitute a complex environment with both spatial and temporal 
heterogeneity (Figure 6). In the upper airway compartments P. aeruginosa is found to 
colonize the paranasal sinuses causing sinusitis [48], whereas P. aeruginosa in the 
lower airways is mainly found in the viscous mucus layer of the bronchi [49]. In the 
respiratory zone P. aeruginosa is more rare, except in the cases of severe lung damage 
[50]. 
 
 
Figure 6: The human airways. The upper airways include the nasal passage, the paranasal sinuses, 
pharynx, and larynx (can also be considered as part of the lower airways). The lower airways consist of 
the conductive zone and the respiratory zone.  The conductive zone refers mainly to the bronchi, and 
the respiratory zone comprises the respiratory bronchioles and the alveoli. Figure adapted from 
Folkesson et al. (2012) [49]. 
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Within the CF airways, P. aeruginosa is faced to adapt to several stresses and 
conditions that stand out from the environment outside the host. Among others, this 
includes the immune system, antibiotics, oxygen levels, and nutrient availability. 
Immune	  system	  
The immune system is considered as one of the most significant challenges for 
microbes invading the CF airways. The immune response includes (aside from the 
impaired mucociliary escalator) components such as neutrophils, macrophages, 
defensins, and antibodies. The type and level of response may be dependent on the 
compartment of the airways. For example the response from neutrophils is more 
predominant in the lower airways than in the sinuses [51]. Neutrophils and 
macrophages suppress infection by phagocytosis of bacterial invaders; however, in 
addition to this invaders need to survive oxidative stress from phagocytosis-mediated 
liberation of reactive oxygen species (ROS) [52]. Nonetheless, ROS also cause 
collateral damage to the host tissues which leads to the loss of lung function [53]. 
Furthermore, part of the immune response relies on the recognition of microbial 
epitopes (e.g. in lipopolysaccharide or flagellar epitopes), and the invading bacteria 
may therefore adapt to the airways by reducing their immunogenicity [54]. 
Antibiotics	  
The antibiotic treatment regime of CF patients varies between countries and clinics 
[55]. In the Copenhagen CF clinic a broad range of classes of antibiotics is used (e.g. 
aminoglycosides, beta-lactams, antimicrobial peptides, macrolides, and 
fluoroquinoles), and treatment depends on the bacteriology and the condition of the 
individual patient [56-58]. A combination of both oral and intravenous administration 
can be used to obtain effective concentrations in different compartments of the lung, 
but the distribution and dynamics of the different drugs will inevitable vary in 
different compartments of the airways [59, 60]. 
Oxygen	  levels	  
One might think that the human airways constitute a highly aerated environment; 
however, both aerobic and anaerobic zones exist. The respiratory zone, where the gas-
exchange occurs, is generally aerobic while oxygen levels in the mucus-enriched 
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zones (conductive zone and paranasal sinuses) can range from aerobic over 
microaerobic to anerobic due poor oxygen diffusion into the mucus [61, 62]. 
Nonetheless, the mucus contains sufficient amount of alternative electron acceptors, 
such as nitrate, to facilitate anaerobic respiration by facultative anaerobes like P. 
aeruginosa [63]. 
Nutrients,	  iron,	  and	  salts	  
The CF airways are considered as a nutrient-rich environment. Mucus is reported to 
be particular rich on amino acids, but also other energy sources such as glucose, 
lactate, and different types of lipids are abundant [64, 65]. Despite the apparent 
nutrient richness, considerable metabolic adaptation from bacterial invaders may still 
be essential for successful persistence in the airways [66, 67]. 
As scavenging of iron is a hallmark of the battle between pathogens and their hosts, 
the iron availability in the CF airways is of interest [68]. The hosts iron-withholding 
processes may limit the amount of free iron, what makes P. aeruginosa dependent on 
siderophores and heme uptake systems to scavenge iron from the host [69]. 
Nonetheless, uptake of free available ferrous iron by P. aeruginosa is also important 
as infections progresses and host tissues are deteriorated from inflammation [70, 71]. 
While iron may be a scarce source, salts (Na+, K+, and C-) are on the other hand 
present in high concentrations due to the abnormal ion transport caused by the 
malfunction of CFTR  [72, 73]. This means invading bacteria may need to cope with 
high osmotic pressures in order to survive [74]. 
3.3 Pseudomonas	  aeruginosa	  
The focus of this thesis is to describe the molecular evolution and genetic adaptation 
of P. aeruginosa within the CF airways described above. The following section will 
therefore serve to describe P. aeruginosa with respect to its the genetic repertoire and 
the most important CF-related phenotypes of P. aeruginosa. 
P. aeruginosa is a Gram-negative bacterium found in a wide variety of ecological 
niches in soil, marshes, and marine habitats. It rarely causes infection in healthy 
humans, but is able to infect damaged tissues or those with reduced immunity, and it 
is for example found in found in skin burns, urinary tract infections, and in the lungs 
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of CF patients [75]. The ability of P. aeruginosa to thrive in a diverse range of 
environments is proposed to be due to a relative large genome size encoding a high 
proportion of regulatory proteins [76]. 
The ‘Pseudomonas Genome Database’ [77] currently contains 13 public available 
genome sequences of P. aeruginosa ranging in size from 6.2 to 6.9 mega base pair 
(Mbp) and with GC contents of around 66%. The genome is most extensively 
annotated with reference to P. aeruginosa strain PAO1 (genome size 6.3 Mbp with 
5,570 predicted open reading frames), which shares 94.7% of its genetic content with 
the strain in focus in this thesis, P. aeruginosa strain DK2 [39]. 
3.3.1	  Pseudomonas	  aeruginosa	  infections	  in	  cystic	  fibrosis	  
The ability of P. aeruginosa to cause infection in CF patients is not pertained to a 
single or a few strains (clone types) of P. aeruginosa. In contrast, many different and 
unique strains are observed to infect CF patients [78]. This suggests that patients pick 
up P. aeruginosa from diverse environmental sources, and accordingly multiple P. 
aeruginosa strain types are typically found to cause intermittent infections in the early 
lives of the individual patient. However, the frequency, duration and severity of 
infections will, despite clinical intervention therapy, increase and as the patient 
regresses into a chronic infection stage, a single strain type is typically observed to be 
dominant (Figure 7) [49]. 
 
 
Figure 7: Clonal diversity and progression P. aeruginosa infections in cystic fibrosis patients. 
Colored squares represent the detection of P. aeruginosa in the airways of a hypothetical CF patient. 
The different colors of the squares symbolize that different P. aeruginosa clone types may be found to 
cause infection. Polyclonal infection patterns are most often found in the early stages of the infection, 
where after a single clone type is observed to dominate. Re-appearance of the same clone type after 
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periods with no detectable P. aeruginosa might either be due to re-colonization from the same 
environmental source, or from hidden reservoirs within the patient [79, 80]. 
3.3.2	  Adaptive	  phenotypes	  of	  Pseudomonas	  aeruginosa	  
Genetic adaptation is found to play a major role in the successful establishment of 
chronic P. aeruginosa infections of CF patients [5, 6, 39, 40, 81, 82]. Accordingly, it 
is observed that natural selection acts on P. aeruginosa in the CF airways to 
accommodate the fixation of mutations causing beneficial phenotypic changes. These 
mutations are here referred to as pathoadative mutations. 
The strains isolated from early and intermittent infections have phenotypes like P. 
aeruginosa found in the environment. They are characterized by being non-mucoid, 
fast growing, and relatively susceptible to antibiotics [83]. However, the phenotypes 
of P. aeruginosa isolates are observed to change together with the transition into the 
chronic infection stage, and isolates from chronic infections are observed to form 
mucoid colonies, reduction in expression of virulence factors, loss of flagella 
dependent motility, amino acid auxotrophy, hypermutability, antibiotic resistance, and 
various lipopolysaccharide (LPS) modifications [84-90]. The genetic basis and 
characteristics of phenotypes related to mucoidity, antibiotic resistance, loss of 
virulence factors, and hypermutation are explained below. 
Mucoidity	  
The mucoid phenotype is characterized by overproduction of the exopolysaccharide 
alginate resulting in a slimy colony morphology when grown on agar plats. It is 
proposed that the alginate functions as a barrier to protect P. aeruginosa from both the 
immune system response and exposition to antibiotics [91-93]. This might explain 
why the mucoid phenotype is considered as a hallmark of chronic infection, and it is 
associated with poor prognosis of CF patients [94]. Constitutive mucoidity is 
genetically most often caused by loss-of-function mutations in mucA which encodes 
an anti-sigma factor, that sequesters (represses) the sigma factor AlgT (sigma22) [95]. 
AlgT controls the expression of a range of stress response genes associated with the 
cell envelope, including the genes required for alginate production. 
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Antibiotic	  resistance	  
Development of increased resistance towards antibiotics is another trait that is 
commonly observed for P. aeruginosa from chronic CF infections. P. aeruginosa is 
generally characterized as being relative resistant to many classes of antibiotics due to 
a low outer membrane permeability, the production of an AmpC beta-lactamase, and 
the expression of multiple drug efflux pumps [96]. The selection pressure enforced by 
antibiotic treatment is therefore hypothesized to promote CF airway colonization 
opportunities for P. aeruginosa as S. aureus was the dominating CF pathogen until 
effective antibiotic therapies were implemented [49]. Nonetheless, despite a high 
intrinsic tolerance or resistance to many antibiotics, P. aeruginosa is still observed to 
develop and enhance its antibiotic resistance by accumulation of mutations. 
Commonly observed resistance mutations are: (a) mutations that increase the activity 
of drug efflux pumps (e.g. drug efflux system MexAB-OprM and MexXY-OprM [97, 
98]); (b) loss-of-function mutations in membrane porine OprD leading decreased 
influx of carbapenems [99]; (c) mutations that increase the resistance towards cationic 
antimicrobial peptides by affecting the composition of the LPS [100-102]; (d) 
mutations that alter the direct targets of antibiotics (e.g. gyrA encoding a DNA gyrase 
targeted by fluoroquinolones [103, 104]); and (e) mutations that increase the activity 
of beta-lactamases [105]. 
Loss	  of	  virulence	  factors	  
P. aeruginosa is able to produce a number of virulence factors which are reported to 
contribute to its pathogenesis. This includes cell-associated virulence determinants 
such as flagella, type IV pili, and LPS, and extracellular virulence factors such as 
siderophores, exotoxins, pyocins, and proteases. Note however, that the role and 
importance of virulence factors is dependent on the infection context, and the 
virulence of the above-mentioned factors is mostly defined with respect to acute 
infection models. Accordingly, it is less counter-intuitive that P. aeruginosa from 
chronic infections is frequently observed to have lost the ability to express virulence 
factors [84, 89, 106, 107]. This loss of virulence factors is hypothesized to be due 
either to a selection against the production of immunogenic determinants, or a 
selection for minimization the energy cost of production of virulence factors [54]. 
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Furthermore, the loss of virulence factors have been found to be caused by genes 
encoding regulators and sigma factors such as Vfr, LasR, RpoN, AlgT, and PvdS [5, 
66, 74, 84]. 
Hypermutation	  
In year 2000 Oliver and colleagues reported a high proportion of P. aeruginosa 
isolates from chronic CF infections to exhibit increased rates of mutation [88]. The 
hypermutable phenotypes were most commonly caused by loss-of-function mutations 
in the mutS and mutL genes encoding components of the DNA mismatch repair 
system, and it was suggested that elevated mutation rates may confer a selective 
advantage in the CF airways. Faster acquisition of for example antibiotic resistance 
mutations may be one explanation for the high prevalence of hypermutators in CF 
infections; however, the exact adaptive advantage from an elevated mutation rate 
remains unclear [108-111]. For example, the hypermutators may exhibit a particular 
mutation bias (mutational signature) that effect not only the rate, but also the genetic 
mechanism of adaptation, as it has been shown for the biased mutagenesis of mucA in 
mutS hypermutators [112]. Another possible explanation is that hypermutators occupy 
a niche, in which there is a selection for fast phenotypic changes, and as such both 
hyper- and normomutators would be able to co-exist in the airways. 
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Chapter	  4 	  
Present	  investigations	  
Chapter 2 has taught us how phylogenomics can be used to decipher the molecular 
evolutionary steps that have occurred since the divergence of compared organisms, 
such as isolates of bacteria. However, the retrospective nature of phylogenomics 
makes the approach dependent on the quality of the collection of bacteria that is of 
interest. Ideally, samples representing all genotypic states should be contained in the 
collection. In practice this is not feasible, and especially lack of information about of 
ancestral states is a problem because samples representing these states are in most 
cases not accessible at the time when the study is conducted. 
Nonetheless, freeze-storage of bacteria provides an opportunity to gain insight to the 
intermediates of evolution. Such freeze-storage of ancestral states have for example 
founded the basis of the longest running laboratory evolution experiment in which 
Lenski and colleagues have followed the evolution within each of 12 test tube cultures 
of Escherichia coli, that have been propagated since year 1988 (corresponding to 
>50,000 bacterial generations) [113]. In a similar way, the systematic sampling and 
freeze-storage of clonal lineages of pathogenic bacteria from clinical settings provide 
collections that can be regarded as ‘evolution experiments’, but with the notable 
distinction that these are run in natural settings. 
Chapter 3 then taught us how chronic P. aeruginosa infections in CF patients 
represent an infectious disease scenario, in which the molecular evolution of clonal 
lineages of P. aeruginosa within the airways of CF patients can be followed. It is 
therefore in this context that this thesis aims to improve our knowledge about 
molecular evolution and pathoadaptation, and our investigation is based on a unique 
collection of P. aeruginosa isolates sampled from Danish CF patients. 
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4.1 The	  Copenhagen	  collection	  of	  Pseudomonas	  aeruginosa	  
The collection of clinical isolates of P. aeruginosa sampled from CF patients dates 
back to 1972, where it was started by Professor Niels Høiby at the Copenhagen CF 
Center at Rigshospitalet in Denmark. Since then, P. aeruginosa have been isolated 
and stored on a regular basis from patients attending the Copenhagen CF Center, and 
today thousands of isolates are stored. 
Molecular epidemiological studies of selected isolates in the collection revealed the 
presence of two dominant strains that have spread among the CF patients by 
interpatient transmission [80]. The two strains are referred to as the DK1 (formerly 
“r”) and the DK2 (formerly “b”) clone type, respectively. The earliest sampled 
isolates of the DK1 and DK2 clone types were sampled in 1973 and 1972, 
respectively, and since then they been able to disseminate through a cohort of around 
40 patients each (Figure 8). This means that it possible to follow the genomic 
evolution of these two clone types over a time-period covering more than 40 years, 
corresponding to around 200,000 bacterial generations [6]. This is in the range of the 
number of generations separating present-day humans and chimpanzees from their 
most recent common ancestor [114]. 
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Today
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Patient died
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Figure 8: Schematic representation of the epidemiology of the P. aeruginosa DK1 and DK2 clone 
types causing infections in Danish CF patients.  Illustration of the initial entry and spread of the DK1 
and DK2 clone types at the Copenhagen CF Center. Figure courtesy of Søren Damkiær. 
Members of the DK1 and DK2 clone types were initially identified from genotyping 
using pulsed field gel electrophoresis (PFGE) and SNP typing based on 13 
polymorphic sites in the P. aeruginosa core genome (Clondiag Chip Technologies, 
Germany) [115]. Neither of these typing methods is able to provide details about 
microevolutionary events, so we started a program to genome sequence selected 
isolates in the Copenhagen CF collection of P. aeruginosa. To this date more than 600 
isolates belonging to more than 50 different clone types have been genome sequenced 
with the DK1 and DK2 clone types being the most extensively investigated. 
4.2 Aim	  of	  thesis	  
Given this unique collection of P. aeruginosa and the ability to do comparative 
genomics, the aim of this thesis has been to use the CF model to study evolution and 
pathoadaptation of bacteria in the course of persistent infections in humans. This has 
been done with a focus on the DK2 clone type, and the articles presented in Chapter 6 
aim to investigate evolution within the CF airways with respect to: 
• Rates and mechanisms of molecular evolution. 
• Population dynamics. 
• Identification of pathoadaptive genes and selective forces. 
4.3 Overview	  of	  results	  
Article	  1:	  Evolutionary	  dynamics	  of	  bacteria	  in	  a	  human	  host	  environment	  
Our first efforts to use genome sequencing to investigate the molecular evolution of P. 
aeruginosa was presented in Article 1 by Yang et al. (2011) [6]. In this article we 
compared the genomes of 12 DK2 isolates sampled from six different patients over 35 
years. Phylogenomic analysis revealed the evolution of the DK2 lineage to be 
characterized by a rather constant accumulation of SNPs exhibiting an overall 
signature of genetic drift (dN/dS=0.8), and only 180 SNPs separated the two most 
distant isolates (CF114-1973 and CF333-2007a). 
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Only the branch separating the 1973-isolates from the post-1979 isolates showed 
significant signs of positive selection (dN/dS=1.6), suggesting that the DK2 lineage 
during this period experienced a more rapid acquisition of adaptive mutations. 
Interestingly, phenotypic characterization of the 12 isolates showed a rapid 
phenotypic change during the same period. We therefore hypothesized that the DK2 
lineage by 1979 had reached an adaptive peak in the fitness landscape mediated by the 
fixation of important pathoadaptive mutations. The presence of such pathoadaptive 
mutations fixated before 1979 was further investigated, and Damkiær et al. (2013) 
found four specific mutations in genes mucA, algT, rpoN, and lasR to explain 40% of 
the total transcriptome changes, to cause conditional mucoidity, and to increase the 
tolerance to towards relevant antibiotics [74]. 
The topology of the phylogenetic tree describing the genetic relationship of the 12 
isolates showed that isolates from the same patient tended to group together. This 
suggested that the DK2 lineage subsequent to transmission evolves as rather separate 
sub-lineages in each individual patient. As the selective conditions in the different 
hosts may be similar, the relationship between genotype and phenotype can be 
elucidated from parallelism in evolution, i.e. independent evolution of the same 
phenotype from mutation of the same locus. Accordingly, we were able to infer the 
genetic details of two phenotypes (increased resistance towards ciprofloxacin and lost 
capacity to catabolize 4-hydroxyphenylacetic acid) by comparing genotypic and 
phenotypic changes in independently evolving sub-lineages. 
Article	  2:	  Mutations	  in	  23S	  rRNA	  confer	  resistance	  against	  azithromycin	  in	  
Pseudomonas	  aeruginosa	  
In Article 2 by Marvig et al. (2012), we characterized another example of convergent 
evolution in which isolates CF333-2007a and CF66-2008 sampled from two different 
patients were found to have independently accumulated the same mutation within 23S 
rRNA [116]. This led us to reveal how mutations in domain V of 23S rRNA confer 
resistance towards the macrolide antibiotic azithromycin. Azithromycin has been used 
in the Copenhagen CF Center to treat P. aeruginosa CF infections since 2001 [56]; 
however, our study is the first to demonstrate in vivo development of resistance in P. 
aeruginosa. Furthermore, the exact mechanism by which azithromycin exerts its 
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effect has not been well understood, and our results suggest that the mode of action of 
azithromycin in vivo involves binding to the 50S ribosomal subunit, and that the 
action is blocked by mutations in 23S rRNA. 
Article	  3:	  Deletion	  and	  acquisition	  of	  genomic	  content	  during	  early	  stage	  adaptation	  
of	  Pseudomonas	  aeruginosa	  to	  a	  human	  host	  environment	  	  
Our initial genome analysis of the DK2 lineage only included a systematic detection 
of SNP mutations. Nonetheless, the dynamics of the overall genomic content of the 
DK2 lineage is of interest to determine the role of loss and acquisition of genetic 
material for long-term adaptation to the CF airways. For example the lineage may 
acquire plasmid-borne antibiotic resistance genes, or on the other hand undergo 
reductive evolution through loss of genetic material that are not essential within the 
host environment. In Article 3 by Rau et al. (2012), we therefore examined the 
dynamics and mechanisms of changes in genetic content during evolution of the DK2 
lineage [39]. At the same time we expanded the genomic dataset from the 12 initial 
isolates, so it now included genome sequences of 45 P. aeruginosa isolates collected 
from 16 individuals over 35 years, and we completed the 6,402,658 bp genome of 
CF333-2007a to strengthen the genetic basis of the analysis. In total 27 deletion 
events that occurred through both illegitimate and homologous recombination were 
detected. On average the deletions contained 45 kilo basepair (kbp) of DNA, and the 
rate of genome reduction was nearly 4 kbp per year. On the other hand, we observed 
no strong evidence of uptake of novel DNA, demonstrating that host adaptation was 
characterized by a reduction of the genomic repertoire rather than acquisition of novel 
functions. Also, the impact on evolution from transposition of IS elements was 
limited, and only five multiplication events of IS elements were observed. This result 
contrast laboratory evolution experiments in which IS elements were shown to 
contribute significantly to mutation generation [4, 117]. 
Article	  4:	  Genome	  Analysis	  of	  a	  Transmissible	  Lineage	  of	  Pseudomonas	  aeruginosa	  
Reveals	  Pathoadaptive	  Mutations	  and	  Distinct	  Evolutionary	  Paths	  of	  
Hypermutators	  
In Article 4 by Marvig et al. (2013), we again expanded the genomic dataset to 
include genome sequences of a total of 55 DK2 isolates [40]. The expansion of the 
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dataset to include isolates from 21 different patients enabled us to perform an open 
search for pathoadaptive genes by tracking patterns of parallel evolution in separate 
hosts. Accordingly, we identified 65 pathoadaptive genes of which most were related 
to antibiotic resistance, the cell envelope, or regulatory functions, suggesting that 
selection from the immune system and drug therapy drives the molecular evolution. 
Furthermore, the sequencing of multiple isolates from the same patient gave us an 
opportunity to study the within-patient population dynamics, and we found evidence 
for all of the following scenarios: (a) stably existence of a single clonal sub-lineage; 
(b) stably co-existence of two independent sub-lineages, possible due to niche-
differentiation; and (c) sequential dominance of competing sub-lineages within the 
same patient. In the latter case the prevalence of pathoadaptive mutations interestingly 
correlated with the evolutionary success of the competing sub-lineages. 
Finally, we observed the presence of hypermutable sub-lineages within 48% of the 
studied patients. While hypermutation may accelerate evolution, our investigations 
also led us to show that hypermutators display differential mutagenesis facilitated by 
mutation of homopolymers. This enabled the hypermutators to follow alternative 
evolutionary pathways that may help to explain their emergence in CF infections. 
Article	  5:	  Within-­‐Host	  Evolution	  of	  Pseudomonas	  aeruginosa	  Reveals	  Adaptation	  
Towards	  Iron	  Acquisition	  from	  Hemoglobin	  
The identification of pathoadaptative genes in the previous article was based on only 
intragenic mutations. Nonetheless, natural selection also acts on mutations located 
outside genes, for example due to the role of intergenic sequences in regulation and 
transcription of neighboring genes. We therefore re-analyzed the data with respect to 
intergenic regions, and in Article 5 we found the intergenic region upstream of the 
phuR gene to be the most densely mutated intergenic region with a total of 13 
mutations [118]. phuR encodes an outer membrane receptor of the Pseudomonas 
heme uptake (phu) system, and this finding led us to elucidate how the mutations lead 
to an increased activity of the phuR promoter. Furthermore, increased expression of 
phuR conferred a growth advantage in the presence of hemoglobin, thus suggesting 
that P. aeruginosa genetically adapt towards iron acquisition from hemoglobin in the 
CF airways. To test the generality of this adaptive trait, we inspected the genomes of 
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two additional P. aeruginosa lineages isolated from CF airways and found similar 
adaptive evolution in both of these lineages. Finally, in all three P. aeruginosa 
lineages phuR promotor mutations coincided with the loss of pyoverdine production, 
suggesting that within-host adaptation towards heme utilization is triggered by the 
loss of pyoverdine production. 
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Chapter	  5 	  
Overall	  conclusions,	  future	  directions,	  and	  perspectives	  
By genome sequencing of 55 isolates of the DK2 lineage of P. aeruginosa sampled 
from CF patients, we have shown how a clinical collection of bacteria constitutes a 
valuable basis for studying the molecular evolution of bacteria in natural environment. 
We analyzed the genomes to identify SNPs, insertions, deletions, and transposition of 
IS elements, but other mutation types (e.g. rearrangements and gene duplications) 
remain to be investigated. Our genome comparisons revealed within-host evolution of 
P. aeruginosa to be characterized by de novo mutation rather than horizontal transfer 
of genetic material, and we were able to give unprecedented estimates of in vivo rates 
of mutation. In this respect, we found certain hypermutable lineages to evolve with 
different rates and spectra of mutations, and this may have had impact on the 
evolutionary trajectories that were available for these hypermutators. Furthermore, 
one of hypermutator lineages had accumulated >2000 SNPs since its divergence from 
the other DK2 isolates, highlighting the difficulty of imposing a simple threshold for 
the number of SNPs between isolates to decide whether they are part of a recent 
transmission chain. 
We observed the occurrence of multiple different DK2 sub-lineages in individual 
patients, and this suggested that population dynamics were driven by both intra-clonal 
competition (clonal interference) and niche specialization (adaptive radiation). We 
therefore propose that multiple and randomly chosen isolates from each patient should 
be genome sequenced to give a more detailed view of the population dynamics, as our 
current study is limited in sense that only a single (or a few) isolates from the same 
sputum sample were sequenced. Also, our genome analysis may be complemented 
with culture-independent sequencing of the P. aeruginosa population 
(metagenomics), or with sequencing of clones sampled from different sites in the 
airways to add spatial resolution our the study. 
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By tracking patterns of parallel evolution, we identified genes that were mutated to 
optimize the fitness of P. aeruginosa within the CF airways. The identification of 
such pathoadaptive genes gave insight into how P. aeruginosa evolves under the 
selective pressures imposed by drug therapy and the host immune system. The role in 
pathogenesis is not known for several of the identified genes, and further investigation 
of these genes may identify them as future therapeutic targets against infection. For 
example, we found evidence that P. aeruginosa during later stages of infection looses 
the capability to scavenge iron by pyoverdine siderophores and instead depends on 
iron acquisition via the phu heme uptake system. Targeting heme utilization might 
therefore be a promising strategy for the treatment of CF infections. 
Continued characterization of pathoadaptive mutations will help linking genotype to 
phenotype. Such knowledge will facilitate better epidemiological predictions and 
provide the clinicians with valuable information on how to treat and segregate 
patients. For example, information about resistance mutations can be used to predict 
antibiotic susceptibility profiles even before phenotypic susceptibility results from 
standard lab tests are available [33]. 
We found evidence that adaptation towards heme utilization might be a general 
adaptive trait across different CF associated P. aeruginosa lineages. Nonetheless, it 
remains unclear how the findings from the DK2 genomes apply to other lineages of P. 
aeruginosa evolving in CF patients, and we anticipate that our dataset will facilitate 
inter-clonal future comparative studies. This might be by comparison to transmissible 
lineages from other countries, but we will also be able to do comparisons to the other 
“local” clone types found in the Copenhagen CF Center. Such local comparisons 
might for example be interesting with respect to shedding new light on interactions 
between different clone types that co-exists in the same patient. Our current study 
already indicates the importance of such interactions as our analysis revealed a DK2 
isolate to have acquired DNA from an unrelated clone type of P. aeruginosa. 
Furthermore, one drawback of the studied collection of DK2 isolates is that all the 
isolates have been sampled from their respective hosts after the onset of chronic 
infection. In order to better understand the genetic adaptation that occurs right after 
the movement from the environmental reservoir to the CF airways, we anticipate that 
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similar studies should be conducted on very young CF patients that experiences 
infection from naïve environmental lineages of P. aeruginosa. For example, the 
identification of pathoadaptive mutations in our study was based on detection of 
parallel evolutionary events. Thereby, we were limited in our ability to identify 
mutations that are of immediate importance for P. aeruginosa upon transition from 
the environmental reservoir to the CF airways, as such events may only have occurred 
once in the history of the DK2 lineage. 
Finally, infectious disease scenarios are not as simple as one host and one pathogen. A 
logical next step will be to integrate genomic information from multiple different co-
infecting pathogens to allow for deciphering interspecies interactions. Also, 
sequencing the genomes of the infected individuals may lead to a better understanding 
of the microbial evolution. 
Overall, in this thesis we were able to: (a) track the molecular evolution of bacteria in 
a natural environment; (b) identify the genes involved in the genetic adaptation to this 
environment; and (c) gain information about the different evolutionary trajectories 
that were available for the bacteria. 
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Laboratory evolution experiments have led to important ﬁndings
relating organism adaptation and genomic evolution. However,
continuous monitoring of long-term evolution has been lacking
for natural systems, limiting our understanding of these processes
in situ. Here we characterize the evolutionary dynamics of a
lineage of a clinically important opportunistic bacterial pathogen,
Pseudomonas aeruginosa, as it adapts to the airways of several
individual cystic ﬁbrosis patients over 200,000 bacterial genera-
tions, and provide estimates of mutation rates of bacteria in a nat-
ural environment. In contrast to predictions based on in vitro
evolution experiments, we document limited diversiﬁcation of
the evolving lineage despite a highly structured and complex host
environment. Notably, the lineage went through an initial period
of rapid adaptation caused by a small number of mutations with
pleiotropic effects, followed by a period of genetic drift with lim-
ited phenotypic change and a genomic signature of negative selec-
tion, suggesting that the evolving lineage has reached a major
adaptive peak in the ﬁtness landscape. This contrasts with previous
ﬁndings of continued positive selection from long-term in vitro
evolution experiments. The evolved phenotype of the infecting
bacteria further suggests that the opportunistic pathogen has tran-
sitioned to become a primary pathogen for cystic ﬁbrosis patients.
microbial evolution | natural population | chronic infection | genome
sequences | transcriptomics
Bacterial populations maintained in deﬁned in vitro systemsare well-suited for experimental evolutionary studies of ad-
aptation to novel environments. It has been observed from such
investigations that the initial rate of adaptation is rapid with a
continuous increase in ﬁtness that later tends to decelerate over
time (1). Experimental evolution has also been used to gain in-
sight into the molecular details of evolution (2–7). Interestingly,
a complex relationship between the decelerating rate of evolu-
tionary adaptation and a constant rate of genomic changes
enriched with nonsynonymous changes has been observed in one
such in vitro experiment (2). The level of diversity that evolves in
a population is thought to increase as a function of environmental
complexity in terms of available ecological niches. Laboratory
experiments with artiﬁcially structured microbial populations
have shown that environmental heterogeneity, such as population
complexity and spatial structure, can generate and maintain pop-
ulation diversity (8–10). Comparable systematic investigations of
bacterial populations living in complex natural environments are
lacking, and the extent to which laboratory evolutionary experi-
ments bear any relevance to evolutionary processes in natural
environments is poorly understood. To address this question, we
investigated the evolutionary dynamics including the roles of
neutral versus selective mechanisms in bacterial populations
evolving over 200,000 generations in the complex natural and
structured environment of cystic ﬁbrosis (CF) airways.
Chronic airway infections in CF patients by the bacterium
Pseudomonas aeruginosa offer a rare opportunity to study evo-
lutionary adaptation of bacteria in natural environments. CF
airways, like other natural environments, constitute a complex
and highly dynamic ecosystem composed of a range of niches
that vary in space and time. Factors such as heterogeneous dis-
tribution of oxygen, nutrients, and other substances, ﬂuctuations
in exposure to the host immune system and therapeutic antibi-
otic treatments, as well as a diverse microbial community struc-
ture in the host all contribute to environmental conditions under
which the bacteria face continuous adaptive challenges (11).
These environmental conditions have been used to explain the
extensive phenotypic diversity often observed in P. aeruginosa
populations from the same CF respiratory specimen (12–14). We
propose that P. aeruginosa infections in CF airways constitute a
valuable natural system for addressing central questions con-
cerning evolutionary biology, and we use this system to investigate
how the highly successful and transmissible DK2 lineage of
P. aeruginosa adapts to this environmental complexity in several
CF patients using genome sequencing, transcriptional proﬁling,
and phenotypic arrays. Based on previous estimates of in situ
growth rates of P. aeruginosa isolates (15), we calculate that the
DK2 lineage has persisted for about 200,000 bacterial generations
in the CF airways of several patients, and as such this study
documents the genomic and functional details of a long microbial
evolution “experiment.”
Results and Discussion
This study was based on a collection of P. aeruginosa isolates
sampled from several hundred Danish CF patients between 1973
and 2008. Initial examination of the clonal relationship among a
subset of the stored isolates using molecular typing methods
revealed that some P. aeruginosa clonal lineages were observed
repeatedly because of transmission among the patients (16). For
the present study, we are focusing on the DK2 lineage (Materials
and Methods), which we have established as one of these trans-
missible lineages and isolated from ∼40 patients since the start of
the sampling program in 1973.
Genomic Evolution of the DK2 Lineage. To enable a detailed char-
acterization of the evolutionary trajectory associated with the
dissemination of the DK2 lineage across multiple patients, we
sequenced the genomes of 12 selected DK2 strains (CF114-1973,
Author contributions: L.J. and S.M. conceived study; L.Y., L.J., M.O.A.S., and S.M. designed
research; L.Y., L.J., R.L.M., S.D., M.H.R., and M.O.A.S. performed research; H.K.J., O.C., and
N.H. contributed new reagents/analytic tools; L.Y., L.J., R.L.M., S.D., C.T.W., M.H.R., S.K.H.,
A.F., M.O.A.S., and S.M. analyzed data; and L.Y., L.J., R.L.M., S.D., A.F., M.O.A.S., and S.M.
wrote the paper.
The authors declare no conﬂict of interest.
*This Direct Submission article had a prearranged editor.
1L.Y. and L.J. contributed equally to this work.
2To whom correspondence should be addressed. E-mail: sm@bio.dtu.dk.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1018249108/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1018249108 PNAS | May 3, 2011 | vol. 108 | no. 18 | 7481–7486
EV
O
LU
TI
O
N
CF43-1973, CF66-1973, CF66-1992, CF66-2008, CF30-1979,
CF173-1984,CF173-2005, CF333-1991,CF333-1997, CF333-2003,
and CF333-2007) isolated from 6 different patients between 1973
and 2008 (Fig. 1 and Tables S1 and S2). We identiﬁed high-quality
SNPs in the nonrepetitive parts of the genomes by mapping se-
quence reads for each isolate against CF333-2007 (Table S3 and SI
Materials and Methods). A total of 368 SNPs have appeared since
the clones diverged from their common ancestor before 1973
(Table S3), and we ﬁnd that there are 180 SNPs between the most
distantly related clones (CF114-1973 and CF333-2007). Based on
the identiﬁed SNPs, we construct a tree representing the evolu-
tionary relationship of the DK2 strains (Fig. 2A andMaterials and
Methods), and as such the tree demonstrates the sequence of mu-
tational events in the DK2 lineage from 1973 and onward.
We predict the DK2 ancestor to be related to the sequenced
strains, as indicated with the predicted root in Fig. 2A, based on
the assumption that the DK2 ancestor would contain wild-type
SNP alleles [i.e., SNP positions with sequences identical to ho-
molog sequences found in the P. aeruginosa reference strains
PAO1 and PA14 (17)]. Despite the genomic diversity among the
1973 isolates, their phenotypes are similar to the well-character-
ized laboratory P. aeruginosa strain PAO1 (Fig. 3 and Table S1).
Because the CF infection process is associated with the appear-
ance of phenotypes of which many are not usually observed among
environmental, wild-type isolates of this species (18–20), we pre-
dict that the immediate ancestor to the DK2 lineage entered the
CF environment shortly before the ﬁrst sampling in 1973. Because
the original infecting DK2 strain is unavailable for analysis, we
cannot precisely determine the pre-1973 events that resulted in
genomic diversity among the isolates sampled in 1973. Although
a complete understanding of the pre-1973 history of the DK2
lineage is not a prerequisite for the present study, we hypothesize
that this diversity may be a result of processes such as (i) an
already-present diversity in the ancestral DK2 lineage before ﬁrst
entry into the CF environment (i.e., the ﬁrst infection caused by
amix of genetically distinct subpopulations of DK2) and/or a rapid
diversiﬁcation of the ancestral DK2 strain upon ﬁrst infection as
observed in patients infected with environmental strains (13, 19)
possibly coupled to a transmission process that retained diversity,
(ii) the storage conditions of these particular isolates in agar slants
at room temperature for an extended period in which genomic
changes may have arisen (21), or (iii) an increased mutation rate
in the lineage before the 1973 sampling. The presence of a mis-
sense mutation in mutY and a molecular signature consistent with
a MutY defect [i.e., a high proportion of transversions (P = 7 ×
10−13) of which 85% are G·C→T·A] in the sublineage branching
into CF43-1973 indeed demonstrates a pre-1973 hypermutator
phenotype for this particular isolate (22). As the two remaining
1973 strains did not show molecular signs of a hypermutator
phenotype, other phenomena may have led to increased genomic
diversiﬁcation in these strains before sampling in 1973.
We derive two conclusions based on the topology of the tree.
First, all isolates sampled from 1979 and onward share a com-
mon branch point (marked with a red circle in Fig. 2A). We
hypothesize that important mutations accumulated in the early
hosts (pre-1979) positioned the DK2 lineage for subsequent re-
productive success in the CF airways in several hosts. Second, the
tree demonstrates a remarkably limited diversiﬁcation of the
sequential isolates present in patients CF333 and CF66 after
1979. This observation is surprising, because CF airways repre-
sent a dynamic and spatially structured environment in which
one would expect a divergent population structure and multiple
coexisting sublineages resulting in a deeply branched phyloge-
netic tree of clones isolated from the same host (8, 12, 13, 23).
Note, however, the disconnected branching of the 1984 and 2005
isolates in patient CF173 (Fig. 2A), which suggests that a re-
placement of the DK2 lineage caused by a secondary trans-
mission event after 1984 has taken place.
Because the DK2 lineage has exhibited a highly successful
phenotype over an estimated period of 200,000 generations of
growth, it provides an excellent system for the detailed study of
molecular evolution in ways that previously have been possible
only in well-deﬁned artiﬁcial laboratory environments. Impor-
tantly, we ﬁnd that SNPs in the protein-coding regions of the ge-
nome have accumulated at a constant rate in the DK2 lineages
since 1973 (Fig. 2 B and C). We can estimate the mutation rate
based on the accumulation of synonymous mutations in the pro-
tein-coding regions of the genome assuming that they are neutral
and not selected for (2, 24). Based on the codon use in
P. aeruginosa (25), we ﬁnd that 25% of all SNPs in the protein-
coding parts of the genome result in synonymous changes (SI
Materials and Methods). We ﬁt a least-squares linear model of
mutation accumulation over time and calculate the mutation rate
as the number of synonymous mutations ﬁxed per generation
(cf. Fig. 2B) divided by the fraction of mutations expected to be
synonymous in the genome. Based on these assumptions, we
ﬁnd that the mutation rate of P. aeruginosa in CF airways is 7.2 ×
10−11 SNPs/bp per generation, which is in the range of previous
estimates for related bacteria (2, 26, 27). Excluding the 1973 iso-
lates from the calculation, we ﬁnd the mutation rate to be 6.9 ×
10−11 SNPs/bp per generation. It is important to note that these
estimates show no indication of increased rates of mutation, as has
been suggested for bioﬁlm-associated cells and CF infection-as-
sociated cells due to oxidative stress or other phenomena (28–32).
Selective Forces Acting on the DK2 Genome. Based on the number
of protein-coding synonymous SNPs, we can estimate the expected
number of nonsynonymous protein-coding SNPs assuming a neu-
tral theory of molecular evolution. This theory predicts the rate of
nonsynonymous substitutions (dN) relative to the rate of synony-
mous substitutions (dS) to approach unity during neutral evolu-
tion. Over- or underrepresentation of nonsynonymous mutations
can be seen as a sign of positive or negative selection, respectively.
Overall, among all mutations in the protein-coding regions of
the genome, we ﬁnd a signiﬁcant underrepresentation of non-
synonymous mutations (dN/dS = 0.79; P= 1.3 × 10−4) (Table S4).
The sign of negative selection is most prevalent in isolates from
1979 and onward (branches G-U in Fig. 2A; dN/dS = 0.70; P =
6.5 × 10−5), whereas calculations based on early isolates (branches
A–F in Fig. 2A) do not support evidence of negative selection (dN/
dS = 0.89; P = 0.10). This observation supports a hypothesis that
a selection of adaptive mutations takes place in the years up to
1979 leading to a highly adapted clone closely related to CF30-
1979 (represented by a red circle in Fig. 2A). Although our results
contrast with previous ﬁndings of strong positive selection in CF
airways (23), it is likely that the earliest stages (before 1973) of
infection by the DK2 lineage were also dominated by positive
selection mechanisms. Indeed, despite of the overall sign of neg-
ative selection, there is a statistically signiﬁcant sign of positive
selection in the lineage (branch F in Fig. 2A) leading to the post-
1979 isolates (dN/dS = 1.58; P = 0.02).
Fig. 1. Isolate sampling points and patient life span. DK2 P. aeruginosa
isolates were collected from six different CF patients during a 35-y time
period. Bacterial isolates are represented by the colored symbols, and gray
bars represent patient life span.
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Phenotypic Changes During Long-Term Adaptation to CF Airways.
The dynamics of phenotype changes in the isolates of the DK2
lineage was characterized both by gene expression proﬁles under
a single growth condition (standard laboratory medium) and by
determination of catabolic activities under different growth con-
ditions. Each method interrogates different aspects of cellular
physiology (whole-genome transcript abundance and cellular cat-
abolic capacity) and is therefore expected to probe different com-
ponents of the genotype/phenotype relationship of the bacteria.
Hierarchical clustering of all recorded expression and catabolic
signals from each isolate showed that strains sampled between
1979 and 2008 are more similar to each other than to the initial
isolates (1973) (Fig. S1 A and B). To further examine the extent of
gene expression changes among the isolates a principal compo-
nent analysis, which transforms a complex data matrix into a small
number of variables, was applied. The ﬁrst principal component
PC1 accounts for most (42%) of the variance in the dataset.
Plotting of the loadings of each isolate on PC1 as a function of time
shows a strikingly simple and clear time-dependent progression,
with a major shift between 1973 and 1979 followed by a period
with few changes (Fig. 3A). After 1979 all of the DK2 isolates
share a very similar gene expression pattern despite the fact that
they cover samples from four different patients taken with a time
span of 29 y (estimated to correspond to ∼150,000 bacterial gen-
erations) and have accumulated 179 mutations.
In analogy with the global transcriptional data, the “cata-
bolome” datasets display a ﬁrst principal component diagram that
documents a lack of variation among strains isolated after 1979
(Fig. 3B). Before 1979 the proﬁle changed rapidly from a wild-type
pattern of catabolism of C and N sources, as observed in a refer-
ence strain (PAO1) and in the 1973 isolates, to the adapted pattern
reﬂecting amutation(s) in a global regulatory gene(s). Surprisingly,
the catabolome as monitored by the Biolog phenotype arrays
shows only loss of function (Fig. S2), which is paradoxical, taking
the abundance of, for example, amino acids in the sputum into
consideration (33). We hypothesize that the airway mucus and the
surrounding environment is rich in a variety of nutrients and that
the competition for these from other infecting species is marginal,
providing ample opportunities for alternative feeding by P. aeru-
ginosa. Overall, our phenotype data are consistent with our geno-
mic data and suggest strong negative selective forces acting on the
evolving populations of the DK2 lineage after 1979.
The observed phenotypic stability and the genomic signature
of negative selection are consistent with a hypothesis that the
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DK2 lineage (represented by the evolved genotype/phenotype of
CF30-1979 and later isolates) becomes positioned on a major
ﬁtness peak in this complex and dynamic natural environment. If
the evolved DK2 lineage is in fact positioned on a major ﬁtness
peak, most new mutations would result in reduced ﬁtness and
therefore not be ﬁxed in the population (negative selection),
whereas neutral (synonymous) mutations would be ﬁxed (genetic
drift), which is in agreement with our ﬁndings.
Parallel Evolution in DK2 Sublineages. The striking similarity be-
tween the phenotypes of DK2 isolates sampled from different
CF patients suggests that the host environments represent par-
allel selective conditions by which evolution is directed. Such
parallelism is expected to generate parallel evolution (20), and a
search for signs of independent evolution of the same traits in
the isolates conﬁrms this. In the case of two phenotypes that
evolved independently in the CF173 and CF333 isolates after
their early separation from CF30-1979, we were able to identify
the genetic details: (i) The lost capacity of both isolates to ca-
tabolize 4-hydroxyphenylacetic acid (4-HPA), a trait identiﬁed in
the Biolog phenotypic arrays, is associated with similar—but not
identical—genetic changes (Fig. 4 A–C); and (ii) increased re-
sistance to the antibiotic ciproﬂoxacin conferred by two in-
dependent gyrAmutations that have previously been described to
contribute to ciproﬂoxacin resistance (34) (Fig. 4D). Consistent
with this, both isolates CF173-2005 and CF333-2007 show in-
creased levels of resistance toward ciproﬂoxacin (Fig. 4D). Ad-
ditionally, both isolates obtained mutations in the genes PA5160
and mexY, which are components of multidrug transport systems
(35) (Fig. 4A).
Mutations with Pleiotropic Effects Drive Adaptation to New Envi-
ronments and Reproductive Success in CF Airways. The genomic
analysis showed that mutations appeared in several global regu-
latory genes during the initial 42,000 estimated generations of
growth. Indeed, we observed more missense and nonsense SNPs
in regulatory genes in the ﬁrst 42,000 estimated generations be-
fore 1979 (11 mutations) compared with the following 167,000
estimated generations after 1979 (5 mutations) (Table S5). Of
particular interest are mutations in the mucA (SI Materials and
Methods) and rpoN genes that occurred before 1973 (as observed
in CF66-1973), and a deletion of the lasR gene that occurred
before 1979 (as observed in CF30-1979). Gene expression con-
trolled by MucA, LasR, and RpoN accounts for approximately
half of the total signiﬁcantly changed gene expression between
CF114-1973 and CF30-1979, which conﬁrms the pleiotropy of
these mutations in the DK2 lineage (SI Materials and Methods).
Notably, transcomplementation of late DK2 isolates with wild-
type RpoN expressed from a recombinant plasmid restored to
a large extent the catabolic proﬁle of wild-type P. aeruginosa (Fig.
S2), suggesting that much of the adapted catabolome activity in
DK2 is directly associated with the rpoNmutation already present
in the CF66-1973 isolate. After 1979 no similarly dramatic global
regulatory changes seem to have occurred in the DK2 lineage.
Based on the phenotypic data described above and tracking of
the mutated alleles of mucA, lasR, and rpoN among DK2 iso-
lates, we conclude that all DK2 clones isolated after 1979 from
more than 40 different patients have a common ancestor with
a genotype and phenotype like the one described for the CF30-
1979 isolate (SI Materials and Methods). These ﬁndings show that
extensive transmission of the DK2 lineage has occurred in the
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Fig. 4. Parallel evolution in CF333 and CF173 isolates. (A) Schematic repre-
sentation of the four parallel, independent genetic changes observed in the
DK2 lineage in CF333 and CF173. The genetic changes include missense/
nonsense mutations in three genes (gyrA, mexY, and PA5160) and deletions
of genes involved in 4-HPA catabolism. (B) Outline of the chromosomal re-
gion with genes required for 4-HPA catabolism (labeled in black) and posi-
tions of the deletions Δ(PA4116-87) (CF333) and Δ(PA4120-22) (CF173). (C)
Growth of strains in minimal medium with 4-HPA as carbon source. (D)
Ciproﬂoxacin minimal inhibitory concentration (MIC; μg/mL) values measured
using Etest strips (AB Biodisk). Error bars represent standard deviations of
three replicate experiments. Asterisks show signiﬁcant differences (P < 0.05).
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clinic after the occurrence of the last (lasR) of the three global
regulatory mutations. Interestingly, in CF66, in whom the origi-
nal DK2 strain found in 1973 went extinct (either by successful
treatment or by competition with other genotypes of P. aerugi-
nosa or both), a later transmission of an adapted DK2 lineage
(the CF30-1979 adapted phenotype) occurred in 1992. This
further supports that reproductive success (ﬁtness) of the DK2
lineage was dependent on the particular “genetic conﬁguration”
found in CF30-1979, and that components of this ﬁtness can be
described by the phenotypes measured here.
The infecting bacteria in CF airways represent a continuous
challenge to the immune system, and it is striking that among the
many transcriptional changes imposed by the three global regu-
latory mutations (mucA, rpoN, lasR), reduced gene expression in
the DK2 isolates is in fact associated with P. aeruginosa antigenic
virulence factors (19, 36, 37). It is well-known that lasR and rpoN
regulate virulence in this organism, and recently we documented
that also mucA exerts control of expression of several virulence
genes (19). It is therefore tempting to speculate that the com-
bined reduction of virulence caused by the three early regulatory
mutations is a key factor in the success of the DK2 lineage of
P. aeruginosa. It should also be noted that very few regulatory
mutations are identiﬁed in the lineage after 1979 (Table S5).
Concluding Remarks
We have presented a detailed analysis of the temporal sequence
of all of the genetic and phenotypic changes that lead to the
successful establishment of a bacterial lineage in a large number
of new parallel environments. The resulting map of evolutionary
changes shows that the DK2 lineage underwent an initial period
of rapid adaptation upon colonization of the cystic ﬁbrosis air-
ways followed by a long period with limited phenotypic change
and a genomic signature of negative selection.
This study of bacterial evolution in a natural environment
challenges the generality of two major ﬁndings from laboratory
evolution experiments. First, our data show that successful and
adapted bacterial populations in natural systems can have ge-
nomic signatures of negative selection, in contrast with previous
ﬁndings of continuous positive selection from evolving populations
in constant, nonstructured in vitro environments (2). We note,
however, that the earliest stages after the DK2 lineage migrated
from the environment to the CF airways (before 1973) may have
been dominated by positive selection. Second, our data demon-
strate that a complex and variable environment can be dominated
by a highly homogeneous population, in contrast to previous
ﬁndings of diversity promotion and maintenance from laboratory
experiments (8–10). These ﬁndings underscore the importance of
studying the molecular details of evolving populations in natural
environments in addition to populations in laboratory systems to
further our understanding of basic evolutionary processes.
P. aeruginosa is an opportunistic pathogen capable of switching
lifestyle as it moves from the environment to compromised hosts.
The successful adaptation of the DK2 lineage in a group of CF
patients in the Copenhagen CF Clinic is associated with severely
reduced growth rate, loss of substantial catabolic activities and
motility, and inactivation of important regulatory functions (Table
S1). It is unlikely that these changes would not affect the organism’s
ﬁtness in its original environment. InCF airways, however, theDK2
lineage has proven to be persistent, dominant, and transmissible.
The overall adapted phenotype of DK2 is therefore one of a true
pathogen, and its evolutionary history illustrates the process of how
an opportunistic pathogen with a broad environmental range can
transition to a primary-host-speciﬁc pathogen for CFpatients.With
the presented map of evolutionary changes behind this shift, it may
now become possible to design novel therapeutic approaches that
speciﬁcally target the adaptive process and in that way block de-
velopment of chronic CF lung infection.
Materials and Methods
Bacterial Isolation. P. aeruginosa isolates sampled from several hundred
Danish CF patients since 1973 have been stored in the Copenhagen Cystic
Fibrosis Clinic. Isolation and identiﬁcation of P. aeruginosa from sputum was
done as previously described (16). The number of P. aeruginosa cfu in such
respiratory secretions may be as high as 107–109 per mL (38). We conﬁrmed
that all strains analyzed in the present study belong to the same lineage
DK2 [formerly the “b” lineage (16)] using three independent methods for
determination of clonal relationships: pulsed-ﬁeld gel electrophoresis, SNP
typing using an ArrayTube microarray (39), and multilocus sequence typing.
Single colonies were cultivated and stored at −80 °C with glycerol. The
initial storage procedure for the earliest clinical isolates (1973) involved
storage in agar slants at room temperature for an extended period before
storage at −80 °C.
Genome Sequencing. Genomic DNA was prepared from P. aeruginosa isolates
using a Wizard Genomic DNA Puriﬁcation Kit (Promega). Genome sequen-
ces of CF333-2007 and CF333-1991 were sequenced by 454 pyrosequencing
with an approximate coverage of 20-fold. Reads were de novo assembled
into contigs by Newbler version 1.1.03.24 (Roche) resulting in 164 and 87
contigs, respectively, that comprised 6,340,400 and 6,350,334 bp, re-
spectively, and the two genome sequences was aligned using MUMmer3
(40) resulting in an alignment covering 6,336,193 bp of the genomes. Iso-
lates CF114-1973, CF43-1973, CF66-1973, CF66-1992, CF66-2008, CF30-1979,
CF173-1984, CF173-2005, CF333-1997, CF333-2003, and CF333-2007 were
sequenced on an Illumina GAII generating 75-bp single-end reads using
a multiplexed protocol to an average coverage of 47-fold (Table S2). The
reads from each isolate were mapped against the reference genome of
CF333-2007 using Bowtie release 0.12.3 (41), and SNP variants were called
using SAMtools release 0.1.7 (42).
Construction of the Phylogenetic Tree. Genome sequences of all isolates show
exhaustive homology to the reference CF333-2007with nogenomealignments
covering less than 97.6% of the reference genome sequence (Table S2). Based
on the SNP mutations identiﬁed in the alignments, we constructed a phylo-
genetic tree representing the evolutionary relationship among the DK2
strains. The branches at which the individual SNP mutations accumulated
were determined by comparing the SNP mutations among the isolates. For
example, if a mutation was found in isolates CF333-1997, CF333-2003, and
CF333-2007, then the particular SNP mutation was assigned to the branch
labeled “Q” in Fig. 2A. Except for two cases, all SNP mutations accumulated in
a parsimonious fashion, such that a consistent tree could be constructed that
shows the sequence of mutational events. This means that if an SNP mutation
is shown to have accumulated on a particular branch, for example, branch K,
then all clones descending from this branch (CF66-1992, CF66-2008, CF333-
1991, CF333-1997, CF333-2003, and CF333-2007) contain the mutated allele.
The only two SNP mutations that exhibit an aberrant evolutionary distribu-
tion that does not ﬁt the observed sequential accumulation were found in
ampC and ftsI. In the case of ftsI, a G188A substitution was found in isolates
CF173-2005, CF66-1992, CF66-2008, CF333-1991, CF333-1997, CF333-2003, and
CF333-2007 but not in CF173-1984 (Fig. 2A). The same ambiguity applies to
ampC, in which an SNP mutation (A320G) was found in CF173-2005, CF66-
1992, CF66-2008, CF333-2003, and CF333-2007 but not in CF333-1991, CF333-
1997, and CF173-1984 (Fig. 2A). The irregular distribution of these particular
SNP mutations may be a result of identical, but independent, mutational
events, direct reversions, or horizontal transfer of DNA encoding the SNP.
Notably, both ampC and ftsI have been reported to be under antibiotic-as-
sociated selection pressure (43, 44).
As the ampC and ftsI loci are the only two cases that confer ambiguity, we
conclude that the tree structure is robust, although we cannot exclude the
possibility that other similar events may be undetectable in the dataset.
Because the immediate ancestor to the DK2 lineage is unavailable, a precise
determination of the root of the tree is not possible. We predict the DK2
ancestor to be related to the sequenced strains as indicated by the predicted
root in Fig. 2A based on the assumption that the SNP positions in the DK2
ancestor would be identical in sequence to the homolog sequences found in
other P. aeruginosa reference strains such as PAO1, PA14, and LESB58.
Estimation of in Situ Bacterial Generations. The estimation of in situ generations
of the DK2 lineage from 1973 to 2008 is based on our previous determination of
in vivo growth rates of P. aeruginosa populations within sputum material
sampled from different CF patients (15). Considering that growth rates of
P. aeruginosa decrease when infection progresses in CF patients, we segregated
the time period from 1973 to 2008 into several intervals and estimated the in
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situ growth rate of each interval according to the in vitro growth rate. Gen-
erations of each isolates were calculated as sum of generations from 1973 to
the isolation years (see details in Table S1 and SI Materials and Methods).
Global Phenotypic Proﬁling. Transcriptomes were measured using Affymetrix
GeneChip for P. aeruginosa. Phenotype microarrays PM1, PM2, and PM3
(Biolog) were used to obtain the metabolic proﬁles of different carbon and
nitrogen sources. Analysis of both types of datasets was performed using
BioConductor software (see SI Materials and Methods for details) (45).
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SI Materials and Methods
Selection of Strains for Study. Pseudomonas aeruginosa isolates
sampled from several hundred Danish cystic ﬁbrosis (CF) pa-
tients since 1973 have been stored in the Copenhagen CF Clinic.
The protocol for sampling and storage of isolates at the clinical
laboratory was not designed with the purpose of sampling mul-
tiple isolates per patient per time point, and in most cases only
single isolates were kept. Isolates were sampled and stored
without prior knowledge of their particular genotype. Our mo-
lecular epidemiological analysis of the frozen collection of iso-
lates showed that among all of the many different strains of
P. aeruginosa isolated from the CF patients in Copenhagen, two
were encountered repeatedly (1). Each of the two dominant
strains, DK1 (formerly the “r” genotype) and DK2 (formerly the
“b” genotype), have been isolated since 1973 from ∼40 patients.
The major criteria for selecting strains for the present study were
to ensure large temporal separation among the isolates, to en-
sure that isolates from several patients were included, and to
ensure that multiple isolates from individual patients were se-
lected. In the case of patient CF333, ∼20 strains isolated be-
tween 1991 and 2007 had been stored and were available for
analysis. All isolates were determined to belong to the DK2
lineage, and for the present study we selected the ﬁrst and last
isolates (1991 and 2007) as well as two additional intermediate
isolates (from 1997 and 2003). In the case of patient CF173, 26
isolates sampled between 1984 and 2005 were available, and we
selected the ﬁrst and last DK2 isolates. Similar to the clonal
infection in patient CF333, DK2 strains were sampled continu-
ally from patient CF173 between 1984 and 2005, although from
2002 and onward both DK1 and DK2 isolates could be isolated
simultaneously from the patient (1). The ﬁrst isolate stored from
patient CF66 was a DK2 strain sampled in 1973. Additional DK2
strains were not observed in this patient until the lineage re-
appeared in CF66 in 1992 because of transmission. All isolates
sampled and stored between 1992 and 2008 were found to be
DK2 strains. For the present study, we selected the 1973 isolate
and the ﬁrst (1992) and last (2008) isolates after reappearance.
The CF30-1979 isolate was the only DK2 isolate from patient
CF30. In the collection of 46 strains isolated from CF patients in
1973 (the earliest isolates available from the clinic), we identiﬁed
four isolates of the DK2 genotype by means of genotyping and
sequencing of single genes. One of the isolates (CF66-1973) had
the same mutations in mucA and rpoN as all subsequent DK2
isolates from all analyzed patients. The three other DK2-1973
isolates had alternative mucA mutations and wild-type rpoN
genes (two of the patients died in 1974 and 1975, respectively)
and the DK2 clones went extinct, and the third patient died in
1991, after which the speciﬁc DK2 clone in this patient went
extinct. There are no indications suggesting that any of these
three DK2 clones were transmitted to other CF patients in the
clinic. Thus, CF66-1973 appears to be the clinical ancestor of all
subsequent DK2 isolates from more than 40 CF patients.
Genome Sequencing. Genomic DNA was prepared from P. aeru-
ginosa isolates using a Wizard Genomic DNA Puriﬁcation Kit
(Promega). Genome sequences of CF333-2007 and CF333-1991
assembled from 454 pyrosequencing-generated data were aligned
using MUMmer3 (2), resulting in the detection of 40 SNPs in the
alignment covering 6,336,193 bp of the genomes. Genomes were
sequenced with an approximate genomic coverage of 20-fold, and
reads were assembled into contigs using Newbler version 1.1.03.24
(Roche). Genome sequences of CF333-1991 and CF333-2007
were assembled into 164 and 87 contigs, respectively, and com-
prised 6,340,400 and 6,350,334 base pairs, respectively. Twenty-
eight of the SNPs were further conﬁrmed by targeted PCR am-
pliﬁcation of the region surrounding the SNP (∼300–500 bp) and
subsequently resequenced at GATC Biotech. Isolates CF114-
1973, CF43-1973, CF66-1973, CF66-1992, CF66-2008, CF30-1979,
CF173-1984, CF173-2005, CF333-1997, CF333-2003, and CF333-
2007 were sequenced on an Illumina GAII generating 75-bp
single-end reads using a multiplexed protocol to an average cov-
erage of 47-fold (Table S2). The reads from each isolate were
mapped against the reference genome of CF333-2007 using
Bowtie release 0.12.3 (3). Alignments were converted to Sequence
Alignment/Map (SAM) format, and SNP variants were called
using SAMtools release 0.1.7 (4). The consensus sequence was
called according to the MAQ consensus model (5).
SNP Detection and Custom Filtering. The resulting raw SNP calls
were ﬁltered by the varFilter algorithm in SAMtools in which
minimum SNP coverage was set to 3 followed by a custom ﬁlter.
The ﬁltered SNPs were further examined to have quality
parameters equal to a subset of 28 SNPs that were conﬁrmed by
targeted PCR and resequencing.
Settings used in Bowtie and SAMtools for mapping and variant
detection were as follows: bowtie -S <ref.fa> <reads.fastq> <out.
sam>; samtools pileup -cv -f <ref.fa> <aln.bam>; samtools.pl
varFilter -d 3 -D 10000. The resulting lists of detected SNPs were
ﬁltered in accordance with the following criteria: (i) The mini-
mum Phred-scaled probability that the SNP call is identical to the
reference was 30 (i.e., P ≤ 0.001); (ii) ambiguous SNP (i.e., M, R,
W, S, Y, and K) calls were removed; and (iii) SNPs must be called
by no less than 50% of the covering reads. Subsequently, the
called SNPs were subject to a manual ﬁltering in which 70 SNPs
were removed. These included 48 SNPs that were removed due to
conﬂict of repetitive regions, 6 SNPs that emerged as a conse-
quence of ungapped alignments near microindels, and 16 SNPs
that displayed abnormal low-quality parameters in comparison
with the subset of conﬁrmed SNPs.
Estimation of the Fraction of SNPs in the Protein-Coding Part of the
Genome That Results in Synonymous Substitutions. We employed
the codon use in P. aeruginosa reference strain PAO1 (6) to cal-
culate the probability that a random mutation would be synony-
mous assuming that the rates of different base changes are the
same (7). We found the total number of possible SNP mutations
within genes to be 16,779,042 (5,593,014 bp of coding sequences
multiplied by 3 possible mutations in each position), of which
25% (4,237,247) would cause a synonymous change.
Estimation of in Situ Bacterial Generations. The estimation of in situ
generations of the DK2 lineage from 1973 to 2008 is based on our
previous determination of in vivo growth rates of P. aeruginosa
populations in sputum material sampled from different CF pa-
tients (8). Using quantitative ﬂuorescent in situ hybridization to
measure cellular levels of rRNA, we have shown that in ﬁve
sputum samples obtained in 2005, the majority (∼90%) of the
P. aeruginosa lung population is actively growing with an average
in vivo doubling time ranging from 115 to 141 min (8). One of
the samples analyzed in our previous study was obtained from
CF333 (previously designated “p7”) in 2005 which harbored no
P. aeruginosa strains other than DK2. The DK2 population in
this sample had an average doubling time of 115 min in vivo,
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which is about 1.5-fold longer than the measured in vitro dou-
bling time during growth in LB.
We observed that earlier isolates have shorter in vitro gener-
ation times than later isolates (Table S1). The development of
this slow-growth phenotype is most likely a consequence of the
stressful CF environment in which the bacterial cells experience
continuous exposure to antibiotics and contacts with the immune
system. For example, growth rate-reducing effects have been
observed for chromosomal mutations that confer antibiotic re-
sistance (9–11). Because of these differences in in vitro doubling
times, we therefore estimate the in vivo doubling times in dif-
ferent time periods as 1.5-fold the measured in vitro doubling
times of the corresponding isolates during growth in LB. This
extrapolation is based on the observation that growth rates of
several isolates from 2005 including two DK2 strains consistently
are 2- to 3-fold reduced compared with PAO1 or CF isolates
from newly infected patients in LB as well as in various minimal
media and sputum medium (8). To calculate the number of
bacterial generations elapsed over the time period from 1973 to
2008, three intervals were deﬁned: 1973 (CF66) to 1979 (CF30),
1979 (CF30) to 1997 (CF333), and 1997 to 2007 (CF333). The
median doubling times of the isolates during in vitro growth in
LB of each of the three intervals are 50, 56, and 74 min, re-
spectively, from which the in vivo doubling times were estimated
to be 74, 83, and 109 min, respectively. The number of gen-
erations for each isolate was calculated as the sum of generations
from 1973 to the isolation year (Table S1). The total number of
bacterial generations was estimated to calculate the mutation
rate. The extrapolation from in vitro to in vivo doubling times is
most likely a simpliﬁcation. However, if we only apply the ex-
perimentally observed in vivo doubling time of 115 min measured
in 2005 in a sample from CF333 and disregard the possibility that
earlier isolates have faster in vivo growth rates, the total number
of generations from 1973 to 2008 is estimated to be 159,965. The
calculated mutation rate based on this number of bacterial gen-
erations is 9.4 × 10−11 SNPs/bp per generation, which is in the
same range of the number calculated from 200,000 generations
(7.2 × 10−11 SNPs/bp per generation).
Affymetrix GeneChip. For transcriptome analysis, all P. aeruginosa
strains were grown aerobically at 37 °C in LB medium starting
from OD600 = 0.01 and harvested at OD600 = 0.5. Harvested
cells were mixed immediately with RNAprotect Bacteria Re-
agent (Qiagen) and stored at −80 °C. RNA was extracted with an
RNeasy Mini Kit (Qiagen) and transcribed to cDNA using
a SuperScript III Reverse Transcriptase (Invitrogen). The cDNA
was puriﬁed with a Qiagen PCR Puriﬁcation Kit (Qiagen) and
fragmented using DNase I (Promega). Fragmented cDNA was
then labeled using labeling reagent (Affymetrix) and terminal
deoxynucleotidyl transferase (Promega). The labeled cDNA was
hybridized on an Affymetrix P. aeruginosa PAO1 gene chip and
stained on a GeneChip Fluidics Station 450. The probe arrays
were ﬁnally scanned with a GeneChip Scanner 3000. The raw
data (.cel ﬁles) were obtained using the Affymetrix GeneChip
Operating System 1.4.
Biolog Phenotype Microarrays. P. aeruginosa strains were streaked
on LB agar plates and incubated at 37 °C until colonies appeared
on the plates (16–30 h). Cells were swabbed from the plates and
suspended in IF-0 GN Base (inoculation ﬂuid) at a density cor-
responding to 42% transmittance in the Biolog turbidimeter. The
cell suspensions were diluted 1:6 in IF-0 minimal medium con-
taining Biolog redox dye mixture D (tetrazolium), and 100-μL
aliquots were added to carbon-source plates (PM1 and PM2A).
For the nitrogen-source plate (PM3B), inoculations were sup-
plemented with 30 mM glucose and 2 μM ferric citrate. The plates
were incubated at 37 °C in an OmniLog plate reader (Biolog) for
72 h, and growth/respiration was measured kinetically by de-
termining the colorimetric reduction of tetrazolium dye. Of the
total 285 substrates available on the three PM plates, 159 were
found informative (supporting consistent growth between repli-
cates for at least one strain and not autoinducing the color
change). Export of OmniLog data was performed using OmniLog
OL_FM/Kin 1.20.02 software (Biolog). The average area beneath
each kinetic curve was used for analysis. Total catabolic function
was calculated as previously described (12). The growth capacity
on 4-hydroxyphenylacetic acid (4-HPA) was conﬁrmed in ABT
minimal medium (8) supplemented with 10mM4-HPA as the sole
carbon source. OD600 was measured after 60 h of growth at 37 °C.
Phenotypic Data Analysis. Analysis for both types of datasets was
performed using BioConductor software (13). Normalization and
probe set summary of the microarray expression data were per-
formed with RMA (14). Hierarchical clustering was generated
using the hclust function based on the Euclidean distance between
strains using all genes measured on the Affymetrix GeneChips or
all conditions measured on the Biolog phenotypic microarrays.
The principal component analysis was conducted using singular-
value decomposition with the svd function in R (15).
RpoN Complementation. Two isolates, CF333-1991 and CF333-
2007, were complemented with a pMe6031 plasmid (16) that
carried a wild-type copy of the rpoN gene through conjugation.
Transformants were selected on pseudomonas isolation agar
plates containing 60 μg/mL tetracycline.
Minimal Inhibitory Concentrations. Minimal inhibitory concentra-
tion values of ciproﬂoxacin were measured using Etest strips (AB
Biodisk) by plating 100 μL of overnight culture on LB plates. The
values were recorded after a 48-h incubation at 37 °C.
Sequencing of lasR,mucA, algU, and rpoN Genes. Sequencing of lasR,
mucA, algU, and rpoN genes was performed by PCR using high-
ﬁdelity DNA polymerase (Fermentas) and four sets of primers:
lasR forward (5′-TCTCGGACTGCCGTACAAC-3′) and lasR
reverse (5′-AATTACCGATCGCCAGCTC-3′) for lasR, mucA
fwd (5′-CTCTGCAGCCTTTGTTGCGAGAAG-3′) and mucA
rev (5′-CTGCCAAGCAAAAGCAACAGGGAGG-3′) for mu-
cA, algU fwd (5′-CCTGAGCCCGATGCAATCCATTTTCG-3′)
and algU rev (5′-GGACAGAGTTTCCTGCAGGGCTTCAC-3′)
for algU gene, and rpoN fwd (5′-CTCGCCAACGACCTGGT-
CAAG-3′) and rpoN rev (5′-GGCGTCGGTCACATCCAGTTG-
3′) for rpoN. Another set of primers was used for rpoN sequencing:
rpoN seq1 (5′-GCCTGGGAAGACATCTACCAGAC-3′) and
rpoN seq2 (5′-GAGCTGAACCAGGAGGCGATG-3′).
Impact of mucA, lasR, and rpoN Mutations on Expression Proﬁles. To
further evaluate the impact of the nonsynonymous mutations in
mucA, lasR, and rpoN on the overall transcriptome changes of the
late DK2 isolates, we compared the expression data of CF30-1979
carrying the three mutations with CF114-1973 without the three
mutations (Table S1). In total, 1,005 genes were signiﬁcantly dif-
ferent according to a Student’s t test (two-tailed, P < 0.01). We
conducted a similar analysis on a set of expression data of an in-
termittent CF isolate (MucA−) and its isogenic MucA+ pair from
a previous study which was done under the same conditions as
ours (17). There were 1,976 genes signiﬁcantly changed due to the
mucA mutation using the same statistical criteria. Between these
two datasets, 471 genes overlapped with the same trend in terms of
up- or down-regulation. In previous investigations, gene sets reg-
ulated by RpoN and LasR were also determined. Due to the lack
of raw data of these two datasets, we could only use the ﬁltered
gene lists, which involved cutoffs of certain fold changes. Thus,
these two datasets might have underestimated the gene numbers
regulated by the two genes relative to themucAmutation analysis.
There were 62 genes regulated by RpoN (18) and 36 genes gov-
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erned by LasR when cells were harvested at OD600 = 0.5 in LB
medium (19). There were 19 and 22 genes, respectively, over-
lapping with the list of signiﬁcant genes in the comparison of CF30-
1979 and CF114-1973. Seventeen out of 19 genes controlled by
RpoNwere also in the list of themucA− versusmucA+ comparison.
In total, among 1,005 signiﬁcant genes comparing CF30-1979
against CF114-1973, 495 genes (49%) can be attributed to muta-
tions in three genes,mucA, rpoN, and lasR (Fisher’s exact test, P=
1.77 × 10−10), supporting the signiﬁcance of the three regulatory
genes in P. aeruginosa in CF airways.
Detection of the Genetic Marker Δ(PA1428–PA1431) in the DK2
Lineage. The lasR gene (PA1430) was removed in the DK2 lin-
eage with a deletion of the region starting from the 342 bp of
PA4128 and ending at 30 bp upstream of the lasI gene (PA1432).
Using primers fwd (5′-AAAGGAATCCAGCATGCACATT-
CG-3′) and rev (5′-AGCCTTTCTGTCCAGAGTTGATGG-3′),
a PCR product of 732 bp was generated for strains carrying the
deletion, whereas an ∼5-kb fragment was produced for strains
without the deletion. The deletion was used as a genetic marker
to check the relation among 85 DK2 isolates from 42 patients
(covering most of the patients who carried the DK2 strains in the
Copenhagen CF Clinic, including those shown in Fig. 1). Since
its ﬁrst appearance in CF30-1979, this deletion was maintained
in all analyzed isolates from 1984 to 2008 (no DK2 isolates were
found between 1979 and 1984), which strongly suggests that all
of the DK2 strains that have been successfully spreading in the
clinic are descendants of CF30-1979.
Genetic Basis of Deﬁcient Growth on 4-HPA in CF333-2007 and CF173-
2005. Most of the genes involved in 4-HPA degradation in P.
aeruginosa are located in an operon between PA4119 and
PA4128 controlled by the transcriptional regulator encoded by
PA4120 (20). The CF333-2007 isolate has a large gap [Δ(PA4116-
87)] that deletes over 80 genes including PA4119–PA4128. Using
primers fwd1 (5′-CCCAGGGCCTGAAGGAAGTG-3′) and rev1
(5′-CTGCTGCAGGTTCAGCGAAC-3′), a 912-bp fragment was
ampliﬁed in CF333-2007 whereas no product was generated in
CF30-1979. To exclude the latter ampliﬁcation being a false neg-
ative, one gene in this region (PA4125) was ampliﬁed using primers
PA4125 fwd (5′-GGCAGATCAACGCGGTATT-3′) and PA4125
rev (5′-GTTCAGGGTGCTGGCTGT-3′). CF173-2005 carries an
∼2-kb deletion (ΔPA4120-22) that removes PA4121 and partially
PA4120 and PA4122. Using primers fwd2 (5′-GGTAGCCGG-
CAAGGTAGT-3′) and rev2 (5′-AGGGTCATGAAGCTGGA-
GAA-3′), a 579-bp DNA fragment was produced for CF173-2005
and an ∼2-kb fragment was ampliﬁed for CF30-1979.
algU Genotypes of 1973 Bacterial Isolates. We note that the CF66-
1973 isolate carries two mutations in the algU gene (Table S1).
The A55G mutation, which is also present in later isolates, has
previously (21) been shown not to neutralize the effects of the
particular mucA ΔG430 mutation present in this and later iso-
lates. In contrast, the other mutation, which is a 4-bp frameshift
insertion, will counteract the effects of the mucA mutation. This
particular algU mutation is not present in later isolates from this
lineage, and most likely has been introduced during growth or
the storage period in agar slants. Similar algU mutations are
present in the other DK2 isolates from 1973, and because none
of these carry the rpoN mutation found in the CF66 isolate, we
have used the CF114 isolate as a reference with the highest re-
semblance to P. aeruginosa wild-type strain proﬁles.
1. Jelsbak L, et al. (2007) Molecular epidemiology and dynamics of Pseudomonas
aeruginosa populations in lungs of cystic ﬁbrosis patients. Infect Immun 75:2214–2224.
2. Kurtz S, et al. (2004) Versatile and open software for comparing large genomes.
Genome Biol 5:R12.
3. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efﬁcient
alignment of short DNA sequences to the human genome. Genome Biol 10:R25.
4. Li H, et al.; 1000 Genome Project Data Processing Subgroup (2009) The Sequence
Alignment/Map format and SAMtools. Bioinformatics 25:2078–2079.
5. Li H, Ruan J, Durbin R (2008) Mapping short DNA sequencing reads and calling
variants using mapping quality scores. Genome Res 18:1851–1858.
6. Grocock RJ, Sharp PM (2002) Synonymous codon usage in Pseudomonas aeruginosa
PA01. Gene 289:131–139.
7. Yang Z, Bielawski JP (2000) Statistical methods for detecting molecular adaptation.
Trends Ecol Evol 15:496–503.
8. Yang L, et al. (2008) In situ growth rates and bioﬁlm development of Pseudomonas
aeruginosa populations in chronic lung infections. J Bacteriol 190:2767–2776.
9. Andersson DI, Levin BR (1999) The biological cost of antibiotic resistance. Curr Opin
Microbiol 2:489–493.
10. Björkman J, Hughes D, Andersson DI (1998) Virulence of antibiotic-resistant
Salmonella typhimurium. Proc Natl Acad Sci USA 95:3949–3953.
11. Björkman J, Nagaev I, Berg OG, Hughes D, Andersson DI (2000) Effects of
environment on compensatory mutations to ameliorate costs of antibiotic resistance.
Science 287:1479–1482.
12. Cooper VS, Lenski RE (2000) The population genetics of ecological specialization in
evolving Escherichia coli populations. Nature 407:736–739.
13. Gentleman RC, et al. (2004) Bioconductor: open software development for
computational biology and bioinformatics. Genome Biol 5:R80.
14. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization
methods for high density oligonucleotide array data based on variance and bias.
Bioinformatics 19:185–193.
15. R Development Core Team (2007) R: A language and environment for statistical
computing pages. The R Project for Statistical Computing. Available at http://www.R-
project.org.
16. Heeb S, et al. (2000) Small, stable shuttle vectors based on the minimal pVS1 replicon
for use in Gram-negative, plant-associated bacteria. Mol Plant Microbe Interact 13:
232–237.
17. Rau MH, et al. (2010) Early adaptive developments of Pseudomonas aeruginosa after
the transition from life in the environment to persistent colonization in the airways of
human cystic ﬁbrosis hosts. Environ Microbiol 12:1643–1658.
18. Dasgupta N, et al. (2003) A four-tiered transcriptional regulatory circuit controls
ﬂagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 50:809–824.
19. Schuster M, Lostroh CP, Ogi T, Greenberg EP (2003) Identiﬁcation, timing, and signal
speciﬁcity of Pseudomonas aeruginosa quorum-controlled genes: A transcriptome
analysis. J Bacteriol 185:2066–2079.
20. Zeng L, Jin S (2003) aph(3′)-IIb, a gene encoding an aminoglycoside-modifying
enzyme, is under the positive control of surrogate regulator HpaA. Antimicrob
Agents Chemother 47:3867–3876.
21. Ciofu O, et al.; Scandinavian Cystic Fibrosis Study Consortium (2008) Investigation of
the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa
isolates from 115 Scandinavian patients with cystic ﬁbrosis and in 88 in vitro non-
mucoid revertants. Microbiology 154:103–113.
Yang et al. www.pnas.org/cgi/content/short/1018249108 3 of 5
B0e
+0
0
1e
+0
5
2e
+0
5
3e
+0
5
4e
+0
5
5e
+0
5
6e
+0
5
D
is
ta
nc
e
CF
33
3_
19
97
CF
33
3_
20
03
CF
30
_1
97
9
CF
17
3_
19
84
CF
17
3_
20
05
CF
33
3_
20
07
CF
66
_2
00
8
CF
33
3_
19
91
CF
66
_1
99
2
PA
O1
CF
11
4_
19
73
CF
66
_1
97
3
CF
43
_1
97
3
A
0
50
10
0
15
0
D
is
ta
nc
e
CF
17
3_
20
05
CF
66
_2
00
8
CF
17
3_
19
84
CF
30
_1
97
9
CF
66
_1
99
2
CF
33
3_
19
91
CF
33
3_
19
97
CF
33
3_
20
03
CF
33
3_
20
07
CF
66
_1
97
3
CF
43
_1
97
3
CF
11
4_
19
73
PA
O1
Fig. S1. Phenotypic relationships and dynamics among DK2 isolates. Dendrograms show the relationships among isolates based on microarray expression data
(A) and Biolog phenotypic data (B). In both cases, the hierarchal clusters contain two major branches: one branch in which all isolates were sampled in/after
1979 (black bars), and another that groups the 1973 isolates together with reference strain PAO1 (gray bars). For each gene, average values of biological
triplicates (A) or duplicates (B) were used for clustering. The hierarchical clustering dendrograms were constructed using the Euclidean distance.
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Fig. S2. Changes in catabolic functions of DK2 isolates relative to PAO1 as measured by Biolog phenotype microarrays. Total catabolic function is a weighted
average across the 159 informative substrates for each strain; 1.0 is the reference level (PAO1), and lower values indicate decay. Values are shown on a log-
transformed scale. DK2 isolates that were sampled after 1979 have a very low capacity of using various substrates compared with those from 1973; all changes
were loss of function and no gains of function were observed. Complementation of CF333-1991 and CF333-2007 with a wild-type copy of rpoN largely restored
the catabolic capacity.
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Table S1. Selected phenotypes and gene sequences
Table S1 (DOC)
aCF strains are labeled with both a patient identiﬁer and the year of isolation.
bIn vitro doubling time was determined in LB liquid cultures. Numbers are average values of triplicates for each isolate (SD < 10%).
c3-O-C12-homoserine lactone signal production controlled by lasR as well as motility phenotypes were measured as previously described (1).
dThe effect of the mucA C382T mutations was neutralized by the algU C448G mutation because there was no induction of algU in the expression data of
CF114-1973.
eThe G647A mutation does not cause functional deﬁciency of LasR in CF66-1973 because the 3-O-C12-homoserine lactone production is positive.
Table S2. Illumina sequencing and mapping statistics
Table S2 (DOC)
aReference genome CF333-2007 comprises 6,350,334 bp.
1. Lee B, et al. (2005) Heterogeneity of bioﬁlms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic ﬁbrosis. J Clin Microbiol 43:5247–5255.
Table S4. Number of observed synonymous and nonsynonymous SNPs in protein-coding regions of the genome
Table S4 (DOC)
The expected number of nonsynonymous SNPs is calculated under the assumption of neutral selection, and the probability of seeing the observed number
of nonsynonymous SNPs given the expected number of SNPs is calculated from the Poisson distribution. The ratio of the rate of nonsynonymous substitutions
(dN) to the rate of synonymous substitutions (dS) was calculated as a measure of the selection pressure acting on the protein-coding genome. The ratio dN/dS is
expected to exceed unity only if natural selection promotes changes in the protein sequence, whereas a ratio less than unity is expected only if natural
selection suppresses protein changes.
Table S3. SNPs in the DK2 lineage
Table S3 (DOC)
Table S5. Nonsynonymous regulatory mutations that were ﬁxed in the DK2 lineage
Table S5 (DOC)
Nonsynonymous regulatory mutations that were ﬁxed in the DK2 lineage in CF333 until 2003 were calculated based on the list B, D, F, I, K, O, Q, and S of Fig.
2A and Table S3. In total, 16 nonsynonymous mutations occurred in regulators, and 11 of these arose before 1979. The annotation is based on Pseudomonas
Genome database V2 (http://www.pseudomonas.com).
aGenes with deletions.
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Mutations in 23S rRNA Confer Resistance against Azithromycin in
Pseudomonas aeruginosa
Rasmus Lykke Marvig,a Mette S. R. Søndergaard,a Søren Damkiær,a Niels Høiby,b Helle Krogh Johansen,b Søren Molin,a and
Lars Jelsbaka
Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark,a and Department of Clinical Microbiology, Rigshospitalet and ISIM, University of
Copenhagen, Copenhagen, Denmarkb
The emergence of antibiotic-resistant Pseudomonas aeruginosa is an important concern in the treatment of long-term airway
infections in cystic fibrosis patients. In this study, we report the occurrence of azithromycin resistance among clinical P. aerugi-
nosaDK2 isolates. We demonstrate that resistance is associated with specific mutations (A2058G, A2059G, and C2611T in Esche-
richia coli numbering) in domain V of 23S rRNA and that introduction of A2058G and C2611T into strain PAO1 results in azi-
thromycin resistance.
Systematic long-term, low-dose azithromycin treatment hasbeen used for cystic fibrosis (CF) patients chronically infected
with Pseudomonas aeruginosa in the Copenhagen CF center in
Denmark since 2001 (3). Even though the use of azithromycin on
CF lung infections has been found to have beneficial clinical ef-
fects (1, 3), it remains unclear how azithromycin works on P.
aeruginosa and if macrolide resistance can emerge.
Using whole-genome sequencing, we have recently described
the dissemination of the DK2 lineage of P. aeruginosa among a
cohort of CF patients in Copenhagen, Denmark (15). The DK2
lineage has persisted for decades in the CF lung environment and
has evolved as independent sublineages in concurrently infected
patients. This makes it possible to search for convergent muta-
tional events that occurred independently in isolates from differ-
ent patients. Isolates CF333-2007 and CF66-2008 sampled from
two different patients were found to have independently accumu-
lated the same 23S rRNA A2045G mutation, while their most re-
cent common ancestors did not (15). Mutations in the proximity
of A2045 (position 2058 in Escherichia coli numbering) in the sec-
ondary structure of domain V of 23S rRNA have previously been
shown to confer resistance toward macrolide antibiotics in other
bacterial species (13). This led us to investigate if the observed
mutations could be associated with azithromycin resistance and if
such putative resistance mutations were found in strains of the
DK2 lineage type present in other CF patients from the Copenha-
gen CF clinic.
We sequenced and analyzed the 23S rRNA genes of nine clin-
ical P. aeruginosa isolates sampled from nine CF patients attend-
ing the Copenhagen CF center at the University Hospital (Table
1). Sequence data for three of the nine isolates were available from
our previous study (15) (Table 1). Bacterial isolation from sputum
and whole-genome sequencing were done as described previously
(6, 15). Sequence reads were mapped against the 23S rRNA alleles
of the P. aeruginosa DK2 reference genome (CF333-2007; Gen-
Bank accession no. CP003149), and single nucleotide polymor-
phisms in the 23S rRNA gene were called by SAMtools release
0.1.7 (10). The number of reads that supported a detected poly-
morphism relative to the total number of reads covering the poly-
morphic site was used to estimate the fraction of 23S rRNA genes
in an individual clone which contained the polymorphism. Ac-
cordingly, polymorphisms present in one, two, three, or four of
the four copies of 23S rRNA would be supported by approxi-
mately 25%, 50%, 75%, and 100% of the reads, respectively.
Three of the strains (CF206-2002, CF223-2002, and CF311-
2002) had mutations in close proximity to the A2045 position in
the secondary structure of domain V of 23S rRNA (13) at which
isolates CF333-2007 and CF66-2008 were found to be mutated
(Table 1). These mutations were A2046G (position 2059 in E. coli
numbering) and C2598T (position 2611 in E. coli numbering),
and bothmutations have been reported to confer macrolide resis-
tance in other bacterial species (13). The three remaining strains
(CF180-2002, CF240-2002, and CF173-2005) did not contain any
polymorphisms relative to the ancestral strain CF30-1979 in do-
main V of 23S rRNA.
We tested the resistance of the isolates toward azithromycin as
described by Köhler et al. (9). Stationary-phase cultures of P.
aeruginosawere incubated with and without 50g/ml azithromy-
cin (16 to 62g/ml have been measured in CF sputum [14]) for 2
h, and after incubation, CFU were determined by plating onto LB
agar plates with and without 20g/ml azithromycin, respectively.
Inhibition of cell growth by azithromycin was calculated as the
number of CFU from cultures grown with azithromycin relative
to cultures grown without azithromycin.
As shown inTable 1, onlyminor ormoderate effects of azithro-
mycin treatment were observed for strains CF333-2007, CF66-
2008, CF206-2002, CF223-2002, and CF311-2002 harboring mu-
tations in domain V of 23S rRNA (15%, 4%, 25%, 12%, and 15%
reduction in CFU, respectively). In contrast, strain CF30-1979,
which closely resembles the ancestor of all DK2 clones isolated
after 1979 (15) and harbors only wild-type 23S rRNA alleles, was
found to bemore inhibited by azithromycin (one-tailed Student’s
t test; P 0.05) and exhibited a 64% reduction in CFU (Table 1).
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The three strains (CF180-2002, CF240-2002, and CF173-2005)
that did not contain any polymorphisms in domain V of 23S
rRNA were all inhibited by azithromycin (one-tailed Student’s t
test; P  0.05) (Table 1). Interestingly, the results also indicated
that CF30-1979, CF180-2002, andCF240-2002 are less susceptible
than PAO1. It is possible that this difference is due to other anti-
biotic-related mutations, e.g., in drug efflux pumps or ribosomal
proteins L4 and L22 (8, 11, 12), present in the clinical strains.
To more directly assess the effects of the A2045G and
C2598T mutations, we separately cloned both mutated and
wild-type rRNA operons into the low-copy-number plasmid
vector pME6031 (5 to 7 copies per cell) (4). The entire rRNA
operon flanked by the genes PA4690 and PA4691 was PCR
amplified fromCF30-1979, CF333-2007, and CF223-2002 tem-
plate DNA and ligated into plasmid pME6031, resulting in the
complementation vectors pMES-23S, pMES-23S(A2045G),
and pMES-23S(C2598T), respectively, which were introduced
into the common laboratory strain P. aeruginosa PAO1 (Table 2).
Strain PAO1-pMES-23S was susceptible to azithromycin like
its parent strain PAO1, whereas no inhibitory effect of azithromy-
cin was observed for either PAO1-pMES-23S(A2045G) or PAO1-
pMES-23S(C2598T) containing mutated 23S rRNA alleles, and
both strains were significantly more resistant than PAO1-pMES-
23S (one-tailed Student’s t test; P  0.001) (Table 1). This result
confirmed the hypothesis that the A2045G andC2598Tmutations
confer resistance to azithromycin in P. aeruginosa.
We note that the resistance phenotype is observed both in strains
PAO1-pMES-23S(A2045G) and PAO1-pMES-23S(C2598T) despite
their capacity to express chromosomally encoded wild-type 23S
rRNA and plasmid-encoded mutated 23S rRNA and in isolates
CF206-2002, CF223-2002, and CF311-2002 in which none of the
polymorphisms were fixed in all four copies of the 23S rRNA gene
(Table 1). This indicates that not all four 23S rRNA alleles have to
contain the mutations in order to confer the resistance phenotype
(12).
With the exception of CF180, none of the other patients in-
fected with susceptible isolates (CF30, CF240, and CF173) had
been subjected to systematic long-term, low-dose treatment with
azithromycin against P. aeruginosa at the time of sampling (Table
1). Moreover, resistant isolates CF333-2007, CF66-2008, and
CF223-2002 were sampled from their respective host patients af-
ter initiation of systematic treatment with azithromycin. In con-
TABLE 1 Resistance against azithromycin of clinical and laboratory strains used in this study
Strain Mutations in 23S rRNAb
Fraction of reads
supporting the
mutations (%)
Start of systematic
treatment with
azithromycin (yr)
Resistance against
azithromycin (%)c
Clinical isolatesa
CF30-1979d None 2001 36 (39)
CF333-2007d A2045G (A2058G) 100 2006 85 (14)
CF66-2008d C1433T, A2045G (C1446T, A2058G) 21, 100 2001 96 (39)
CF206-2002 C2598T (C2611T) 53 2006 75 (32)
CF223-2002 C2598T (C2611T) 73 2001 88 (35)
CF311-2002 A93G, A2046G (A106G, A2059G) 26, 70 2004 85 (23)
CF180-2002 C1433T (C1446T) 25 2001 14 (27)
CF240-2002 None 2006 35 (32)
CF173-2005 None 2006 0
Laboratory strains
PAO1 None N/Af N/A 0
PAO1-pMES-23S None N/A N/A 1 (1)
PAO1-pMES-23S(A2045G) A2045Ge N/A N/A 96 (22)
PAO1-pMES-23S(C2598T) C2598Te N/A N/A 92 (14)
a Names of clinical isolates are given according to their patient origin and sampling year (i.e., isolate CF30-1979 was sampled from patient CF30 in 1979). All clinical isolates belong
to the P. aeruginosa DK2 clone type.
b The corresponding E. coli 23S rRNA position is given in parentheses.
c Inhibition of cell growth by azithromycin was calculated as the number of CFU from cultures grown with azithromycin relative to cultures grown without azithromycin. The assay
was replicated at least three times for each strain, and 95% confidence intervals are given in parentheses. No CFU appeared in cultures grown with azithromycin for strains PAO1
and CF173-2005.
d Whole-genome sequence of the isolate has been described previously (15).
e The strain carries a mutated 23S rRNA allele on the low-copy-number plasmid vector pME6031.
f N/A, not applicable.
TABLE 2 List of plasmids and strains used for cloning purposes
Strain or plasmid Relevant characteristics Reference
E. coli CC118 (ara-leu) araD lacX74 galE galK phoA20 thi-1 rpsE rpoB argE(Am) recAl 5
P. aeruginosa PAO1 7
pME6031 PVS1-p15A shuttle vector; Tcr 4
pMES-23S A 5.95-kb SacI-PstI fragment containing the rRNA operon from CF30-1979 inserted into pME6031 This study
pMES-23S(A2045G) A 5.95-kb SacI-PstI fragment containing the rRNA operon from CF333-2007 inserted into pME6031 This study
pMES-23S(C2598T) A 5.95-kb SacI-PstI fragment containing the rRNA operon from CF223-2002 inserted into pME6031 This study
Marvig et al.
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trast, the resistant isolates CF206-2002 andCF311-2002, both car-
rying mutations in domain V of 23S rRNA, were sampled from
patients who had not been subjected to systematic treatment with
azithromycin. It is possible that the presence of these resistant P.
aeruginosa isolates is either the outcome of earlier treatments with
macrolide antibiotics directed against infections caused by other
CF pathogens (e.g., Staphylococcus aureus) in these patients or the
result of transmission from patients treated with azithromycin.
In this study, we report the occurrence of azithromycin resis-
tance among clinical P. aeruginosa isolates of the DK2 lineage.
Sequencing of 23S rRNA genes revealed the resistance to be asso-
ciated with mutations at specific loci (A2045, A2046, and C2598),
and the effect of two of themutations (A2045G andC2598T) were
validated by trans complementation into the laboratory strain
PAO1. Even though the use of azithromycin on P. aeruginosa CF
lung infections has been found to have beneficial effects (1, 3), the
exact mechanism by which azithromycin exerts this effect is not
well understood. In vitro, the effect has been shown to be depen-
dent on interaction with the ribosomes (2, 9), and our results
suggest that the mode of action of azithromycin in vivo also in-
volves binding to the 50S ribosomal subunit and that the action is
blocked by mutations in 23S rRNA.
Further studies are required to investigate the diversity of re-
sistance mutations, how different antibiotic treatment regimens
influence the resistance development, and how the effect of azi-
thromycin is dependent on the growth physiology of P. aerugi-
nosa.
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Summary
Adaptation of bacterial pathogens to a permanently
host-associated lifestyle by means of deletion or
acquisition of genetic material is usually examined
through comparison of present-day isolates to a
distant theoretical ancestor. This limits the resolution
of the adaptation process. We conducted a retrospec-
tive study of the dissemination of the P. aeruginosa
DK2 clone type among patients suffering from cystic
fibrosis, sequencing the genomes of 45 isolates col-
lected from 16 individuals over 35 years. Analysis of
the genomes provides a high-resolution examination
of the dynamics and mechanisms of the change in
genetic content during the early stage of host adap-
tation by this P. aeruginosa strain as it adapts to the
cystic fibrosis (CF) lung of several patients. Consid-
erable genome reduction is detected predominantly
through the deletion of large genomic regions, and up
to 8% of the genome is deleted in one isolate. Com-
pared with in vitro estimates the resulting average
deletion rates are 12- to 36-fold higher. Deletions
occur through both illegitimate and homologous
recombination, but they are not IS element mediated
as previously reported for early stage host adapta-
tion. Uptake of novel DNA sequences during infection
is limited as only one prophage region was putatively
inserted in one isolate, demonstrating that early host
adaptation is characterized by the reduction of
genomic repertoire rather than acquisition of novel
functions. Finally, we also describe the complete
genome of this highly adapted pathogenic strain of
P. aeruginosa to strengthen the genetic basis, which
serves to help our understanding of microbial evolu-
tion in a natural environment.
Introduction
Entry of a bacterium into a new environment provides an
opportunity for expanding the possible niches it can
inhabit. The inherent fitness of the bacterium towards the
new environment as well as improvement of fitness by
genetic adaptation will decide if entry is also followed by
successful persistence. Modification of the genetic
makeup of the organism may be the result of multiple
mechanisms. For example, already present DNA can be
changed by single nucleotide polymorphisms, small inser-
tions and deletions and genome rearrangements. Also,
larger genetic elements can be entirely lost or novel DNA
may be gained by the processes of transformation, con-
jugation and transduction.
Depending on the environment certain mechanisms
might be more prevalent than others. Acquisition of novel
DNA can, e.g. be important for antibiotic resistance adap-
tation and acquisition of virulence enhancing elements for
host infection (Hacker and Kaper, 2000; Campos-García,
2010). On the other hand adaptation towards permanent
association with a host may be characterized by reductive
evolution through extensive gene loss affecting functions
that are no longer essential (Shigenobu et al., 2000).
Studies of genome reduction are normally carried out
either on present isolates compared with a theoretical
ancestor or using in vitro evolutionary experiments. The
former method is limited by a low resolution of the suc-
cession of events as the most recent common ancestor
(MRCA) is usually millions of years older than the present
day species that are investigated. In vitro evolution experi-
ments allow for high resolution of the genomic change but
the necessary time-scales are difficult to obtain and
extrapolating directly from in vitro to in vivo should be
done with caution.
Based on these two types of studies late stage reduc-
tive evolution is known to occur by pseudogene formation
Received 15 April, 2012; revised 4 May, 2012; accepted 5 May, 2012.
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and subsequent gradual loss of small genomic regions,
whereas the process of reduction in the early stages is
less clear with reports emphasizing either gene-by-gene
non-functionalization (Silva et al., 2001; Dagan et al.,
2006) or the loss of large contiguous regions (Moran and
Mira, 2001; Nilsson et al., 2005).
For the lack of useful model organisms for in vivo moni-
toring of adaptation to a distinctly different environment,
Pseudomonas aeruginosa infection of cystic fibrosis (CF)
patients provides a useful alternative as well as an oppor-
tunity for studying the initial stages of host adaptation and
the associated mechanisms of evolution. Pseudomonas
aeruginosa is a highly versatile bacterium present in water
and soil habitats but also capable of acute infection in a
range of hosts from amoeba and plants to humans
(Rahme et al., 2000; Pukatzki et al., 2002). Its vast array
of functionalities also enables colonization of the lungs of
CF patients, a colonization that is rapidly followed by
genetic adaptation to be able to successfully persist in the
new CF lung environment (Smith et al., 2006; Rau et al.,
2010).
A specific clone of P. aeruginosa, DK2, with a history of
infecting a large number of CF patients over at least 35
years was recently described by Yang and colleagues
(2011a), providing an opportunity for studying the early
stages of adaptation to a host environment. The initial
study correlated the phenotypic change with a SNP-
based phylogeny based on genome sequences of 12
P. aeruginosa DK2 isolates collected from six individuals
over 35 years. Here, we describe the complete genome of
this highly adapted pathogenic strain of P. aeruginosa. In
addition, by sequencing the genomes of additional 33
DK2 clones sampled from 16 CF patients we have inves-
tigated the dynamics in the overall genomic content of the
DK2 lineage, and focused on the role of genome reduc-
tion, acquisition of new DNA, and movement of mobile
genetic elements in long-term adaptation to the new envi-
ronment offered by its human hosts.
Results
Isolates of the DK2 clone type have been extensively
collected at the Copenhagen CF centre at Rigshospitalet,
Denmark, over a long time period ranging from 1973 and
onwards. By sequencing the genomes of 45 DK2 isolates
sampled from 16 individuals over a period of 35 years we
have conducted a retrospective study of the dissemina-
tion of the P. aeruginosa DK2 clone type among CF
patients attending the Copenhagen CF centre (Fig. 1). A
previous study of DK2 strains by Yang and colleagues
(2011a) dealt with the evolutionary relationship of isolates
from six patients as determined by genome-wide SNP
analysis based on a draft genome scaffold. To enable a
more detailed investigation of the genetic content of this
highly successful invader of the airways of CF patients,
we completed and annotated the genomic features of
clone CF333-2007, which has been sampled in 2007 from
patient CF333 chronically infected with the DK2 strain for
more than 16 years.
P. aeruginosa DK2 genome features
The entire genome sequence of P. aeruginosa DK2 clone
CF333-2007a was completed using both Illumina and 454
reads in a hybrid de novo assembly strategy in which
contigs were oriented based on the gene synteny in other
P. aeruginosa strains. The CF333-2007a genome of
P. aeruginosa DK2 (which we label PADK2) has a size of
6 402 658 bp comprising 5884 genes, which corresponds
Fig. 1. Overview the patient origin and
sampling time of the P. aeruginosa DK2
isolates used in this study. Bacterial isolates
are represented by grey circles and their
location in the phylogenetic tree in Fig. 3 is
indicated by capital letters. If multiple isolates
are sampled the same year from a patient,
they are represented by stacked circles.
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to a coding density of 89.3% (Fig. 2). These numbers are
similar to those of other assembled P. aeruginosa
genomes as is the GC content of 66.3%. A large fraction
of the genome is homologues to the other completed
P. aeruginosa genomes of strains PAO1, LESB58, PA14
and PA7 (92.5%, 93.4%, 93.2% and 86.6% respectively)
(Winsor et al., 2011), whereas 216 kbp containing 195
genes were found to be unique to the DK2 strain relative
to the other four strains.
The majority of this unique DNA (55%) was contained in
three genomic islands related to heavy metal resistance
(GI4, GI7 and GI12 respectively), indicating a former
habitat of environmental origin with the presence of heavy
metals. In total, there are 12 genomic islands (GIs) in the
PADK2 genome constituting roughly 489 kbp (Table 1).
The genome also contains two relatively small prophage
regions, approximately 8 and 16 kbp each as well as eight
different insertion sequence (IS) element types belonging
Fig. 2. Genome map of P. aeruginosa DK2. First and second outer circles denote CDS (blue) and rDNA (red); The third circle shows the
location of genomic islands; the subsequent three rings display blast comparisons of the DK2 genome to P. aeruginosa PAO1 (red), PA14
(green), LESB (blue); the next ring depicts the GC content of the PADK2 genome.
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to five different IS families. One IS element, IS222, is
previously characterized while the other seven (ISPa36 to
ISPa42) are new and added to the IS Finder Database
(Siguier et al., 2006). Three IS elements belong to the
TN3 family and all carry passenger genes (3, 6 and 14),
while the other IS elements carry no passenger genes.
Two CRISPR loci are present in the genome. One con-
sists of two CRISPR regions flanking CRISPR-associated
(cas) genes, while the other locus is devoid of cas genes.
Apart from the spacers within the CRISPR regions, the
former locus is identical to a CRISPR-cas system in
P. aeruginosa strain PA14, where it has a different func-
tionality than typical systems as it does not confer phage
resistance but rather is mediating phage regulation of
biofilm formation (Zegans et al., 2009; Cady et al., 2011).
Reductive evolution is prevalent in the DK2 lineage
Bacterial long-term adaptation to a host environment
often includes reductive evolution in which non-essential
functions are lost over time. We located all contiguous
genome reductions of  1 kbp among 44 DK2 isolates
sampled from chronically infected CF patients, and in a
maximum-parsimonious phylogenetic manner we recon-
structed the sequence of reductive events that was most
likely to explain the observed genome reductions (Fig. 3).
Table 1. Genomic islands present in the P. aeruginosa DK2 genome.
GI Start End Size Functiona
GI1 667531 680249 12719 Prophage
GI2 1836969 1862655 25687 Serotype O3 O-antigen biosynthesis
GI3 2296150 2341644 45494
GI4 2495033 2601031 105998 Copper resistance
GI5 2794504 2804831 10328 CRISPR region
GI6 2828700 2863808 35108 Pyoverdin biosynthesis
GI7 3056897 3144981 88084 Prophage, chromate/copper/silver resistance
GI8 3275228 3286591 11363
GI9 3708420 3723852 15432 Type III secretion
GI10 4214902 4228275 13373 Non-ribosomoal peptide synthetase modules
GI11 5097794 5188335 90541 Type IVb pilus (PAGI-5-like GI)
GI12 6054401 6091531 37131 Arsenic resistance, nucleoside metabolism
a. The annotated function of a subset of genes within the GI.
Fig. 3. Maximum-parsimonious phylogenetic tree reconstructing the sequence of large deletion events within the DK2 lineage. The tree is
based on the genome sequences of 45 DK2 isolates which according to their genetic content locates in the nodes of the tree designated by
capital letters. Refer to Table 3 or Fig. 1 to see the location of each isolate. The size of each node represents the total size (kbp) of genomic
regions that have been deleted since the previous node. If more than one deletion has occurred, the circle is divided, and each subdivision
corresponds to the size of each deletion (c.f. Table 2). The total quantity of deleted regions in an isolate represented by node J can for
instance be found by summing all the deletion events along the path from the root to node J (52 + 1.8 + 80 = 133.8 kbp). The root represents
the most recent common ancestor (MRCA) of all isolates.
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In total, 27 reductive events occurred during infection and
since one specific deletion was observed thrice the 27
events comprised 25 different deletions (Table 2 and
Table S1). The high consistency in the phylogeny (25/
27 = 0.93) allows for an accurate depiction of the evolu-
tionary relationship among the clones and predicted the
clones to share a common ancestor located at the node
between the branch point of the four earliest isolates
sampled in 1973 (CF114-1973, CF105-1973, CF43-1973
and CF66-1973). The ancestor had a predicted approxi-
mate genome size of 6 535 548 bp. In total, 968 kbp
(15%) of the genome were found to be deleted in at least
one of the descendant DK2 clones sampled from chroni-
cally infected CF patients. Consequently, 968 kbp (~ 968
genes) of the ancestral P. aeruginosa DK2 genome is
non-essential for survival in the human hosts.
The extent of reductive evolution varies significantly
between isolates, but every isolate displays a reduced
genomic content compared with the predicted ancestor.
The level of genomic reduction is most extensive in CF240-
2002 with a total reduction of 525 kbp since the MRCA
corresponding to a loss of 8% of the entire genome. The
majority of the reduction observed in CF240-2002 is spe-
cific to this isolate lineage only (472 kbp), the largest event
being the loss of 146 kbp spanning mainly core genomic
regions as well as minor accessory regions. The large
deletions in CF240-2002 are caused by six separate
events while most other reductions in individual isolates
are the cause of only one event. The high number of large
deletions in CF240-2002 could be stochastic, however, the
genome of CF240-2002 contains missense mutations in
two exonuclease genes, sbcB and sbcC, involved in
recombination. In E. coli, mutation of sbcB enhances ille-
gitimate recombination and increases the rate of deletion
(Allgood and Silhavy, 1991), hence, the increased number
of deletion events and the large quantity of lost regions in
CF240-2002 could have a deterministic origin.
In total, 27 reductive events above 1 kbp are observed
during the infection period with an average loss of
44.5 kbp per event (median 26.6 kbp). The lost genomic
regions constitute both core regions and accessory
regions, the latter containing, e.g. a pathogenicity island
and genomic islands encoding heavy metal resistance
genes, part of the DNA unique to the DK2 genome
(Table 2). Overall, 56% of the lost regions belong to the
core genome while 44% belong to the accessory genome,
which is a significant over-representation considering the
overall percentage of the accessory genome is 8.5%.
Deletion rates are high compared with in vitro estimates
Based on the knowledge of lost sequences and time
points of strain isolation it is possible to obtain an estima-
tion of the deletion rate during the reductive evolution. All
DK2 clones sampled from chronic infections after 1973
share the same ancestor as recognized by proposed key-
adaptive mutations in three global regulators (mucA, lasR
and rpoN) and SNP-based phylogenetic analyses (Yang
et al., 2011a). The latter suggested clone CF30-1979,
which is the earliest clone to possess all three key-
adaptive mutations, to closely resemble this common
ancestor of all isolates sampled from chronic infections
from 1979 and onwards (Yang et al., 2011a). In agree-
ment with this, our analysis of genome reduction pre-
dicted CF30-1979 to represent an ancestor of all
subsequently sampled clones (Fig. 3 and Table 3). There-
fore, all deletions present in clones isolated after CF30-
1979 most likely occurred after the year 1979, which
therefore can be used as a reference point. The individual
DK2 patient sub-lineages share evolutionary trajectory
over several time periods before divergence, and the
deletions of each patient sub-lineage are therefore not
Table 2. Description of deleted regions.
Node Length acc./corea Function
A 1 160 acc.
A 5 287 core Exopolysaccharide (pslAB)
A 24 134 acc. Chromate transport, arsenic
resistance, copper resistance
A 35 534 core
B 2 795 acc.
C 1 455 core Exopolysaccharide (pslFG)
C 50 834 acc. Phage
D 1 957 core Homoprotocatechuate metabolism
(hpc)
D 26 610 acc. RND efflux pump, silver efflux
pump
E 4 332 core
E 4 754 acc.
E 91 043 acc. PAGI-5
F 67 272 core Homoprotocatechuate metabolism
(hpc)
G 1 775 core
H 40 295 core Homoprotocatechuate metabolism
(hpc)
I 7 156 core Homoprotocatechuate metabolism
(hpc)
I 38 588 acc.
I 60 758 core Virulence (pqsL, phzM/A1), biofilm
(bfiRS), efflux (mexG-I)
I 91 043 acc. PAGI-5
I 128 817 core/(acc.) Iron uptake (pyoverdin)
I 145 995 core/(acc.) Exopolysaccharide (pslA-I)
J 80 345 core Homoprotocatechuate metabolism
(hpc)
K 148 735 core/(acc.) Adhesion (cupA1-5), cobalt/zinc
cadmium resistance, virulence
(katalase, ExoY toxin, hydrogen
cyanide)
L 91 043 acc. PAGI-5
M 26 104 core Denitrification
N 20 141 acc./(core) Iron uptake (pyoverdin)
O 3 532 core
a. The column defines whether a deleted sequence belongs to core
or accessory genome. If both types are noted both types are present
within the sequence although the latter only in low percentage.
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independent measures; however, the results will nonethe-
less provide a good indication of the deletion rate. Aver-
aging the reduction rate per year for only the latest isolate
for each patient (12 isolates) gives an overall deletion
rate of 3723 bp per year. Estimating the deletion rate
for the CF240-2002 sub-lineage gives a deletion rate of
22 637 bp per year.
Using previous estimates of in vivo doubling times (74–
109 minutes), it is also possible to estimate the number of
generations from 1979 to each end-point isolate (Yang
et al., 2008; 2011a). A deletion rate of 3723 bp per year
then corresponds to 0.62 bp per generation, which is 12-
to 36-fold higher than previously reported in vitro deletion
rates of 0.05 and 0.017 bp per generation for Salmonella
enterica grown in rich medium (Nilsson et al., 2005).
Although the extensive reduction observed in CF240-
2002 significantly contributes to the high deletion rate,
exclusion of this isolate from the calculations still result in
a high rate of deletion (0.41 bp per generation).
For bacteria usually 20 bp of homologous sequence is
required for homologous recombination (Ehrlich et al.,
1993). Out of the 27 large deletions found here, seven of
these contain homologous regions above 20 bp in length
in the deletion end-point regions. The homologies of three
of these are long and spans more than 100 bp. The
remaining 20 deletions caused by illegitimate recombina-
tion have an average length of deletion end-point identity
of 5.5 bp with 10 of the deletions having homologous
regions below 5 bp.
Parallel reductive evolution
Two genomic regions have been lost in parallel for more
than two sub-lineages during the infection period indicat-
ing a selective pressure against encoded functions in the
region. In addition to this there are seven examples of
overlap between two lost regions. One of the two parallel
reductions is the fivefold parallel loss of genes encoding
enzymes for homoprotocatechuate (hpc) catabolism, a
sub-pathway in tyrosine catabolism. Although some of the
five observed reductions also include the loss of large
genomic regions surrounding hpc catabolism genes (up to
79 kbp) all five reductions include genes for this pathway
making it the likely selective target of deletion.
The second example of parallel reductive evolution is
the threefold loss of a region highly similar to the patho-
genicity island PAGI-5, although the region in the DK2
isolates do not contain the main region of virulence genes
(NR-II) identified in PAGI-5. This GI (GI11) spans 90 kbp
and the threefold independent loss therefore constitutes a
large fraction of the accessory genome reductions (50%).
Two genomic islands closely related to PAGI-5 are
pKLC102 and PAPI-1, both of which are mobilizable at
respective frequencies of 10% and 0.16% (Qiu et al.,
2006; Klockgether et al., 2007). Since PAGI-5 shares
similar integration and transfer gene modules as PAPI-1
and pKLC102 it could possess similar mobilization fre-
quencies. Accordingly, the threefold independent loss of
the PAGI-5 homologue need not signify a selection
against its presence. In fact, the preservation of the
PAGI-5 homologue in many lineages could indicate that
the GI contributes to fitness of the DK2 lineage.
We also note that deletion of different parts of the psl
gene cluster occurred on three occasions (Table 2), which
suggest selective pressure for loss of Psl exopolysaccha-
ride production.
Acquisition of novel DNA
For rapid adaptation, acquisition of novel DNA can play a
crucial role. However, during evolution of the DK2 lineage
in the CF airways, acquisition of novel genetic elements,
e.g. viruses or plasmids, seems to be less important in
changing the genomic content. De novo assemblies of all
genomes were performed to detect genetic elements not
already present in the original infecting clone. Only 54 kbp
of novel DNA sequence was found in CF114-1973 with
half of it being homologous to phage D3 sequence indi-
cating the insertion of a related prophage. However,
since CF114-1973 is the first of the early 1973 clones to
have diverged (Yang et al., 2011a), the sequence could
have been present also in the ancestor and merely lost
in the branch leading to subsequent isolates. No novel
sequence could be found in other isolates.
Table 3. Location of isolates on the nodes in the phylogenetic tree in Fig. 3.
A: CF114-1973 D: CF173-2005 I: CF240-2002 J: CF333-2005
B: CF43-1973 E: CF243-2002 J: CF66-1992 J: CF333-2007a
B: CF105-1973 F: CF243-1986 J: CF66-2002 J: CF333-2007b
C: CF66-1973 G: CF222-2001 J: CF180-2002 J: CF333-2007c
C: CF30-1979 G: CF223-2002 J: CF248-2002 K: CF333-2003a
C: CF173-1984a G: CF311-2002 J: CF333-1991 K: CF333-2003c
C: CF173-1984b H: CF173-1992 J: CF333-1992a K: CF333-2004b
C: CF173-1984c H: CF173-1994 J: CF333-1992b L: CF206-2002
C: CF173-1991 H: CF173-1995 J: CF333-1994 M: CF66-2008
C: CF224-2002 H: CF173-1997 J: CF333-1997 N: CF333-2004c
D: CF173-2002 H: CF173-1999 J: CF333-2004a O: CF333-2003b
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The above is the only putative example of prophage
insertion in the genomes of any DK2 strains during infec-
tion indicating a low level of temperate phage attack or
high level of phage resistance in the DK2 population.
Contrary, a GI containing two prophage regions was lost
in the branch leading to CF66-1973 and all strains iso-
lated subsequent to 1973. The spacers in the two
CRISPR loci present in the DK2 lineage also remain
unchanged for the duration of infection, indicating further
the absence of temperate phage attack or simply that
the systems are not functional. The identical system
described by Cady and colleagues (2011) for strain PA14
was functional although 105 SNPs (within 8140 bp) differ-
entiate it from the system in the DK2 strain.
Limited IS element expansion during infection
The P. aeruginosa DK2 genome contains eight different IS
element types of which all exist in the 1973 isolates and
have consequently not been acquired during infection.
Only one type, IS222, was observed to differ in copy
number in the DK2 isolates. IS222 existed in the five
same loci in the genomes of CF114-1973, CF105-1973
and CF43-1973. During the branch leading to node C it
was copied twice and is therefore present in seven loci in
isolate CF66-1973 and all subsequent isolates. Further-
more, a duplication event of IS222 occurred in CF43-1973
hence having six copies, as well as in an ancestor to
isolates CF66-1992, CF66-2002 and CF66-2008 leading
to eight copies of IS222 in these isolates.
Discussion
The early stages of P. aeruginosa adaptation to the CF
airways are characterized by the loss of large genomic
regions. Whether the deletions are caused by drift or
selection is unknown, but large deletions of core genome
could facilitate the loss of beneficial genes, making
the bacteria susceptible to Muller’s ratchet. Although
the largest proportion of reductions resides in the core
genome there is a significant overrepresentation of reduc-
tive evolution in the accessory genome. This might also
be expected as accessory functions often ensures prolif-
eration in certain niches and here we, e.g. see the loss of
some of the genes encoding heavy metal resistance in
certain isolates. Probably, many of the accessory func-
tions in the genome are neutral at best and therefore more
prone to loss by drift or even selection against their
functions.
The time scale in other studies of naturally evolved
human pathogens compared with a known or theoretical
ancestor is usually of a different magnitude spanning mil-
lions of years. Burkholderia mallei provides such an
example with 1.4 Mbp lost over 3.5 million years (Song
et al., 2010) and Mycobacterium leprae another with 408
out of 2977 genes deleted over 66 million years (Gomez-
Valero et al., 2007). In these cases there is no information
on the deletion dynamics. Consequently, due to a lack of
intermediary strains rough estimates of in vivo deletion
rates and dynamics have not been reported until now.
In vitro deletion rates have been reported for Salmo-
nella enterica grown in rich medium rendering several
biosynthesis functions superfluous (Nilsson et al., 2005).
The observed deletion rates for the DK2 lineage is,
however, 12- to 36-fold higher than those reported for the
S. enterica evolutionary experiment. The S. enterica
genome is around 4.8 Mbp while the P. aeruginosa DK2
genome is 6.4 Mbp, which could suggest that P. aerugi-
nosa has a larger potential for genome reduction. In addi-
tion, P. aeruginosa is a versatile organism with a diverse
metabolic repertoire, for which there is no need in the
more confined human airways environment.
The CF lung contains a multitude of microbial species
together with an active phage community, suggesting that
this environment could constitute a rich source of new
genomic material (Willner et al., 2009; Rolain et al., 2011).
However, during the infection period of the DK2 lineage
only little or no novel DNA was acquired. Only part of a
prophage region was possibly acquired in CF114-1973.
The prophage region was not present in other isolates,
suggesting either that it entered in the branch leading to
CF114-73 or was present in the shared ancestor but sub-
sequently lost before the isolation of other 1973 strains.
Even though the phage community in the CF lung has
been shown to constitute a reservoir of, e.g. antibiotic
resistance genes (Willner et al., 2009), no sign of impact
of this is observed in the DK2 lineage. Possibly, the DK2
strains have reduced potential for uptake and acceptance
of novel DNA as several receptors for DNA uptake, e.g.
pili, flagella and LPS are either lost, reduced or altered
during infection (Yang et al., 2011a,b). Investigating the
phage community of explant lungs also revealed absence
of phages in the highly diseased apical lobes, in contrast
to other less diseased lung areas, suggesting phage
resistance within that microbial community (Willner et al.,
2012). Hence a possible feature of highly adapted
P. aeruginosa strains in the CF lung is resistance towards
phage predation. Regardless, since the DK2 clone
emerges as a highly successful colonizer of the CF lung it
stands to reason that lateral acquisition of DNA is in no
way essential for P. aeruginosa adaptation to the CF lung
and probably plays a limited role in this.
Transposable elements can impact evolution of an
organism by inserting in new locations altering gene func-
tionality or catalysing deletions by providing opportunity
for homologous recombination. In the infecting lineage
only one transposable element, IS222, seems capable of
movement and the limited increase in copy number from
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5 to 7 for most isolates, only affecting two genes, demon-
strates its low significance in generating direct mutations
compared with the high number of SNPs occurring in the
genome over time (Yang et al., 2011a). This is in contrast
to recent in vitro experiments revealing an important con-
tribution of IS elements to mutation generation (Barrick
et al., 2009; Gaffe et al., 2011). In the early stages of
reductive evolution it has been suggested that extensive
proliferation of IS elements occurs based on the high
densities of these in fairly recent host-restricted species,
such as B. mallei, Bordetella pertussis, Shigella flexneri
and Salmonella enterica Typhi (Parkhill et al., 2003;
Moran and Plague, 2004; Song et al., 2010). In B. mallei
and B. pertussis there seems to be a link between the
location of IS elements and large deletions and inver-
sions, suggesting that IS elements function as catalysts
for reductive evolution, and this mechanism was therefore
proposed to be a key component in the early stage.
However, at the very earliest point in adaptation of
P. aeruginosa to the CF airways the proliferation of IS222
is still too limited for catalysis of reductions, which creates
a potential for only very large (usually deleterious) reduc-
tions. Although the smallest distance between IS222 in
later isolates is only 6 kbp the second-smallest is close to
340 kbp. Possibly, with a higher density of IS222 or the
presence of another IS element with faster duplication the
rate of reduction would be increased. Even though IS
elements were estimated to be involved in nearly all large
deletions in B. mallei, we see here in the earliest of stages
substantial genome reduction of up to 8% of the genome
without any involvement of IS elements.
Instead of IS mediated genome reduction we observe
mechanisms of homologous recombination and more fre-
quently, illegitimate recombination. Likely, this proportion
is due to the abundance of non-homologous regions over
homologous regions. Nilsson and colleagues (2005) also
found mainly non-homologous end regions of reductions
during S. enterica in vitro reductive evolution (6 regions)
while one end region contained 40 bp with high identity
when investigating the early stages of in vitro reductive
evolution. These provide two examples of the earliest
stage of host adaptation and both present reductive evo-
lution through mainly illegitimate recombination.
The adaptation of the DK2 lineage to the CF lung envi-
ronment provides for the first time insight into the early
stages of adaptation of a bacterial pathogen to its human
host. This early stage is exemplified by substantial reduc-
tive evolution predominantly through deletions of large
genomic regions. Genomic change through uptake of
novel DNA is on the other hand very limited, which is likely
a reflection of gain of function being less important during
transition to a permanent host association. The movement
of mobile genetic elements is likewise scarce as IS
element multiplication is low. Accordingly, IS elements are
not involved in the process of genome reduction observed
here. In spite of this high deletion rates are readily occur-
ring through mechanisms of deletion mainly consisting of
illegitimate recombination and to a lesser extent homolo-
gous recombination. Consequently, the involvement of IS
elements is dispensable even for extensive genome
reduction. Deletion rates are most likely determined by
several factors, one of them being the genome reduction
potential. This could explain the high deletion rate of the
DK2 lineage as a significant portion of the coding capacity
of P. aeruginosa should be geared towards its normal
environmental habitats and therefore dispensable in the
host environment.
Experimental procedures
Bacterial strains and genome sequencing
Forty-five isolates of the P. aeruginosa DK2 clone type
were sampled over 35 years from 16 CF patients attend-
ing the Copenhagen Cystic Fibrosis Clinic at the Univer-
sity Hospital (Fig. 1). Isolation and identification of
P. aeruginosa from sputum was done as previously
described (Hoiby and Frederiksen, 2000). Sequencing of
all isolates, except CF510-2006, was performed as earlier
described (Yang et al., 2011a) on Illumina’s GAIIx or
Hiseq2000 platforms generating 75 base single-end
reads using a multiplexed protocol to an average cover-
age depth of 11- to 99-fold (except CF333-1991 which
was 454-sequenced only; cf. Yang et al., 2011a).
Assembly and annotation of the P. aeruginosa
DK2 reference genome
The initial study of the P. aeruginosa DK2 clone type
was based on a draft genome sequence of isolate
CF333-2007a that was represented in 87 contigs
assembled from 524 464 reads with an average length
of 232 nucleotides generated from 454 pyrosequencing
(Yang et al., 2011a). Isolate CF333-2007a was also
sequenced on an Illumina GAII platform which gener-
ated 5 791 129 75-bp reads to complement the 454 gen-
erated reads and to increase the overall read coverage.
By combining the two data sets into a hybrid assembly
strategy, and by using knowledge of gene synteny in the
genomes of other strains of P. aeruginosa genomes, we
were able to complete the genome of CF333-2007a over
several rounds of improvement:
First, the Illumina reads were de novo assembled with
the assistance of genome sequences of P. aeruginosa
PAO1, PA14, LESB58 and CF510-2006, respectively,
using the Columbus module of Velvet version 1.0.16
(Zerbino and Birney, 2008). Each of reference-assisted de
novo assemblies were then used to extend and close
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gaps between the 87 original contigs using Minimus2
(Sommer et al., 2007), resulting in 49 new contigs.
We then manually inspected the 49 contigs and found
all gaps to be caused by repetitive regions due to the
following reasons: (i) copies of distant repeats collapsed
onto one another into a single contig with ambiguous
assemblies at the flanks, (ii) misassembly caused by col-
lapse of tandem repeats, and (iii) incorrectly assembled
chimeric contigs. For example, reads from the four nearly
identical ribosomal RNA operons co-assembled into a
single contig. Although this resulted in gaps in the de novo
draft genome, we closed these gaps by first ordering the
de novo contigs based on other available P. aeruginosa
genome sequences followed by local re-assembly of the
reads flanking the gaps. In the same way, gaps caused by
tandem units of nearly identical repeats could be resolved
by local re-assembly where only exact match reads were
used, and chimeric contigs leaving orphan contig ends
were broken up and re-assembled. A single gap consist-
ing of 10 identical repeat units could not be resolved in
silico, but was instead confirmed by PCR. In addition, the
in silico gap closure was validated by PCR spanning 13
other gaps, including the gaps flanking the ribosomal RNA
operons.
Finally, the Illumina reads was iteratively mapped back
against the closed genome to correct small sequence
errors, which would be identified as mutations. Pileups of
the reads mapped by Novoalign (Novocraft Technologies)
(Krawitz et al., 2010) were produced by SAMtools release
0.1.7 (Li et al., 2009), and single nucleotide polymor-
phisms (SNPs) called by the varFilter algorithm in SAM-
tools (samtools.pl varFilter -d 3 -D 10000 (–N 10) and
SNP quality scores  50) were corrected in the genome
sequence. In total, 531 nucleotides were corrected. The
read alignments surrounding all putative indels were
manually inspected, and 37 were corrected.
The final genome sequence was annotated using the
NCBI Prokaryotic Genomes Automatic Annotation Pipe-
line (http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.
html) and deposited at GenBank (Accession No.
CP003149).
The accessory genome of P. aeruginosa DK2 was
defined as genomic regions not present in at least two
other fully sequenced P. aeruginosa genomes (strains
PAO1, PA14, LESB, PA7) (Winsor et al., 2011). Alignment
through MUMmer3 was used to locate accessory regions.
Remaining regions were designated as core regions.
Genome sequencing and phylogenetic analysis of
outgroup isolate CF510-2006
Clone CF510-2006 was isolated from a CF patient with an
acute P. aeruginosa infection in 2006. Initial molecular
genotyping using ArrayTube microarrays (Wiehlmann
et al., 2007) showed that the isolate was genetically
related to the DK2 clone type. However, the phenotype
characteristics of the isolate were incompatible with con-
temporary DK2 strains present in chronically infected
patients (Jelsbak et al., 2007; Yang et al., 2011a) which
strongly suggest that the CF510-2006 isolate has little or
no history of growth in the CF environment prior to its
isolation. This is also supported by SNP profile compari-
son to DK2 isolates from Yang and colleagues (2011a),
which show that CF510-2006 is more closely to clones
isolated in 1973 than later isolates (see details below).
The sequencing of the CF510-2006 genome was done by
AGOWA (Berlin, Germany). First, 454 pyrosequencing
reads were generated to an approximate genomic read-
coverage of 50-fold that was assembled into 1205
contigs. Second, Sanger sequence reads from end-
sequencing and primer walking of a fosmid genome
library were used to close the majority of gaps to obtain a
final genome containing 6 683 163 bp assembled into 71
contigs, which we annotated using the NCBI Prokaryotic
Genomes Automatic Annotation Pipeline and deposited at
GenBank under the accession AJHI00000000.
The genome of CF510-2006 was analysed with respect
to the set of 363 SNPs that was previously identified in the
reconstruction of the phylogenetic relationship of the
P. aeruginosa DK2 lineage (Yang et al., 2011a). A total of
358 of these SNP-positions were present in the CF510-
2006 genome, and were in all cases identical to the pre-
viously predicted MRCA of the DK2 lineage. The MRCA
was predicted based on the assumption that its sequence
at the informative SNP sites would be identical to the
homologue sequences found in P. aeruginosa reference
strains PAO1, PA14, LESB58 and PA7 (Winsor et al.,
2011).
Analysis of genome reduction in multiple clones of the
DK2 lineage
To examine the genetic content of each of the DK2 clones
we first identified deletions larger than 1 kbp by alignment
of reads against the genome sequence of CF510-2006.
Hereby, regions not present in the clones could be
detected (i.e. regions to which no reads aligned). Illumina
reads from all isolates were mapped onto the genome of
CF510-2006 using Novoalign (Novocraft Technologies)
(Krawitz et al., 2010) and further processed by SAMtools
release 0.1.7. A custom script was used to identify candi-
date regions larger than 1 kbp that was not present in the
sequenced isolate as compared with CF510-2006. Sub-
sequently, the candidate regions were manually inspected
and exact deletion coordinates were verified by retrieving
reads bridging the two regions adjacent to each deletion
end. The genome sequence of isolate CF333-1991, which
was assembled from 454 pyrosequencing reads, was
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aligned to the CF510-2006 genome using MUMmer3
(Kurtz et al., 2004) and deleted regions were extracted
from the alignment.
Some deletions spanned several contigs in CF510-
2006 with unassembled sequence in between. For such
cases, the corresponding contiguous sequence was iden-
tified in CF333-2007a and used instead based on the
assumption that synteny would be preserved between the
two isolates.
Mobile genetic elements
Genomic islands in the P. aeruginosa DK2 genome were
detected by comparative genomics and prediction
approaches. The first approach involved alignment to ref-
erence P. aeruginosa strains PAO1, PA14 and LESB58
genomes using MUMmer3 (Kurtz et al., 2004). Regions in
the DK2 genome above 8 kbp and not present in two or
more reference strains were designated as a genomic
island. Additional genomic islands above 8 kbp were pre-
dicted using Islandviewer (Langille and Brinkman, 2009).
Prophage regions in the DK2 genome were predicted
using Prophinder (Lima-Mendez et al., 2008) using a nor-
malized score of 0.5 as a cut-off, and Prophage Finder
(Bose and Barber, 2006) using number of hits and pre-
dicted phage components as selection criteria. IS ele-
ments were located in the DK2 genome using ISsaga
(Varani et al., 2011) (http://www-is.biotoul.fr). The expan-
sion or loss of the IS elements during infection for Illumina
sequenced isolates was tracked by analysis of reads
bridging the IS element and its flanking regions. A change
in location of an IS element or its multiplication was then
detected as a change or increase in flanking regions while
the loss of an IS element was detected as a loss of a
flanking region.
The presence of CRISPRs in the DK2 genome was
detected using CRISPRfinder (Grissa et al., 2007).
Deletion rates
Deletion rates per year were assessed for the most
recently sampled isolate for each patient. The size in bp of
deleted regions occurring since isolate CF30-1979 was
divided by number of years from 1979 up until isolation
year. The year 1979 and isolate CF30-1979 was chosen
as reference time-point since CF30-1979 was isolated
this year and based on SNP analysis (Yang et al., 2011a),
it is very closely related to the ancestor of all isolates from
1979 and onwards.
Deletion rates per generation were calculated employ-
ing a previously described estimation of in vivo doubling
times of the DK2 lineage (Yang et al., 2008; 2011a).
These doubling times were used to estimate the number
of generations from 1979 to the isolation year of the most
recent isolate from each patient. Deletion rates per gen-
eration were then calculated using the number of genera-
tions from 1979 and the quantity of genome reduction that
occurred after isolate CF30-1979.
Uptake of novel DNA
The genomes of Illumina sequenced isolates were de
novo assembled using Velvet (version 1.0.17) (Zerbino
and Birney, 2008) with the Columbus module providing
reference assisted assembly. First, reads were mapped
onto contigs of CF510-2006 using Novoalign (Novocraft
Technologies) (Krawitz et al., 2010) and the assembly
data were used during Velvet read assembly with CF510-
2006 as reference. A coverage cut-off of 5 and a minimum
contig length of 100 bp were used as parameters for
velvetg while k-mer length of 35 was used for velveth. De
novo assembled genomes were aligned to the genome of
CF510-2006 using MUMmer3 (Kurtz et al., 2004) to
locate novel sequence in each isolate. Any novel
sequence not present in the genome of CF510-2006 was
subsequently aligned to the genome of CF114-1973, to
verify if the sequence was present in the earliest diverged
isolate.
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Abstract
Genome sequencing of bacterial pathogens has advanced our understanding of their evolution, epidemiology, and
response to antibiotic therapy. However, we still have only a limited knowledge of the molecular changes in in vivo evolving
bacterial populations in relation to long-term, chronic infections. For example, it remains unclear what genes are mutated to
facilitate the establishment of long-term existence in the human host environment, and in which way acquisition of a
hypermutator phenotype with enhanced rates of spontaneous mutations influences the evolutionary trajectory of the
pathogen. Here we perform a retrospective study of the DK2 clone type of P. aeruginosa isolated from Danish patients
suffering from cystic fibrosis (CF), and analyze the genomes of 55 bacterial isolates collected from 21 infected individuals
over 38 years. Our phylogenetic analysis of 8,530 mutations in the DK2 genomes shows that the ancestral DK2 clone type
spread among CF patients through several independent transmission events. Subsequent to transmission, sub-lineages
evolved independently for years in separate hosts, creating a unique possibility to study parallel evolution and identification
of genes targeted by mutations to optimize pathogen fitness (pathoadaptive mutations). These genes were related to
antibiotic resistance, the cell envelope, or regulatory functions, and we find that the prevalence of pathoadaptive mutations
correlates with evolutionary success of co-evolving sub-lineages. The long-term co-existence of both normal and
hypermutator populations enabled comparative investigations of the mutation dynamics in homopolymeric sequences in
which hypermutators are particularly prone to mutations. We find a positive exponential correlation between the length of
the homopolymer and its likelihood to acquire mutations and identify two homopolymer-containing genes preferentially
mutated in hypermutators. This homopolymer facilitated differential mutagenesis provides a novel genome-wide
perspective on the different evolutionary trajectories of hypermutators, which may help explain their emergence in CF
infections.
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Introduction
A molecular and mechanistic understanding of how bacterial
pathogens evolve during infection of their human hosts is
important for our ability to fight infections. The advent of high-
throughput sequencing techniques now offer unprecedented
nucleotide resolution to determine the relatedness among infecting
bacterial isolates and to unveil genetic adaptation within infected
individuals and in response to antibiotic therapy [1–7]. Unraveling
the genetic content of pathogens helps to identify the genes that
make certain bacterial lineages more pathogenic than others.
Nonetheless, the pathogenicity of a bacterial clone can also evolve
via the mutational changes of pre-existing genes, a mechanism
which is also known as pathogenicity- or pathoadaptive mutations
[8]. While several studies have provided insight into the genomic
evolution of primary bacterial pathogens such as Yersinia pestis [6]
and Vibrio cholera [2] causing acute infections, only little is known
how these observations relate to opportunistic pathogens causing
long-term infections [1].
The opportunistic pathogen Pseudomonas aeruginosa is a common
environmental inhabitant, which is also capable of causing both
acute and chronic infections in a range of hosts from amoeba and
plants to humans. For example, P. aeruginosa causes chronic airway
infections in most patients with cystic fibrosis (CF), and is directly
associated with the morbidity and mortality connected with this
disease. Chronic CF infections provide an opportunity for long-
term monitoring of the battle between the infecting bacteria and
the host immune defense and clinical intervention therapy [9,10],
and thus offer a direct method for observing evolutionary
mechanisms in vivo. In an effort to understand the evolutionary
mechanisms facilitating the transition of P. aeruginosa from its
environment to a human host, we have previously found no
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evidence for horizontal acquisition of genes to play a role [9].
Instead, we suggested the establishment of long-term chronic
infections to be a matter of tuning the existing genome via
pathoadaptive mutations.
The within-host mutation rate is a key factor in determining the
potential for bacterial pathogens to genetically adapt to the host
immune system and drug therapies, and knowledge about in vivo
growth dynamics of bacterial pathogens and their capacity for
accumulation of mutations is essential for the design of optimal
interventions. Interestingly, the generation of mutations is
frequently accelerated in clinical populations of P. aeruginosa that
evolves as so-called ‘hypermutators’ due to deficient DNA
mismatch repair systems [11]. Although the hypermutable
phenotype is also observed for other species in a range of
conditions [12–16], the impact of this phenotype in a natural
environment and in relation to infections remains less clear.
Here we analyze the genome sequences of 55 isolates of the
transmissible P. aeruginosa DK2 clone type causing chronic
infections in a cohort of Danish CF patients. Our collection,
comprising both normal (normomutator) and hypermutable
isolates, enabled a comparative analysis of evolutionary trajectories
of individual sub-lineages of the DK2 clone type making it possible
to identify genes targeted by pathoadaptive mutations. Further-
more, the long-term population dynamics and structure of the
clonal expanding DK2 lineage was elucidated by a high-resolution
phylogeny, and an examination of the mutation dynamics of
homopolymers (homopolymeric tracts of identical nucleotides, e.g.
GGGGG) provided novel genome-wide evidence for the potential
advantage of differential mutagenesis associated with the hyper-
mutator phenotype.
Results and Discussion
Strain collection and maximum-parsimonious phylogeny
We sequenced the genomes of a collection of 55 P. aeruginosa
DK2 clones sampled from Danish CF patients between 1972 and
2008 (Figure 1 and Table S4). The sequence data of 45 of the
isolates have previously been reported [9,10]. Most patients
(n = 19) were represented by only a single or a few (#4) isolates.
However, two patients were represented by 11 and 15 isolates
(CF173 and CF333, respectively).
We identified a total of 7,326 unique SNPs in the 55 DK2
genomes, that could be explained by 7,368 mutational events
(consistency index 0.99) using a maximum-parsimonious phylo-
genetic model to elucidate the evolutionary relationship of the P.
aeruginosa DK2 population (Figure 2). The high consistency of
the tree reflects the unidirectional, clonal evolution from the
root of the tree to the tips, thus enabling inferences about the
succession of mutations and the relationship among P. aeruginosa
DK2 clones.
Prevalence of mutS, mutL, and mutY hypermutators
From the phylogenetic tree we observed a linear correlation
between the number of SNPs and the time of sampling (i.e. a
constant rate of mutation accumulation during the clonal
expansion of the DK2 lineage) (Figure 3). However, nine sub-
lineages (indicated by filled circles in Figure 3) deviated from
this trend and had accumulated mutations at higher rates. In
one of these isolates, CF224-2002a, we found that 265 of the
273 SNPs accumulated in the branch leading to the isolate were
densely clustered in two chromosomal regions with SNP
densities (1.2 and 1.8 SNPs per kb, respectively), that are much
higher than expected (0.043 SNPs per kb assuming a random
distribution of SNPs) (Figure S1). The most likely explanation
for these high SNP densities is that the two genomic regions are
the result of recombination events with DNA from a P. aeruginosa
strain(s) unrelated to the DK2 clone type. Another study by
Chung et al. observed similar indications of within-patient
recombination events in P. aeruginosa [17].We found no evidence
for additional recombination events among the 55 genome
sequences.
The excess numbers of mutations in the remaining eight deviant
isolates were the result of increased mutation rates due to
mutations in mismatch repair and error prevention genes. Seven
isolates had non-synonymous mutations in one of the DNA
mismatch repair (MMR) genes mutS (n = 2) and mutL (n = 4) or
both (n= 1), and their excess numbers of SNPs showed a highly
increased transition:transversion ratio consistent with MutS or
MutL defects (Table 1) [3,11,17–19]. Moreover, one isolate
(CF173-1991) had a mutation in mutY and a molecular signature
consistent with a MutY defect (i.e. a high proportion of
transversions) (Table 1).
We did not find other mutations in mutS or mutL among the
remaining genome sequences, but three additional early isolates
(CF84-1972, CF43-1973, and CF105-1973) had mutations in mutY
as well as having the molecular signature associated with a MutY
defect (Table 1).
In total, we found 11 hypermutator strains among the 55
isolates. These mutators were found in ten of the 21 patients in our
study (48%), which is comparable to previous findings (36%) [11].
Our results include two patients (CF211 and CF224) from whom
we isolated both hypermutators and normal (normomutator)
clones documenting the co-existence of both types. Indeed, the
identification of both a hypermutable and a normal sub-lineage in
years 1997 and 2006 from patient CF211 suggests at least 9 years
of co-existence within this patient (Figure 2). It is possible that the
sub-lineages with different mutation rates occupy different niches
within the hosts, each niche representing different selection
pressures.
Author Summary
Pseudomonas aeruginosa is the dominating pathogen of
chronic airway infections in patients with cystic fibrosis
(CF). Although bacterial long-term persistence in CF hosts
involves mutation and selection of genetic variants with
increased fitness in the CF lung environment, our
understanding of the within-host evolutionary processes
is limited. Here, we performed a retrospective study of the
P. aeruginosa DK2 clone type, which is a transmissible
clone isolated from chronically infected Danish CF patients
over a period of 38 years. Whole-genome analysis of DK2
isolates enabled a fine-grained reconstruction of the
recent evolutionary history of the DK2 lineage and an
identification of bacterial genes targeted by mutations to
optimize pathogen fitness. The identification of such
pathoadaptive genes gives new insight into how the
pathogen evolves under the selective pressures of the host
immune system and drug therapies. Furthermore, isolates
with increased rates of mutation (hypermutator pheno-
type) emerged in the DK lineage. While this phenotype
may accelerate evolution, we also show that hypermuta-
tors display differential mutagenesis of certain genes
which enable them to follow alternative evolutionary
pathways. Overall, our study identifies genes important for
bacterial persistence and provides insight into the differ-
ent mutational mechanisms that govern the adaptive
genetic changes.
Within-Host Evolution of Pseudomonas aeruginosa
PLOS Genetics | www.plosgenetics.org 2 September 2013 | Volume 9 | Issue 9 | e1003741
Mutation rate of homopolymers
We next designed our mutational analysis to detect small
insertions and deletions (microindels). A total of 1,204 unique
microindels were discovered. The inheritance was explained by
1,380 parsimonious events and was congruent with the SNP-based
phylogeny although the consistency for the microindels was lower
(0.87) than for the SNPs (0.99). The higher rate of homoplasy
among microindels would a priori be expected as microindels
accumulate with high rates at mutational hotspots consisting of
simple sequence repeats (SSRs) [20]. Accordingly, 93% of the
inconsistent microindels were located in SSRs. As expected from
current knowledge [21,22], we observed that the seven mutL/mutS
hypermutators were particularly prone to mutation within SSRs
consisting of homopolymers, and as a result 86% of the
microindels that accumulated in the mutS/mutL hypermutable
sub-lineages were localized in homopolymers whereas this was
only true for 21% of the microindels within the remaining sub-
lineages (Table 1).
Highly mutable loci have been shown to be important for
pathogenesis and host adaptation of several pathogens [23]. For
example, increased mutation rates of homopolymers in MMR-
deficient P. aeruginosa strains have been shown in vitro to be
important for mutational inactivation of the regulatory gene
mucA [24], which is pivotal for adaptation in CF airways.
Nonetheless, we only have a limited understanding of the
homopolymer mutation dynamics at a genome-wide level and of
the impact of increased mutation rates of homopolymers in
relation to host adaptation. However, our collection of genome
sequences from both normal and hypermutator isolates,
sampled from the airways of CF patients, provides an
opportunity to shed new light on homopolymer mutation rates
and their impact on adaptation.
For each of the seven mutS/mutL hypermutator sub-lineages we
calculated the mutation rates of homopolymers of different lengths
(Figure 4). We observed that longer homopolymers were more
likely mutated than homopolymers of shorter lengths, and for
homopolymers of 3–6 nucleotides length the mutation rate
increased exponentially (R=0.995; Student’s t-test, P=0.0026).
One might expect large homopolymers to exhibit higher
probabilities of mutation, because they are distributed more
frequently outside coding regions. However, we observed no
evidence of this playing a role, as mutation rates of intergenic and
intragenic homopolymers were similar (Figure S2). Instead, the
size-dependent mutation rate of homopolymers is likely to be a
Figure 1. Patient origin and sampling time of genome sequenced P. aeruginosa DK2 isolates. The collection of 55 P. aeruginosa isolates of
the DK2 clone type was sampled from 21 different CF patients over 38 years. Bacterial isolates are indicated by symbols, and if multiple isolates were
sampled the same year from a patient, they are represented by stacked symbols. The isolates are named from the patient from whom they were
isolated, and their isolation year (e.g. isolate CF173-1991).
doi:10.1371/journal.pgen.1003741.g001
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consequence of the mechanistically determined probabilities of
strand-slippage during replication [20].
Distinct evolutionary paths in hypermutators
The size-dependent mutation rates of homopolymers of
different lengths suggest that different genes have different
probabilities of mutation. In this way, certain genes, in which
variation is appreciated, may harbor sequences that are more
frequently mutated in contrast to essential genes in which genetic
changes are strongly selected against [23]. In agreement with this,
we find that genes annotated as essential genes in P. aeruginosa
PAO1 [25] are less likely to contain large homopolymers $7 nt
(Fisher’s exact test, P=0.037) (Table S1).
Survival of bacteria in human hosts has previously been
suggested to be positively influenced by rapid modulation of the
cell envelope. In agreement with this (and in opposition to essential
genes), we find that genes functionally related with the composi-
tion of the cell envelope are more likely to contain large $7 nt
homopolymers (Fisher’s exact test, P=0.002) (Table S1). This
leads us to speculate that hypermutators have a selective
advantage over their normal counterparts, not only because they
can speed up evolution, but also because they are creating a bias
Figure 2. Maximum-parsimonious reconstruction of the phylogeny of the P. aeruginosa DK2 clones. The phylogenetic tree is based on
7,326 SNPs identified from whole-genome sequencing, and lengths of branches are proportional to the number of mutations. Outlier isolate CF510-
2006 [9] (not shown) was used as an outgroup to determine the root of the tree. Branches leading into mutS, mutL, or, mutY hypermutable isolates
are named as indicated by italic letters. Statistics on mutations accumulated in the specific branches are summarized in Table 1. Circles labeled A1, A2,
B1, B2, C1, and C2, respectively, denotes the position of the first and last genotype of each of the DK2 sub-lineages A, B, and C which were observed
to have infected patient CF173.
doi:10.1371/journal.pgen.1003741.g002
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towards a different evolutionary path by homopolymer facilitated
differential mutagenesis.
In support of our hypothesis, we find that mutS/mutL
hypermutators acquire 3.7 more mutations in cell envelope genes
containing large homopolymers ($7 nt) relative to cell envelope
genes without large homopolymers, and that the accumulation of
mutations in the homopolymer-containing cell envelope genes is
due to mutations within the homopolymers. Accordingly, 50% of
mutations in homopolymer-containing cell envelope genes are
indels whereas this is only true for 5% of the mutations in the
remaining genes (9/164 vs. 8/8; Fisher’s exact test, P=6.261026).
In further support of our hypothesis on differential mutagenesis
we find two genes (PADK2_15360 and PADK2_03970) in which
all seven mutS/mutL hypermutators, but no other isolates, carries
mutations. Given the number of mutations within each of the
seven hypermutable sub-lineages and all other lineages this
observation is highly unexpected by chance (P(X$2),binom(X;
5976; 2.961027)=1.661026; where 2.961027 is the probability
of an average length gene to be mutated in only the mutS/mutL
sub-lineages). One of the genes, PADK2_15360, encodes an outer
membrane receptor protein, and all seven hypermutators are
independently mutated in the same 76G homopolymer located at
position 1127–1133 within the 2958 nt gene. Since none of the
other 48 isolates contain mutations within PADK2_15360, we
suggest that mutations in this gene represent a hypermutator-
specific adaptive target for rapid modulation of the cell envelope.
All seven mutations are frameshift mutations causing premature
stop codons resulting in truncated proteins without a putative
TonB dependent receptor domain (Pfam family PF00593) located
in the C-terminal part of the protein. We hypothesize that this
domain is localized in the outer membrane where it, due to its
potential surface-exposure, could be a target of recognition by the
immune defense.
Time-measured phylogenetic reconstruction of the DK2
lineage
To further investigate the within-host evolutionary history of the
DK2 lineage and to estimate the dates of divergence between DK2
Figure 3. Total number of SNPs accumulated in each DK2
isolate. The number of SNPs accumulated in each of the isolates since
their most recent common ancestor (MRCA) is plotted against isolate
sampling year.
doi:10.1371/journal.pgen.1003741.g003
Table 1. Statistics on mutations accumulated in hypermutable sub-lineages.
Brancha
Clone at tip
of branch
mutS, mutL, and,
mutY mutationsb SNPs
Transitions:
Transversion
ratio
Microindels
(% within
homopolymers)
TJ CF206-2002 mutL(1248–1249insGCGCC) 656 54:1 142 (90%)
TD CF211-1997a mutL(C1420T)c MutL(R474W) 300 59:1 79 (94%)
TK CF211-2006a mutL(C1420T)c MutL(R474W) 599 53:1 114 (82%)
IH CF222-2001 mutS(T347C; 1096–1097insC; G1561A) MutS(V116A; A521T) 1149 43:1 219 (90%)
RE CF224-2002b mutL(792–802DTATGGTGCGCG; C1477T) MutS(P493S) 596 65:1 126 (86%)
KD CF243-2002 mutS(G506A; G1300A; C1495A),
mutL(T875C; G1452A)
MutS(R169H; E434K; R499S),
MutL(V292A; M484I)
2534 86:1 268 (75%)
IE CF311-2002 mutS(G1567A) MutS(E523K) 284 40:1 104 (94%)
QG1-5 CF84-1972, CF43-1973,
CF105-1973
mutY(G925A) MutY(V309M) 106 1:5 11 (9%)
JC CF173-1991 mutY(T785A) MutY(L262H) 59 1:6 5 (20%)
Other None 1085 2:1 312 (21%)
aBranch names are denoted in phylogenetic tree in Figure 2.
bPosition of mutations (consequences at the amino acid level is only shown for SNP mutations).
cMutation accumulated in an ancestor shared by clones CF211-1997a and CF211-2006a.
doi:10.1371/journal.pgen.1003741.t001
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isolates, we applied Bayesian statistics to infer time-measured
phylogenies using a relaxed molecular clock rate model (Figure 5).
We excluded the hypermutator isolates and isolate CF224-
2002a containing recombined regions from the analysis, as they
would otherwise interfere with the phylogenetic analysis. Based on
this analysis, the mean mutation rate was estimated to be 2.6
SNPs/year (95% highest posterior density (HPD; see Materials
and Methods) 1.8–3.2 SNPs/year) which is equivalent to 461027
SNPs/year per site or 9610211–11610211 SNPs/bp per gener-
ation assuming 3700–4500 generations per year [26]. Our
estimated mutation rate is in the same range as those estimated
for Shigella sonnei (661027 SNPs/bp/year) [7] and Vibrio cholerae
(861027) [2] but in between the rates reported for Yersinia pestis
(261028) [6] and Staphylococcus aureus (361026) [27].
The topologies of the Bayesian phylogenetic reconstruction and
the maximum-parsimonious phylogeny were congruent, and the
relationship among the clones correlated with patient origin and
the time of sampling (Figure 2; Figure 5).
We have previously shown that a set of specific mutations first
observed in CF30-1979 and in all isolates sampled after 1979 were
important for the reproductive success of the DK2 lineage and its
dissemination among multiple individuals [10]. Using the phylo-
genetic reconstruction, we estimate that isolates sampled after
1979 diverged from a common ancestor in year 1970 (95% HPD,
1961–1976) [10]. Furthermore, our phylogenetic data document
that the transmission potential of the DK2 lineage has been
maintained over several decades. The most recent transmission
event is predicted to have occurred in year 1997 (95% HPD,
1991–2001), as this is the latest time estimate of a predicted
ancestor shared by isolates from different patients (CF177-2002
and CF223-2002). Since we have not investigated DK2 isolates
from all patients chronically infected with this lineage it remains a
possibility that transmission has occurred subsequent to this time.
Seven patients are represented by multiple isolates, and in six of
the patients at least two of the isolates clustered as monophyletic
groups according to patient origin (Figure 2; Figure 5). This is in
agreement with a model in which independent sub-lineages of the
DK2 clone evolved separately within individual patients, and it
excludes the possibility of continuous and near-perfect mixing of
strains between patients. The patient-linkage was most prevalent
for patient CF333 from which all 15 isolates constituted a single
monophyletic group, and the isolates branched in general
according to their sampling year giving a linear evolutionary
trajectory with an average distance of 6.1 SNPs (,2.3 years) from
the line of descent (Figure 2; Figure 5).
In contrast, we observed an unexpected DK2 population
dynamics in patient CF173 in which the isolates clustered as three
different monophyletic groups with four, five and two isolates,
respectively (Figure 2). This shows that patient CF173 was infected
by three distinct sub-lineages rather than only a single sub-lineage.
Interestingly, the three sub-lineages carried by patient CF173 can
be distinguished based on the sampling year of the isolates.
Accordingly, the isolates from the different clusters are sampled in
the time-periods 1984–1991 (cluster A), 1992–1999 (cluster B) and
2002–2005 (cluster C), respectively. This points to a replacement
of the earlier sub-lineages around years 1991–1992 and 1999–
2002, respectively, caused by secondary transmission events.
Alternatively, it could be the result of co-existing lineages whose
time-dependent sampling was caused by shifts in relative
abundance or changes in sampling probability from different
niches.
Parallel evolution of genes involved in host adaptation
The presence of independently evolving DK2 sub-lineages
made it possible to search for recurrent patterns of mutation and
to identify bacterial genes that have acquired mutations in parallel
in different individuals [1,28]. Overall, we found no evidence for
either intragenic bias of the mutations or for positive selection
within coding regions (dN/dS= 0.66 including all mutations; Text
S1), and we would therefore expect the 7,383 intragenic mutations
to be distributed randomly among the 5,976 P. aeruginosa DK2
genes. This means that on average a gene would acquire 1.2
mutations, and we would expect only 1.3 genes to acquire
mutations more than 6 times (P(X.6),binom(X; 7,383;
597621)=2.261024). Nonetheless, we identified 65 genes that
were mutated more than 6 times when comparing across all DK2
sub-lineages (see Table S2 for the full list of all 65 genes). The high
mutation number within these genes could be the result of a
Figure 4. Mutation rates of homopolymers. Rates of mutation of homopolymers of different sizes are shown for seven DK2 sub-lineages
evolving with amutS/mutL DNA MMR-deficiency. The rates were calculated as the number of observed indels per homopolymer per mutS/mutL MMR-
deficiency caused SNP (see Materials and Methods).
doi:10.1371/journal.pgen.1003741.g004
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Figure 5. Bayesian phylogenetic reconstruction and divergence date estimates of the P. aeruginosa DK2 clones. Bayesian statistics were
used to estimate the divergence times of predicted ancestors. The tree was based on 736 unique SNPs identified from whole-genome sequencing.
Circles labeled A1, A2, B1, B2, C1, and C2, respectively, denotes the position of the first and last genotype of each of the DK2 sub-lineages A, B, and C
which were observed to have infected patient CF173. The position of CF173-1991 (A2) is approximated from an equivalent Bayesian phylogenetic
analysis including the hypermutator isolates (Figure S3).
doi:10.1371/journal.pgen.1003741.g005
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positive selection for mutations, which is supported by our
observation that increased pressures of selection acts on the top
most mutated genes (Figure 6). Accordingly, the signature for
selection for SNPs accumulated in the 65 top most mutated genes
(dN/dS= 1.11) was positive and significantly higher than for SNPs
accumulated in other genes (dN/dS= 0.69; Fisher’s exact test,
P=5.261025).
These findings suggest that the 65 genes with multiple
mutations undergo adaptive evolution (i.e. they are pathoadap-
tive genes involved in host adaptation), although the presence of
neutral mutational hotspots or fast acquisition of secondary
mutations within the same gene may contribute to the high
mutation number in some genes. To exclude the possibility that
the high mutation numbers were the result of recombination
events or because of particularly large gene sizes, we left out
mutations from recombined regions and large genes (.5 kb)
from our analysis.
A large part of the identified pathoadaptive genes were
associated with antibiotic resistance (n = 14), including the genes
ampC, emrB, ftsI, fusA, gyrA/B, mexB/Y, pmrB, pprA, oprD, and rpoB/C
(Figure 7 and Table S2), in which mutations have been shown to
confer resistance against a range of antibiotics, e.g. beta-lactams,
tetracyclines, quinolones, chloramphenicol, macrolides, fusidic
acid, aminoglycosides, polymycins and penicillins [29–37]. As
such, the detection of multiple mutations in known antibiotic
resistance genes confirmed the ability of our approach to identify
genes involved in host adaptation. The exact amino acid changes
caused by nine out of 16 unique non-synonymous mutations found
within the genes gyrA/B and rpoB have previously been shown to
confer resistance against fluoroquinolones and rifampicin, respec-
tively (Table S3).
Another major group of pathoadaptive genes (n = 18) were
functionally related to the cell envelope (Figure 7 and Table S2).
Possibly, these mutations have been selected to evade the host
immune response [38] or, especially in the case of lpxO2, to
prevent interaction from LPS-targeting antibiotics [39]. Also,
mutations in 13 genes involved in gene regulation were identified
in our analysis, suggesting that remodeling of regulatory networks
is a key evolutionary pathway in host adaptation as it seems to be
in evolving Escherichia coli populations [40]. Among the regulatory
genes that acquired mutations were four yet uncharacterized genes
encoding components of two-component regulatory systems, a
gene-category which is significantly overrepresented (88/5823 vs.
7/58 Fisher’s exact test, P=6.761025) among the pathoadaptive
genes (Table S2). We suggest that these uncharacterized regulatory
genes as well as other genes identified as involved host adaptation
represent potential therapeutic targets.
Mutations in pathoadaptive genes correlate with strain
displacement events within patient CF173
The adaptive benefits of a mutation are usually investigated by
introduction of single or multiple mutations into isogenic strains
and testing for fitness effects associated with the mutation(s) in
controlled experimental conditions (such as competition experi-
ments). Such testing is most effective when the phenotype (e.g.
antibiotic resistance) can be easily interpreted in relation to the
fitness impact. However, for mutations for which no or only subtle
phenotypic changes are apparent it is difficult to directly test the
fitness effects. In addition, the impacts on fitness of specific
mutations must be assessed in the same environment as the one in
which the mutation was selected. This is obviously not possible in
case of human airway infections. To circumvent these limitations,
we hypothesize that the count of mutations within the pathoa-
daptive genes can be used as a measure of the fitness of individual
clones of P. aeruginosa. To investigate this hypothesis we took
advantage of the two strain displacements (or changes in strain
abundances) that occurred in patient CF173 in the years 1991–
1992 and 1999–2002, which suggested that CF173 was infected by
three succeeding DK2 sub-lineages A (1980–1991), B (1990–
1999), and C (2000–2005).
We assume that the succeeding sub-lineage must be better
adapted (i.e. having a higher fitness) than the previous sub-lineage,
which was outcompeted. When determining the number of
mutations found in the sub-lineages A, B, and C within the
pathoadaptive genes, it was striking that the succeeding genotype
consistently had a higher count of mutations than the previous
genotype (Figure 7). In this way, the counts of mutations correlated
with the strain displacement observed within patient CF173. We
suggest that the mutation count can be used to predict the fitness
of emerging DK2 clones, and that the pathogenicity scoring
together with the information about the specific mutations can be
used as a novel approach for clinicians to treat and segregate
patients. It should be noted that our results cannot simply be
ascribed to the succeeding genotypes having more mutations in
general as no significant positive correlation existed between the
Figure 6. Increased pressures of selection for mutations in the top most mutated genes.Measures of the selection pressures were plotted
for genes acquiring$X mutations during the evolution of the DK2 lineage. Plot A shows the dN/dS ratio, and plot B shows the ratio of indels relative
to silent SNPs.
doi:10.1371/journal.pgen.1003741.g006
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total number of mutations and the number of mutations within the
pathoadaptive genes (R=0.30; Student’s t-test, P=0.28).
Conclusions and implications
By genome sequencing of 55 isolates of the transmissible DK2
clone type of P. aeruginosa, we have provided a detailed view of the
evolution of a bacterial pathogen within its human host. The
sampling from multiple patients offered the opportunity to detect
loci that were independently mutated in parallel lineages, here
referred to as pathoadaptive genes, whereas sampling multiple
times from the same patient gave an opportunity to study the
within-patient population dynamics.
Several of the pathoadaptive genes identified here were
associated with antibiotic resistance, gene regulation, and compo-
sition of the cell envelope. Some of these genes have been found in
other studies of genomic evolution in CF pathogens to be
important for adaptation [1,3,17]. Genomic analysis of additional
P. aeruginosa lineages from different patients and clinical settings
will enable a systematic identification of genes that are repeated
targets for selective mutations during adaptation to life in the CF
lung. Importantly, we also identified genes of unknown function
and without prior implication in pathogenesis. Further investiga-
tions of the function of these genes are required to determine their
potential as future therapeutic targets against the infection.
An exceptional 21-year time series of 11 isolates sampled from
patient CF173 revealed a complex population dynamics in which
the patient was infected by three distinct sub-lineages of the DK2
clone type, each sub-lineage being dominant over several years
until its final decline or disappearance. This observation illustrates
the power of high-throughput sequencing in relation to uncovering
pathogen dynamics within infected individuals. We further
observed that the cumulative count of mutations within pathoa-
daptive genes increased for each of the succeeding sub-lineages.
This means that emerging sub-lineages carried a cumulative
palette of pathoadaptive mutations and not only adaptive
mutations conferring an advantage for a newly introduced
selection force that may have triggered the removal of the
preceding lineage.
Figure 7. Pathoadaptive genes. Genes identified from parallel evolution to be involved in host adaptation. Colors of squares denotes if the gene
was mutated relative to the MRCA of the DK2 clones. Only genes mutated in any of the isolates from CF173 are shown (see full list of pathoadaptive
genes in Table S2). The presence of mutations is shown for the first and last genotypes of each of the DK2 sub-lineages A, B, and C, which were
observed to have infected patient CF173. The total sum of mutations observed within each of the genotypes is indicated at the top. Genes are
grouped by function. Details about specific mutations and their fixation in the DK2 isolates are given in Table S5, Table S6, and Figure S4.
doi:10.1371/journal.pgen.1003741.g007
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The identification of pathoadaptive genes involved in host
adaptation and our finding that the specific count of mutations
within these genes act as a classifier that predict the pathoge-
nicity of emerging sub-lineages of the DK2 clone type, should
enable better epidemiological predictions and provide valuable
information for the clinicians on how to treat and segregate
patients.
The presence of hypermutable lineages within 48% of the
studied individuals might be the outcome of an accelerated
acquisition of beneficial mutations within hypermutators [11,41–
43]. Nonetheless, our examination of mutation dynamics of
homopolymers provided a novel genome-wide perspective on the
impact and potential advantage of differential mutagenesis
associated with the hypermutator phenotype. Showing a clear
exponential correlation between the rate of change and the size of
the homopolymer, we confirmed homopolymers to be hotspots for
differential mutagenesis, and we identified two homopolymer-
containing genes to be preferentially mutated in hypermutators.
In conclusion, we have shown how collections of isolates of
bacteria sampled from chronically infected patients constitute a
valuable basis for studying evolution of pathogens in vivo, and our
results facilitates comparative studies as sequencing datasets
become increasingly available.
Materials and Methods
Bacterial strains and genome sequencing
The study encompasses 55 isolates of the P. aeruginosa DK2 clone
type that were sampled over 38 years from 21 CF patients
attending the Copenhagen Cystic Fibrosis Center at the University
Hospital, Rigshospitalet (Figure 1). Isolation and identification of
P. aeruginosa from sputum was done as previously described [44].
Sequencing of 45 of the isolates was previously reported by Yang
et. al. [10] and Rau et al. [9]. Two of the previously sequenced
isolates (CF333-1991 and CF510-2006) were re-sequenced
together with ten new isolates on an Illumina HiSeq2000 platform
generating 100-bp paired-end reads using a multiplexed protocol
to an average coverage depth of 63–212 fold. Sequence reads from
all isolates are deposited in the Short Read Archive under
accession number ERP002277 (accession numbers for individual
samples are provided in Table S4).
Mutation detection and analysis
Reads were mapped against the P. aeruginosa DK2 reference
genome (CF333-2007a; Genbank accession no. CP003149)
using Novoalign (Novocraft Technologies) [45], and pileups of
the read alignments were produced by SAMtools release 0.1.7
[46]. Single nucleotide polymorphisms were called by the
varFilter algorithm in SAMtools in which minimum SNP
coverage was set to 3 (samtools.pl varFilter -d 3 -D 10000).
Only SNP calls with quality scores (Phred-scaled probability of
sample reads being homozygous reference) of at least 50 (i.e.
P#1025) were retained. Microindels were extracted from the
read pileup by the following criteria; (1) quality scores of at least
500, (2) root-mean-square (RMS) mapping qualities of at least
25, and (3) support from at least one fifth of the covering reads.
The false-negative rates were found to be 2% and 3% by in silico
introduction of random base-substitutions and microindels
(lengths 1–10 bp), respectively. To avoid false-positives, the
reference genome was re-sequenced by Illumina sequencing to
exclude polymorphisms caused by errors in reference assembly.
Also, Illumina re-sequencing of CF333-1991 confirmed all the
SNPs (and found no other SNPs) that were previously reported
for this isolate by use of pyrosequencing [10]. Indeed, the
confirmation by re-sequencing of CF333-1991 and the fact that
many isolates are only discriminated by a few mutations verify
that our genomic analysis has a very low false-positive rate.
A maximum-parsimonious phylogenetic analysis was used to
predict the relationship and mutational events among the clones of
the DK2 clone type. The tree consistency index (CI=m/s) was
calculated as the minimum number of changes (m) divided by the
number of changes required on the tree (s). The CI will equal 1
when there is no homoplasy.
For the calculation of average distances of the 15 CF333
isolates to their line of descent, the line of descent was defined as
the direct lineage from the most recent common ancestor
(MRCA) of all 15 isolates until the MRCA of the three most
recently sampled isolates (CF333-2007a, CF333-2007b, CF333-
2007c).
To provide the most accurate estimates of the relative
homopolymer mutation rates in the mutS/mutL MMR-deficient
sub-lineages, we calculated the rates per mutS/mutL MMR-
deficiency caused SNP. This corrected count of SNPs were found
by subtracting the fraction of SNPs expected to have accumulated
due to the normal underlying mutation rate, i.e. SNPs not caused
by the mutS/mutL MMR-deficiency. For this purpose a 2:1
transition to transversion ratio was assumed for the normal
background mutation rate. This means that the SNP count of
hypermutator branch ‘‘KD’’ composed of 2,534 SNPs (Table 1),
hereof 29 transversions, was corrected to 2,447 mutS/mutL MMR-
deficiency caused SNPs. All results and conclusions were
unaffected from this correction.
Bayesian evolutionary analysis
Bayesian analysis of evolutionary rates and divergence times was
performed using BEAST v1.7.2 [47]. BEAST was run with isolate
CF510-2006 as an outgroup [9] and the following user-determined
settings; a lognormal relaxed molecular clock model which allows
rates of evolution to vary amongst the branches of the tree, and a
general time-reversible substitution model with gamma correction.
Results were produced from three independent chains of 50
million steps each, sampled every 5,000 steps. The first 5 million
steps of each chain were discarded as a burn-in. The results were
combined, and the maximum clade credibility tree was generated
(using LogCombiner and TreeAnnotator programs from the
BEAST package, respectively). The effective sample-sizes (ESS) of
all parameters were .500 as calculated by Tracer v1.5 (available
from http://beast.bio.ed.ac.uk/Tracer), which was also used to
calculate 95% HPD confidence intervals of the mutation rate (i.e.
an interval in which the modeled parameter resides with 95%
probability). The root of the tree was predicted to be in year 1943
(95% HPD, 1910–1962). Note, as this estimate is based on isolates
primarily sampled after year 1980, the same accumulation rate of
SNPs might not hold true for the evolution of the DK2 clone type
before 1980.
Supporting Information
Figure S1 Distribution of SNPs accumulated in the branch
leading to CF224-2002a. Genomic overview of the distribution of
SNPs accumulated in the branch leading to isolate CF224-2002a
according to the predicted phylogeny in Figure 2. The positions of
the two genomic regions, in which the majority of the SNPs were
found, and the remaining 8 SNPs are all indicated by text. The
results provide evidence of two events in which imported DNA
have recombined into the chromosome of CF224-2002a. The high
density of polymorphisms suggests the imported DNA to origin
from a P. aeruginosa strain(s) unrelated to the DK2 clone type. No
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genes related to mobilization and transfer of DNA was present
within a 10 kb range of the predicted boundaries of the
horizontally transferred regions, so we have no evidence for
elements specialized for horizontal gene transfer to play a role.
(EPS)
Figure S2 Mutation rates of homopolymers in intragenic and
intergenic regions. Rates of mutation of homopolymers of different
sizes are shown for intragenic and intergenic homopolymers,
respectively. The rates are averages of the seven DK2 sub-lineages
evolving with a mutS/mutL MMR-deficiency. The rates were
calculated as the number of observed indels per homopolymer per
mutS/mutL MMR-deficiency caused SNP (see Materials and
Methods).
(EPS)
Figure S3 Bayesian phylogenetic reconstruction and divergence
date estimates of the P. aeruginosa DK2 clones. Bayesian statistics
were used to estimate the divergence times of predicted ancestors.
The tree is based on 7,326 unique SNPs identified from whole-
genome sequencing. Circles labeled A1, A2, B1, B2, C1, and C2,
respectively, denotes the position of the first and last genotype of
each of the DK2 sub-lineages A, B, and C which were observed to
have infected patient CF173.
(EPS)
Figure S4 Maximum-parsimonious reconstruction of the phy-
logeny of the P. aeruginoisa DK2 clones. The phylogenetic tree is
based on 8,530 mutations (SNPs and indels) identified from whole-
genome sequencing. Outlier isolate CF510-2006 (not shown) was
used as an outgroup to root the tree. Italic letters indicate branch
names, and lengths of branches are proportional to the number of
mutations. The specific mutations that have accumulated during
each specific branch are listed in Table S5 (SNPs) and Table S6
(indels).
(EPS)
Table S1 Prevalence of homopolymers in essential genes and
genes functionally related to the composition of the cell envelope.
(DOCX)
Table S2 Full list of pathoadaptive genes (n = 65).
(XLSX)
Table S3 Non-synonymous mutations in genes rpoB, gyrA and
gyrB. For each of the mutations, we have listed studies of our
knowledge to have shown or indicated the specific mutation to
confer resistance against an antibiotic.
(DOCX)
Table S4 List of sequenced samples and corresponding
Sequence Read Archive (SRA) accession numbers.
(XLSX)
Table S5 Full list of SNPs.
(XLSX)
Table S6 Full list of indels.
(XLSX)
Text S1 Mutational signature of genetic drift.
(DOCX)
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Abstract: 17 
Pseudomonas aeruginosa airway infections are a major cause of mortality and 18 
morbidity of cystic fibrosis (CF) patients. In order to persist P. aeruginosa depends on 19 
acquiring iron from its host, and multiple different iron acquisition systems may be 20 
active during infection. This includes the pyoverdine siderophore and the 21 
Pseudomonas heme utilization (phu) system. While the regulation and mechanisms of 22 
several iron-scavenging systems are well described, it is not clear whether such 23 
systems are target for selection during adaptation of P. aeruginosa to the host 24 
environment. Here we investigate the within-host evolution of the transmissible P. 25 
aeruginosa DK2 lineage. We find a positive selection for promoter mutations leading 26 
to the increased expression of phuR encoding an outer membrane receptor of the phu 27 
system. By mimicking conditions of the CF airways in vitro, we experimentally 28 
demonstrate that increased expression of phuR confers a growth advantage in the 29 
presence of hemoglobin, thus suggesting that P. aeruginosa genetically adapt towards 30 
iron acquisition from hemoglobin. To rule out that this adaptive trait is specific to the 31 
DK2 lineage, we inspected the genomes of two additional P. aeruginosa lineages 32 
isolated from CF airways, and we found similar adaptive evolution in both of these 33 
lineages. Furthermore, in all three lineages phuR promoter mutations coincided with 34 
the loss of pyoverdine production, suggesting that within-host adaptation towards 35 
heme utilization is triggered by the loss of pyoverdine production. Targeting heme 36 
utilization might therefore be a promising strategy for the treatment of P. aeruginosa 37 
infections in CF patients.  38 
3 
Introduction: 39 
Iron is an essential component for virtually all forms of life.  This includes bacterial 40 
pathogens that depend on acquiring iron from their hosts in order to replicate and 41 
cause disease [1]. A general defensive mechanism of the host is therefore to withhold 42 
iron from invading bacteria to prevent their growth, but this defense is counter 43 
measured by bacterial pathogens as they posses specific systems to scavenge iron 44 
from their hosts. While the regulation and mechanisms of several of such iron-45 
scavenging systems are well described [1], not much is known about how the within-46 
host selection pressures act on the pathogens ability to acquire iron. This is especially 47 
relevant during long-term chronic infections in which invading bacteria genetically 48 
adapt to the host environment. 49 
The opportunistic pathogen Pseudomonas aeruginosa is a common environmental 50 
inhabitant which is capable of causing long-term chronic infections in the airways in 51 
patients with cystic fibrosis (CF), and P. aeruginosa infections are directly associated 52 
with the morbidity and mortality of CF patients. Chronic infections in CF patients 53 
provide an opportunity for long-term monitoring of the battle between the infecting 54 
bacteria and the host [2-6], and thus offer a direct method for observing the genetic 55 
adaptation of P. aeruginosa to the human host environment. 56 
Most iron in the human body is bound in hemoglobin, which is an oxygen transport 57 
protein in red blood cells [1]. If not bound by essential proteins such as hemoglobin, 58 
iron is withheld and stored by binding to proteins like transferrin, lactoferrin, and 59 
ferritin. P. aeruginosa is known to scavenge iron from the human host by both 60 
siderophore-based systems or heme acquisition systems [7].  61 
Siderophores are low-molecular weight molecules secreted from bacteria. The strong 62 
association of iron to siderophores enables them to remove iron from the human iron-63 
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storage proteins whereupon the siderophore-iron complex can be taking up by cognate 64 
receptors at the bacterial surface. The major siderophore secreted by P. aeruginosa is 65 
pyoverdine [7], and iron-loaded pyoverdine is taken up by the outer membrane 66 
receptor FpvA [8, 9]. 67 
Alternatively, iron contained in the heme group of hemoglobin can be taken up by 68 
either of two heme uptake systems in P. aeruginosa. The two systems are the 69 
Pseudomonas heme utilization (phu) system and the heme assimilation system (has) 70 
[10]. The two systems are different in the sense that the phu system is dependent on 71 
the direct uptake of heme by the outer membrane receptor PhuR, whereas the has 72 
system encodes a secreted hemophore HasA that returns heme to an outer membrane 73 
receptor HasR. 74 
It is not clear to what extent the different iron uptake systems in P. aeruginosa play a 75 
role for survival in the lungs of CF patients. Detection of pyoverdine in the sputa of 76 
some CF patients have proposed pyoverdine to play a key role in infection [11, 12]; 77 
however, quantification of transcription of iron uptake systems in sputum samples 78 
suggested multiple systems to be active and that siderophore-mediated uptake may 79 
not be dominant in all patients [13, 14]. 80 
In an effort to understand the genetic adaptation of P. aeruginosa to the CF airways, 81 
we recently mapped all mutational changes in the P. aeruginosa DK2 lineage as it 82 
spread among 21 Danish CF patients by interpatient transmission [2]. The study 83 
showed that the selective forces driving the evolution of P. aeruginosa in the CF 84 
airways could be inferred from convergent evolution of DK2 sub-lineages evolving in 85 
parallel in separate hosts. Here, we further analyze the genomic data and provide 86 
evidence that within-host evolution of P. aeruginosa is characterized by adaptation 87 
towards iron acquisition from hemoglobin. 88 
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 89 
Results and discussion: 90 
Parallel evolution of mutations in the phuR promoter region 91 
It is known that P. aeruginosa genetically adapt to CF patients during long-term 92 
chronic infections, and several studies have genome sequenced isolates of P. 93 
aeruginosa sampled longitudinally from the airways of CF patients to map the 94 
mutations that accumulate during infection [2-6]. In one such study, we mapped all 95 
the mutations that had occurred in the P. aeruginosa DK2 lineage during 36 years of 96 
infection [2]. Whole-genome analysis of 55 DK2 isolates enabled a fine-grained 97 
reconstruction of the evolutionary relationship of the DK2 lineage, and the study 98 
identified several genes to be targeted by mutation to optimize pathogen fitness within 99 
the host environment (pathoadaptation). Nonetheless, only intragenic mutations (i.e. 100 
mutations within genes) were included to identify such pathoadaptive patterns of 101 
mutation. Here, we therefore re-analyzed the data with respect to intergenic regions as 102 
selection might act also on such sequences due to their role in regulation and 103 
transcription of neighboring genes. 104 
The 6,402,658 bp genome of the P. aeruginosa DK2 strain contains 4,883 intergenic 105 
regions with an average size of 146 bp, and the intergenic regions constitute a total of 106 
714,368 bp. Marvig et al. (2013) found 1,365 intergenic mutations meaning that one 107 
would expect an average length intergenic region to be hit by 0.3 mutations (or 108 
0.0019 mutation/bp). Searching for recurrent patterns of mutation of the same genetic 109 
loci makes it possible to identify positive selection for mutations effecting genes 110 
important for host-adaptation [2, 15, 16]. We therefore focused on the intergenic 111 
regions with the highest densities of mutations, and interestingly found the 180-bp 112 
intergenic region containing the promoters of the phu system to be the most 113 
6 
frequently mutated with a total of 13 mutations (0.072 mutation/bp) (Figure 1). This 114 
number of mutations is 38-fold higher than what would be expected by chance and 115 
represents a significant increase in mutation density (P(X≥0.072)~pois(X; 116 
0.0019)=0.002).  117 
 118 
 119 
Figure 1: Maximum-parsimonious phylogenetic tree showing the genetic relationship of the 11 120 
DK2 clones included in this study. The phylogenetic tree is adopted from Marvig et al. (2013) and is 121 
based on mutations identified from whole-genome sequencing. Lengths of branches are proportional to 122 
the number of mutations, except in the case of the truncated branch leading to isolate DK2-CF222-123 
2001. Instead, the large number of mutations that have accumulated in isolate DK2-CF222-2001, due 124 
to hypermutation caused by a deficient DNA mismatch repair system, is indicated at the end of the 125 
truncated branch [2]. Blue and red circles denote mutations in pvdS and in the intergenic region 126 
upstream of phuR, respectively.  127 
  128 
All of the 13 mutations are located within a narrow region from position -91 to -21 129 
relative to the start codon of phuR, and eight of the mutations are within the annotated 130 
promoter region of phuR (Figure 2). Furthermore, two positions (positions -35 and -131 
57) were subject to convergent evolution as they were independently mutated in 132 
parallel evolving DK2 sub-lineages. 133 
 134 
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Figure 2: Overview of the intergenic region upstream of phuR. The alignment shows homologue 136 
sequences from different isolates with genetic variants highlighted in bold. Wild type sequences of P. 137 
aeruginosa strains PAO1, DK1, DK2, and C are shown at the top of the alignment. Abbreviations of 138 
sequence alleles from different isolates are indicated in parenthesis (WT and M1-M10). Positions of 139 
promoters, Fur boxes, and a binding site of AlgT regulatory protein are indicated with black lines 140 
above the alignment. Positions are relative to the start codon of phuR. 141 
 142 
Effect of intergenic mutations on phuR promoter activity 143 
We hypothesized that the mutations, due to their location immediate upstream of 144 
phuR, could cause an effect on the activity of the phuR promoter. To investigate this 145 
hypothesis, we cloned the phuR promoter region from six of the mutated DK2 clones 146 
in front of a luciferase reporter (luxCDABE) and chromosomally integrated the 147 
transcriptional fusion in P. aeruginosa PAO1 at the attB site by use of the mini-CTX2 148 
derived plasmid pHK-CTX-lux. The transcriptional fusions enabled us to compare the 149 
phuR::lux expression from the mutated promoter regions (M1-M6) relative to the 150 
expression from a construct with a wild type promoter region (WT). A construct 151 
without an inserted promoter region was used to correct for background expression 152 
from the lux gene cassette integration. 153 
Measurements of the phuR::lux expression at exponential growth (OD600=0.15) in 154 
Luria-Bertani (LB) medium revealed that all six mutant alleles (M1-M6) caused a 155 
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  GCAAAAACAGGTGAACTTTGCCACAAAACGCATATCTGAATCCATTTGATAATTAT---TTGCATTAGCGTTTTTCTGGCAGTACCTTGTGCGCCCGACGTCCCCCTGGCTATTCGCCACCGGCCCGACCCAAGGAGTCCCACATG          PAO1//DK2//DK1//PACS2//39016//2192
  GCAAAAACAGGTGAACTTTGCCACAAAACGCATATCTGAATCCATTTGA-AATTAT---TTGCATTAGCGTTTTTCTGGCAGTACCTTATGCGCCCGACGTCCCCCTGACTATTCGCCACCGGCCCGACCCAAGGAGTCCCAC           CF173-2005
  GCAAAAACAGGTGAACTTTGCCACAAAACGCATATCTGAATCCATTTGATAATTAT---TTGCATTAGCGTTTTTCTGGCAGTACCCTGTGCGCCCGACGTCCCCCTGGCTATTCGCCACCGGCCCGACCCAAGGAGTCCCAC          CF173-2002
  GCAAAAACAGGTGAACTTTGCCACAAAACGCATATCTGAATCCATTTGATAATTAT---TTGCATTAGCGTTTTTCTGGCAGTATCTTGTGCGCCCGACGTCCCCCTGACTATTCGCCACCGGCCCGACCCAAGGAGTCCCAC          CF180-2002/2943C/r7p19t5
  GCAAAAACAGGTGAACTTTGCCACAAAACGCATATCTGAATCCATTTGATAATTAT---TTGCATTAGCGTTTTTCTGGCAGTACCCTGTGCGCCCGACGTCCCCCTGACTATTCACCACCGGCCCGACCCAAGGAGTCCCAC          CF222-2001
  GCAAAAACAGGTGAACTTTGCCACAAAACGCATATCTGAATCCATTTGATAATTAT---TTGCATTATCGTTTTTCTGGCAGTACCTTGTGCGCCCGACGTCCCCCTGGCTATTCGCCACCGACCCGACCCAAGGAGTCCCAC          CF240-2002
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significant increase in promoter activity with changes in expression from 5 to112 fold 156 
(Table 1). The highest increases in expressions (93 and 112 fold) were observed for 157 
alleles M1 and M2 originating from clones DK2-CF66-2008 and DK2-CF173-2005, 158 
respectively. The M1 and M2 alleles contain a 3-bp insertion and a 1-bp deletion, 159 
respectively, in the repressor-binding site (Fur box 1) of the ferric uptake regulator 160 
(Fur) known to control the expression of the phuR promoter [10]. As Fur mediates a 161 
strong repression of phuR under iron-rich conditions [10], we find it likely that the 162 
indels in the M1 and M2 derived phuR promoters alleviates Fur repression. 163 
 164 
Origin of phuR promoter Allele Mean luminescence SD Fold change P-value 
PAO1 WT 365 ±1018 1  
DK2-CF66-2008 M1 34111 ±3379 93 0.00021 
DK2-CF173-2005 M2 40726 ±3422 112 0.00004 
DK2-CF173-2002 M3 1879 ±3422 5 0.16 
DK2-CF240-2002 M4 7584 ±496 21 0.00038 
DK2-CF222-2001 M5 8968 ±610 25 0.00023 
DK2-CF180-2002 M6 6723 ±701 18 0.00088 
DK1-CF128-1992 M8 13329 ±1482 37 0.00024 
DK1-CF128-2009 M9 12205 ±603 33 0.00007 
DK1-CF30-2011 M10 9563 ±1586 26 0.0011 
Table 1: Activities of the phuR promoters originating from different clinical isolates of P. 165 
aeruginosa. Luminescence production from laboratory reference strain PAO1 [17] with phuR::lux 166 
reporter fusions were measured at exponential growth (OD600=0.15) in Luria-Bertani (LB) medium and 167 
normalized for differences in cell density. Mean luminescence production and standard deviations (SD) 168 
were calculated from three biological replicates. Statistical analysis concerning the difference between 169 
two means was done using a Student's t test, and the P-values denote the probability of the mutated 170 
alleles to have expression equal to wild type (WT).  171 
 172 
 173 
 174 
9 
phuR promoter mutations confer a growth advantage in presence of hemoglobin 175 
The increased expression from the mutated phu promoters suggested that the 176 
mutations had become fixated due to a positive selection in the CF airways towards 177 
iron acquisition from hemoglobin. To test this hypothesis, we replaced the wild type 178 
phuR promoter of isolate DK2-CF30-1979 with the mutated phuR promoter of isolate 179 
DK2-CF173-2005 by allelic replacement, and tested whether the constructed mutant 180 
strain DK2-CF30-1979-M2 had a growth advantage relative to the isogenic wild type 181 
strain DK2-CF30-1979. We chose to test the consequence of the phuR promoter 182 
mutations in the genetic background of isolate DK2-CF30-1979 as this isolate is an 183 
immediate ancestor of isolate DK2-CF173-2005 [18].  For the growth experiment we 184 
used a minimal medium supplemented with hemoglobin and apo-transferrin to 185 
‘mimic’ the conditions of the CF airways. 186 
 187 
 Doubling time (hours)  
Growth medium DK2-CF30-1979 DK2-CF30-1979-M2 P-value 
LB 1.27±0.05 1.35±0.07 0.16 
ABTGC + 10 uM Fe3+ 2.74±0.02 2.69±0.03 0.23 
ABTGC + 10 uM Fe3+ + 100 µg/mL apo-TF 3.08±0.10 3.07±0.04 0.91 
ABTGC + 2.5 uM Hb + 100 µg/mL apo-TF 2.76±0.24 2.13±0.09 0.01 
Table 2: Growth rates of strains DK2-CF30-1979 and DK2-CF30-1979-M2 at exponential growth 188 
phase in different media. Abbreviations Hb and apo-TF are used for hemoglobin and apo-transferrin, 189 
respectively. Note that the ABTGC minimal medium standard recipe was modified so that no iron 190 
source other than the one stated in the table was added to the growth medium. Mean doubling times 191 
were calculated from three biological replicates. Statistical analysis concerning difference between two 192 
means was done using a Student's t test, and the P-values denote the probability of the two strains to 193 
have equal means. 194 
 195 
Confirming our hypothesis, we found that the allelic-replacement mutant DK2-CF30-196 
1979-M2 grew significantly faster than its isogenic WT counterpart when hemoglobin 197 
10 
was present of as sole iron source (Table 2), while no difference were observed for 198 
rich medium and media supplemented with Fe3+ as sole iron source.  199 
 200 
Adaptation towards heme utilization is a general adaptive mechanism 201 
Our results demonstrate parallel adaptation of the DK2 lineage towards hemoglobin 202 
utilization in five different CF patients. This indicates that similar selective conditions 203 
for heme utilization exist across different patients. Now, we speculated if the fixation 204 
of phuR promoter mutations is an adaptive mechanism specific to the DK2 lineage, or 205 
if phuR promoter mutations constitute a general genetic mechanism of P. aeruginosa 206 
towards heme utilization in the CF airways. To further investigate the generality, we 207 
inspected the genomes of two other lineages of P. aeruginosa isolated from CF 208 
airways. 209 
In addition to the DK2 lineage, our previous investigations have revealed another 210 
distinct clone type, known as the DK1 clone type, which have also spread among 211 
Danish CF patients [19]. We sequenced and analyzed the phuR promoter region of 212 
five DK1 isolates sampled in years 1992-2011 in addition to an ancestral DK1 isolate 213 
from 1973. Whereas the sequence of the phuR promoter of the ancestral 1973-isolate 214 
(DK1-CF33-1973) was identical to the wild type sequence of strains PAO1 and DK2, 215 
all five evolved DK1 isolates had accumulated 1-4 SNPs in the promoter region, and 216 
three of the DK1 SNPs were identical to SNPs found in the evolved DK2 isolates. We 217 
tested the activity of three of the mutated promoters from the DK1 isolates (M8-218 
M10), and found that all three mutated alleles gave rise to increased levels of 219 
transcription similar to what have been observed for mutated DK2 alleles (Table 1). 220 
Our result provides strong evidence for convergent adaptive evolution of different 221 
lineages of P. aeruginosa towards iron acquisition from hemoglobin. 222 
11 
To rule out that the adaptive trait was specific for P. aeruginosa CF infections at the 223 
Copenhagen CF Center, we analyzed the public available data for the genomic 224 
evolution of the P. aeruginosa C lineage within patient NN attending the CF clinic at 225 
Hannover Medical School, Germany [6]. Interestingly, the C lineage, which has 226 
colonized patient NN over at period of over more than 20 years, also accumulated two 227 
SNPs in the phuR promoter region (Figure 2). Remarkably, the two SNPs are identical 228 
to SNPs found in the DK1 and DK2 lineages, and this observation suggests that these 229 
mutations were also positively selected for in the host environment. 230 
 231 
Selection against pyoverdin secretion might lead to a shift in iron source 232 
The siderophore pyoverdine has previously been found in sputum of CF patients, thus 233 
pyoverdine-mediated uptake of iron has been considered important for the survival of 234 
P. aeruginosa in the CF airways [11]. Nonetheless, we observed both lineages DK1, 235 
DK2, and C to have accumulated nonsynonymous mutations in the alternative sigma 236 
factor PvdS which is required for pyoverdine synthesis (Figure 1 and Figure 3), and 237 
the evolved C clone NN80 was accordingly observed to have lost its ability to 238 
produce pyoverdine in contrast to is predecessors (C clones NN2 and NN11) [6]. 239 
 240 
 241 
 242 
 243 
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 244 
Figure 3: Overview of pvdS mutations in the DK1 and C lineages. Mutations that have accumulated 245 
in evolved isolates relative to their ancestor are shown. Refer to Figure 1 for overview of pvdS 246 
mutations in the DK2 lineage. 247 
 248 
This led us to examine the production of pyoverdine in the DK1 and DK2 isolates, 249 
and we again observed a negative correlation between pyoverdine production and 250 
mutations in PvdS (Figure 4). Accordingly, only the ancestral DK1 and DK2 isolates 251 
carrying wild type alleles of pvdS were able to produce pyoverdine, whereas all 252 
isolates carrying mutated alleles of pvdS were unable to produce pyoverdine (DK1-253 
CF173-2002 was not tested). 254 
Siderophores are generally regarded as highly immunogenic [20], and selection 255 
against pyoverdine production might have driven the accumulation of pvdS mutations 256 
leading to loss of pyoverdine production in the evolved isolates. At the same time, we 257 
observed a positive selection for phuR promoter mutations in the CF airways 258 
presumable leading to a growth advantage when acquiring iron from hemoglobin. We 259 
therefore propose a model in which the CF airways impose a selective pressure on the 260 
invading bacteria forcing them to genetically adapt towards a shift to hemoglobin as 261 
an alternative iron source. This is of particular interest because inflammation may 262 
cause micro-bleeds, which leads to the presence of hemoglobin at the delicate CF 263 
lung epithelia in the presence of both host and bacterial proteases [21]. 264 
 265 
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 266 
Figure 4: Pyoverdine production in isolates of P. aeruginosa. The presence of pyoverdine secreted 267 
to the supernatant of bacterial cultures grown in pyoverdine inducing medium was quantified by 268 
measurement of absorbance at OD405 and normalized against the cell density (OD600). The means and 269 
standard deviations calculated from three biological replicates are shown in the barplot. 270 
 271 
Conclusions and implications  272 
Our results provide evidence that P. aeruginosa fixates phuR promoter mutations to 273 
genetically adapt toward acquisition of iron from hemoglobin during chronic CF 274 
infections. This adaptive trait may be directly selected for due to an abundance of 275 
heme-bound iron in the CF lung. Furthermore, we also observed that phuR promoter 276 
mutations coincided with the loss of pyoverdine production, suggesting that selection 277 
for increased heme utilization may be secondary to the loss of the pyoverdine iron 278 
uptake system. Therefore, targeting heme utilization might be a promising strategy for 279 
the treatment of CF infections. 280 
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CF patients commonly experiences iron deficiency, and P. aeruginosa possible 281 
contributes to iron deficiency by depletion of the host iron storage and causing 282 
inflammation [22, 23]. In this regard, expanding of our knowledge of adaptation of P. 283 
aeruginosa to the CF lung may help to lessen the impact of P. aeruginosa infection 284 
and improve patient condition. 285 
 286 
Materials and Methods: 287 
Bacterials strains and media 288 
Isolates of the P. aeruginosa DK1 and DK2 clone types were sampled from Danish 289 
CF patients attending the Copenhagen Cystic Fibrosis Clinic. Isolation and 290 
identification of P. aeruginosa from sputum was done as previously described [24]. 291 
Luria-Bertani (LB) broth was used for routine preparations of bacterial cultures. 292 
ABTGC minimal medium were composed of 2 g/L (NH4)2SO4, 6 g/L Na2HPO4, 3 g/L 293 
KH2PO4, 3 g/L NaCl, 1 mM MgCl2, 0.1 mM CaCl2, 0.01 mM FeCl3, 2.5 mg/l 294 
thiamine supplemented with 1% glucose, 0.5% casamino acids. No FeCl3 was added 295 
to ABTGC minimal medium for the growth rate experiments presented in Table 2.   296 
Pyoverdine inducing medium was composed of ABTGC minimal medium with 50 297 
µM iron chelator 2,2’-dipyridyl (DIPY). Escherichia coli strain CC118(λpir) was 298 
used for maintenance of recombinant plasmids [25] in medium supplemented with 8 299 
µg/mL of tetracycline. Allelic replacement constructs were transferred to P. 300 
aeruginosa by triparental mating using helper strain E. coli HB101/pRK600 [26]. For 301 
marker selection in P. aeruginosa 50 µg/mL of tetracycline was used. Genetic 302 
techniques were performed using standard methods, and Sanger sequencing was used 303 
for verification of genetic construct and allelic replacement mutants. 304 
Sequencing of phuR promoter region and pvdS gene in DK1 isolates 305 
15 
Sequencing of DK1 isolates was performed as earlier described [18]. Accordingly, 306 
genomic DNA was purified from P. aeruginosa isolates using Wizard Genomic DNA 307 
purification kit (Promega, Madison, WI-US) and sequenced on Illumina’s GAIIx or 308 
Hiseq2000 platforms. Reads were mapped against the reference genome sequence 309 
using Novoalign (Novocraft Technologies, Selangor, Malaysia) [27], and pileups of 310 
read alignments were produced by SAMtools release 0.1.7 [28].  311 
Constrcution of reporter fusions and luminescence measurements 312 
The lux gene cassette (luxCDABE) was subcloned from the plasmid pUC18-mini-313 
Tn7T-Gm-lux [29] fragment into mini-CTX2  [30] using the restriction sites XhoI and 314 
PstI to produce pHK-CTX2-lux used for the transcriptional fusion experiments. A 315 
220-bp fragment containing the intergenic region upstream of phuR was amplified 316 
from genomic DNA using Phusion polymerase (Thermo Scientific) with the primers 317 
PhuR_F-PstI (5’-GAGACTGCAGAGGCTGGGAGTGCTGCTCAT-3’) and 318 
PhuR_R-XhoI (5’-ACATCTCGAGAAGGGCGGGGAGAGCGGCAT-3’) and 319 
ligated with T4 DNA ligase into pHK-CTX2-lux after double-digestion of PCR 320 
fragment and vector with restriction enzymes XhoI and PstI. The resulting plasmids 321 
were introduced into P. aeruginosa strain PAO1 by transformation as previously 322 
described [29].  323 
Allelic replacement of phuR promoter region in DK2-CF30-1979 324 
A 1296-bp fragment containing the intergenic region upstream of phuR was amplified 325 
from genomic DNA of DK2-CF173-2005 using Phusion polymerase (Thermo 326 
Scientific) with the primers PhuSi_F-XbaI (5’-327 
ACATTCTAGACGGACGTCGCTGGCCTCG-‘3) and PhuRi_R-SacI (5’-328 
GAGAGAGCTC-TCTCGTGGCCCTGGCGGTAG-3’). The PCP fragment was 329 
ligated into vector pNJ1 [31] after digested with the restriction enzyme XbaI and 330 
16 
SacI. Allelic replacement construct was transferred into strain DK2-CF30-1979 by 331 
triparental mating and merodiploid mutants were selected by plating the conjugation 332 
mixture on LB agar plates with tetracycline. Colonies were restreaked on selective 333 
plates before being streaked on 8 % (wt/vol) sucrose-LB plates without NaCl. 334 
Sucrose-resistant and tetracycline-sensitive colonies were restreaked on sucrose-LB 335 
plates and screened for the presence of mutated allele by PCR followed by restriction 336 
fragment length polymorphism (RFLP) analysis. Positive mutants was finally 337 
sequenced by Sanger sequencing at LGC genomics (Germany).  338 
 Measurement of growth and luminescence in reporter fusion strains 339 
Overnight culture of the reporter fusion strains were diluted 40 times in fresh LB, and 340 
aliquots of 100 µL were transferred to a black (clear bottom) 96 well microtiter plate 341 
(Nunc). Three technical replicates were used for each strain, and measurements of 342 
growth (OD600) and luminescence were recorded in a Synergy Hybrid H1 reader 343 
(BioTek) with six minutes intervals for ten hours and under shaking conditions (200 344 
rpm) at 37°C. Data was analyzed using a custom made script in R version 2.15.2 [32]. 345 
Experiment was repeated three times to obtain biological replicates. 346 
Growth rate measurements 347 
Growth rate experiments were carried out in 10 mL Falcon tubes under shaking (200 348 
rpm) at 37°C.  Cultures were then inoculated to a starting OD600 of 0.005 in 50 mL 349 
minimal media in 250 mL baffled shake flasks and measurements of OD600 was 350 
started nine hours after the inoculation and recorded every 30 min. In the experiment 351 
were cells were cultivated in LB, the measurements were started after two hours. The 352 
experiment was stopped when the cells reached stationary growth phase typically 353 
after around 23 h of growth in minimal media. Growth experiments were repeated 354 
three times for each strain in each condition to obtain biological replicates. 355 
17 
Pyoverdine quantification assay 356 
Pyoverdine concentrations were quantified as previously described [33]. All strains 357 
were grown in pyoverdin inducing medium for up to OD600>1.5. Cultures were 358 
moved into 2 mL micro-centrifuge tubes and centrifuged at 16,000 g for two minutes. 359 
The supernatants were diluted in 100 mM Tris-HCl buffer (pH 8), and pyoverdine 360 
concentrations were quantified by measurement of absorbance at OD405. Finally, the 361 
values of absorbance at OD405 were normalized against the cell densities (OD600) for 362 
each strain. The procedure was repeated for three independent biological replicates. 363 
 364 
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